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GENERAL INTRODUCTION 
Introduction 
Palladium-catalyzed reactions have found numerous applications in organic synthesis, 
especially in processes involving C-C bond or C-X bond formation.  The Larock research 
group has developed numerous palladium-mediated annulation methodologies, which 
generally involve multiple bond formations, for instance, the Larock indole synthesis.  These 
methodologies afford efficient and general protocols for the preparation of heterocyclic 
compounds, many of which exhibit remarkable biological activities.  Usually, catalytic 
amounts of palladium catalysts are employed and moisture, oxygen and various functional 
groups can be readily tolerated. 
Recently, during the course of investigating palladium-catalyzed reactions, the Larock 
group discovered a novel palladium rearrangement process, namely the through-space 
palladium migration, which has also been observed independently by other groups.  This 
chemistry appears to be fairly general and occurs between a variety of different carbon atoms.  
This through-space shift of a palladium moiety is apparently mechanistically important, and it 
is also synthetically useful, because it provides an alternative way to introduce a palladium 
moiety into an organic molecule.  At this point, palladium migration chemistry has been 
successfully employed to prepare numerous heterocycles and carbocycles.   
The Larock group has also developed chemistry, that involves the facile coupling of 
nucleophiles and arynes readily generated from silylaryl triflates. The carbanion generated 
from nucleophilic attack on an aryne appears to be able to further attack a neighboring 
electrophile to afford cyclization products.  These tandem coupling-cyclization reactions have 
been employed to prepare various heterocycles exhibiting interesting biological activities. 
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This dissertation is focused on palladium migration chemistry involving intramolecular C-
H activation processes and the tandem aryne coupling-cyclization reaction.  The contents 
described in this dissertation are published or will be published shortly.   
Dissertation Organization 
This dissertation is divided into four chapters.  Each of the chapters is written according to 
the guidelines for a full paper in the Journal of Organic Chemistry and is composed of an 
abstract, introduction, results and discussion, conclusions, experimental section, 
acknowledgments and references.  
Chapter 1 describes a novel synthesis of pi-allylpalladium complexes from simple aryl 
iodides and alkynes via a consecutive aryl to vinylic to allylic palladium migration.  This 
process presumably proceeds by carbopalladation of the alkyne, consecutive vinylic to aryl to 
allylic palladium migration, and subsequent displacement by a pivalate anion.  This multiple 
migration process appears to involve an equilibrium between organopalladium(IV) hydrides 
and organopalladium(II) intermediates. The results from deuterium labeling experiments are 
consistent with the proposed mechanism.  This chapter also reports an investigation of the 
reaction mechanism of the aryl to aryl palladium migration process.  It appears that 
palladacycle(IV) hydrides or palladacycle(II) intermediates may both be involved, and a 
proton transfer mechanism is not favored. 
Chapter 2 describes a synthesis of substituted carbazoles, indoles and dibenzofurans by the 
palladium-catalyzed cross-coupling of alkynes and appropriately substituted aryl iodides.  
This process proceeds by carbopalladation of the alkyne, a heteroatom-directed vinylic to aryl 
palladium migration, and ring closure via intramolecular arylation or a Mizoroki-Heck 
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reaction. Results from deuterium labeling experiments are consistent with the proposed 
mechanism. 
Chapter 3 describes the preparation of biologically-interesting fluoren-9-one and xanth-9-
one derivatives by a novel aryl to imidoyl palladium migration, followed by intramolecular 
arylation.  The fluoren-9-one synthesis appears to involve both a palladium migration 
mechanism and a C-H activation mechanism through an unprecedented organopalladium(IV) 
hydride intermediate. The results from the deuterium labeling experiments are consistent with 
the proposed dual mechanism. 
Chapter 4 reports the synthesis of xanthone, thioxanthone and acridone derivatives from 
the coupling-cyclization of silylaryl triflates and substituted benzoates.  The reaction of 
silylaryl triflates, CsF and ortho heteroatom-substituted benzoates affords a general and 
efficient way to prepare biologically-interesting xanthones, thioxanthones and acridones.  
This chemistry presumably proceeds by a tandem intermolecular nucleophilic coupling of the 
benzoate with an aryne and subsequent intramolecular electrophilic cyclization. 
Finally, all of the 1H and 13C NMR spectra of the starting materials and products are 
compiled in appendices A-D. 
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CHAPTER 1. CONSECUTIVE VINYLIC TO ARYL TO ALLYLIC PALLADIUM 
MIGRATION AND ARYL TO ARYL PALLADIUM MIGRATION 
 
Based on a communication published in the Angewandte Chemie International Edition and a 
full paper accepted by the Journal of the American Chemical Society 
Jian Zhao and Richard C. Larock* 
Department of Chemistry, Iowa State University, Ames, IA 50011 
larock@iastate.edu 
 
Abstract. A novel synthesis of pi-allylpalladium complexes from simple aryl iodides and 
alkynes is disclosed.  This process presumably proceeds by carbopalladation of the alkyne, 
consecutive vinylic to aryl to allylic palladium migration involving intramolecular C-H 
activation, and subsequent displacement by a pivalate anion.  This migration process appears 
to involve an equilibrium between organopalladium(IV) hydrides and organopalladium(II) 
intermediates. The results from deuterium labeling experiments are consistent with the 
proposed mechanism.  The reaction mechanism of an aryl to aryl palladium migration process 
has also been investigated.  It appears that palladacycle(IV) hydrides or palladacycle(II) 
intermediates may both be involved, and a proton transfer mechanism is not favored. 
 
Introduction 
Palladium-catalyzed reactions have found numerous applications for constructing new 
bonds in organic synthesis.  Organopalladium intermediates are often generated by oxidative 
addition of an organic halide or triflate, the transmetallation of an organometallic species, or 
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the direct C-H activation of an arene, but the former process is the most frequently used 
method to introduce a palladium moiety into an organic molecule.  After the organic halide or 
triflate has undergone oxidative addition to Pd(0), the metal usually stays where the halogen 
or triflate originally resides, and subsequent bond formation occurs at this position too.   
However, there are some examples in which the bond forming reaction does not occur at 
the position where oxidative addition takes place.  The rearrangement of a palladium moiety 
along a saturated hydrocarbon chain by a sequence involving Pd-H elimination and 
subsequent readdition has been disclosed and developed into very useful methodology.1  
There are also a few reports of the “through-space” migration of palladium between remote 
carbons.  The synthesis of 9-benzylidene-9H-fluorenes from diphenylacetylene and aryl 
halides has been reported by Larock, et al., and a mechanism involving facile 1,4-migration 
of palladium between a vinylic position and an arene has been proposed.2  Larock et al. and 
Gallagher et al. both observed palladium migration between the ortho positions of biaryls in 
the Heck reaction of unsymmetrical o-halobiaryls with ethyl acrylate (eq. 1).3  Aryl to 
benzylic4 and alkyl to aryl5 palladium migrations have also been reported.   
I
X
+ CO2Et
X
CO2Et
+
X
CO2Et
X = Me, OMe, NMe2, CO2Et, NO2
cat. Pd (1)
 
pi-Allylpalladium complexes are usually generated by the oxidative addition of allylic 
compounds bearing a good leaving group.6  Alternatively, the reaction of organopalladium 
compounds with 1,3- and 1,2-dienes can also afford pi-allylpalladium complexes.7  Although 
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pi-allylpalladium chemistry has been extensively investigated and become a very useful 
methodology in organic synthesis,8 there have been few recent reports on developing new 
ways of generating pi-allylpalladium complexes from simple starting materials.   
Recently, we communicated a novel synthesis of pi-allylpalladium complexes from the 
coupling of aryl halides and acetylenes (eq. 2).9  We now wish to provide a full account of 
this consecutive vinylic to aryl to allylic palladium migration involving multiple C-H 
activation processes, which provides a new route to prepare pi-allylpalladium intermediates.  
This chemistry presumably proceeds by carbopalladation of the alkyne, consecutive vinylic to 
aryl to allylic palladium migration, and subsequent displacement by a pivalate anion. 
R2R1
Pd
XX
R1
Me R2+ cat. Pd (2)
 
For the aryl to aryl palladium migration in biaryls, we have proposed a mechanism which 
proceeds via a palladacycle(II) or a palladacycle(IV) hydride involving C-H activation 
processes, and this mechanism is supported by calculations carried out by Jenks, et al.10  
However, an alternative mechanism which involves proton transfer has also been proposed 
and supported by other calculations.2d  Since the theoretical calculations are apparently not 
conclusive, experimental evidence obtained from appropriately designed systems is highly 
desirable for a clear picture of the aryl to aryl palladium migration mechanism to emerge. 
Results and Discussion 
 Optimization Studies.  In order to obtain “optimal” reaction conditions for the consecutive 
vinylic to aryl to allylic palladium migration reaction, we first employed the reaction of 
methyl 4-bromobenzoate and 4,4-dimethyl-2-pentyne as our model system.  All the 
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optimization results were summarized in Table 1.  Methyl 4-bromobenzoate and 4,4-
dimethyl-2-pentyne were first treated with 5 mol % Pd(OAc)2, 5 mol % 
bis(diphenylphosphino)methane (dppm), 2 equiv of NaOAc in 10 mL of N,N-
dimethylformamide (DMF) solvent at 100 oC.  After 1 d of reaction, none of the desired 
product was observed (Table 1, entry 1).  Repeating this reaction in the presence of n-Bu4NCl 
(TBAC), a trace amount of the ester product was evident by GC-MS analysis (entry 2).  
When CsO2CCMe3 (CsPiv) was employed as the base, surprisingly, a 19% yield of an ester 
mixture was obtained (entry 3).  Running the reaction in the presence of TBAC does not 
improve the yield (entry 4).  The reaction using CsOAc as the base does not afford any 
product.  Changing the ratio of aryl halide and alkyne decreased the reaction efficiency 
(entries 6 and 7).  We also ran the reaction in the presence of water, which presumably should 
increase the solubility of the CsPiv base.  However, the yield is lower (entry 10).   Assuming 
the reaction efficiency could be improved by trapping the generated pi-allylpalladium 
complex with good nucleophiles, we ran the reaction in the presence of morpholine and 
diethyl malonate.  Unfortunately, we did not see any of the desired amine or ester products 
(entries 9 and 10).  We then conducted the reaction in more dilute conditions, and a lower 
yield was observed (entry 11).  When the reaction was run using 10 mol % Pd(OAc)2 and 10 
mol % dppm, a 27% yield of a mixture of esters was obtained (entry 12).  Repeating the 
reaction under more concentrated conditions affords a 35% yield of the ester products (entry 
13).  We then increased the reaction temperature to 125 oC, and a slightly higher 42% yield 
was obtained (entry 14).  Finally, we switched the solvent to N,N-dimethylacetamide (DMA) 
and a 50% yield of the ester mixture was isolated by flash chromatography (entry 15).  
Running the reaction at a higher temperature does not improve the reaction efficiency (entry  
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 Table 1. Optimization Studiesa 
Br
CO2Et
+
Me
t-Bu
t-Bu
EtO2C
Me3CCO2
EtO2C
Me3CCO2
t-Bu
EtO2C
t-Bu
O2CCMe3
+
3a 3b 3c
+
 
entry ArX (equiv) 
Alkyne 
(equiv) 
% 
cat. base solvent additive 
temp. 
(oC) 
% yield 
(3a:3b:3c) 
1 1 1 5 2 NaOAc DMF  100 - 
2 1 1 5 2 NaOAc DMF 1  TBAC 100 trace 
3 1 1 5 2 CsPiv DMF  100 19 (3:3:4) 
4 1 1 5 2 CsPiv DMF 1  TBAC 100 18 (3:3:4) 
5 1 1 5 2 CsOAc DMF  100 - 
6 2 1 5 2 CsPiv DMF  100 14 (3:3:4) 
7 1 2 5 2 CsPiv DMF  100 15 (3:3:4) 
8 1 1 5 2 CsPiv DMF 5   H2O 100 5 (3:3:4) 
9 1 1 5 2 CsPiv DMF 5  
morpholine 100 - 
10 1 1 5 2 CsPiv DMF 5 diethyl 
malonate 100 - 
11 1 1 5 2 CsPiv DMF  100 11 (3:3:4)b 
12 1 1 10 2 CsPiv DMF  100 27 (3:3:4)c 
13 1 1 10 2 CsPiv DMF  100 35 (1:1:2)c 
14 1 1 10 2 CsPiv DMF  125 42 (1:2:10)c 
15 1 1 10 2 CsPiv DMA  125 50 (1:2:18)c 
16 1 1 10 2 CsPiv DMA  140 45 (1:2:20)c 
aAll reactions were conducted on a 0.5 mmol scale in 10 mL of solvent for 24 h, and the 
ratio in parentheses was determined by 1H NMR spectroscopy (sealed vial, under Ar).  
bThis reaction was run in 20 mL of DMF solvent. cThis reaction was conducted in 5 mL of 
DMA. 
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16).  We also conducted the reaction under microwave heating conditions, but only a 44% 
yield of the product was obtained after 20 min. Therefore, the best conditions so far 
discovered for this transformation are: 10 mol % Pd(OAc)2, 10 mol % dppm, 125 oC,  and 5 
mL of DMA in the presence of 2 equiv of CsO2CCMe3.   
Reaction Scope and Limitations.  After we had good reaction conditions in hand, we 
investigated the reaction scope and limitations as shown in Table 2.  The reaction of p-
iodoanisole and 1-phenyl-1-propyne under our usual palladium migration conditions using 
CsO2CCMe3 as the base has been observed to give a 20% yield of a 1:1 E/Z  
Table 2. Multiple Palladium Migrationa 
X
R1
Me
R2
R2
Me3CCO2
R1
R2
O2CCMe3
R1
+ +
c
cat. Pd0
Me3CCO2
R1
+
R2
a b
 
entry X R1 R2 products % yield (a:b:c) 
1 I OMe Ph 1a/b 20 (1:1:0)b 
2 Br H t-Bu 2a/b, 2c 35 (1:2:7)c 
3 I H t-Bu 2a/b, 2c 44 (1:2:12)c 
4 Br CO2Et t-Bu 3a/b, 3c 50 (1:2:18)c 
5 Br Cl t-Bu 4a/b, 4c 42 (1:2:20)c 
aAll reactions were conducted on a 0.5 mmol scale for 24 h, and the ratio of 
ArX to alkyne was 1:1 (sealed vial, under Ar).  bThis reaction was run using 5 
mol % Pd(OAc)2, 5 mol % dppm, 100 oC, 10 mL of DMF, and 2 equiv of 
CsO2CCMe3.  cThe reactions reported in entries 2-5 were run using 10 mol % 
Pd(OAc)2, 10 mol % dppm, 125 oC,  and 5 mL of DMA in the presence of 2 
equiv of CsO2CCMe3.   
mixture of 2-(4-methoxyphenyl)-3-phenyl-2-propenyl pivalate (1a/b).  The reaction of 
bromobenzene with 4,4-dimethyl-2-pentyne affords a 35% yield of a 1:2:7 mixture of   three 
esters 2a, 2b and 2c (entry 2).  When iodobenzene was employed, a 44% yield of a mixture of 
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three esters 2a, 2b and 2c was obtained in a 1:2:12 ratio (entry 3).  The reaction using 4-
chloro-bromobenzene affords a 42% yield of the products (entry 5).  When R2 is a Ph group, 
only two isomers are generated.  When R2 is a t-Bu group, the yield is higher and three 
isomers are generated.  The ratio of the three isomers is dependent on the reaction time and 
temperature.  It appears that longer times and higher temperatures generally favor the 
formation of isomer c.   
Reaction Mechanism.  Although these reactions only proceed in relatively low yields, and 
three isomers are usually obtained, which somewhat limits applications in synthesis, the 
mechanism of this unique transformation is fairly important and quite interesting.  This 
process appears to involve palladium migration from a vinylic to an aryl to an allylic position 
and subsequent displacement by a pivalate anion (Scheme 3).  Intermediate A, generated by 
oxidative addition of the aryl halide to Pd(0), adds to the alkyne to produce vinylic palladium 
intermediate B, which apparently then oxidatively adds the neighboring C-H bond to the 
palladium to form palladacycle C.11  Subsequent reductive elimination affords D.  This 
results in palladium migration from a vinylic to an aryl position via C-H activation, a process 
we have reported earlier.3  To initiate a second C-H activation, the palladium moiety 
apparently rotates into the vicinity of the methyl group.  Insertion of palladium into the 
neighboring C-H bond affords palladacycle E, which undergoes reductive elimination with 
transfer of the palladium moiety to the allylic position.  This unprecedented migration process 
generates palladium intermediate F, which rapidly isomerizes to the corresponding pi-
allylpalladium species G.   This unusual process provides a new route for the preparation of 
pi- allylpalladium species, which have proven very versatile as intermediates in organic 
synthesis.  The three isomeric ester products are presumed to arise by attack of the pivalate 
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anion on the palladium intermediate G.  This proposed mechanism indicates that the 
migration of palladium is always accompanied by a simultaneous migration of hydrogen in 
the opposite direction.  Thus, the observation of a hydrogen or deuterium shift should provide 
convincing evidence for the palladium migration, since the shift of palladium is technically 
difficult to observe.      
Scheme 3. Proposed Mechanism 
Me
R2
PdX
HR1
Pd
Me
R2
H X
R1
Me
H
PdXR1
Me
H
R2
PdX
R1
R2
H
X Pd
H
R1
PdX
R2
H
H
R1
R2R1
Me R2
Me3CCO2-
ArPdX
ArI
Pd(0)
E
a/b + c
G
Pd
X
R2
A
B
C
D
F
 
Bromobenzene-d5 (99% deuterium) and 4,4-dimethyl-2-pentyne were allowed to react with 
10 mol % Pd(OAc)2, 10 mol  % bis(diphenylphosphino)methane (dppm), and 2 equiv of 
CsO2CCMe3 in DMA at 125 oC (Table 3, entry 1).  E and Z-4,4-dimethyl-2-phenylpent-2-
enyl pivalate (12a/b) and 1-tert-butyl-2-phenyl-2-propenyl pivalate (12c) were obtained in a 
ratio of 1:2:7.  The formation of the deuterated product is proposed in Scheme 4.  The ester 
12c was isolated in a 20% yield and found to contain 40% deuterium in the allylic position 
and 95% hydrogen in the ortho position of the aromatic ring.  Since the 1H NMR spectrum of 
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12c could result from the presence of a mixture of esters 18 and 19 in an appropriate ratio 
(Scheme 5), it was important to establish the exact nature of these products.  A determination 
of the molecular weight of these ester products should clarify the situation.  However, the 
vinylic position in 12a/b and the allylic position in 12c also contain either a hydrogen or a 
deuterium, which complicates the situation and makes the analysis more difficult.  
Table 3. Deuterium Labeling Experimentsa 
Me
t-Bu
+
10% Pd(OAc)2
10% dppm
2 CsPiv
DMA, 100 oC
Z
O2CCMe3
t-Bu
Y
12c-15c
Br
X5 X4Z
t-Bu
Y
X4
O2CCMe3
12a/b-15a/b
+
 
entry X additive product Y Z 
1 D - 12c 95% H 40% D 
2 D 10 D2O 13c 55% H 75% D 
3 D 10 H2O 14c 95% H 40% D 
4 H 10 D2O 15c 40% D 40% D 
aThe ratio of deuterium to hydrogen has been determined by 1H NMR 
spectroscopy. 
To eliminate the interference from the vinylic position, the mixture of ester products was 
treated with O3 and Me2S at -78 oC, and then the ketones 16 and 17 obtained were analyzed 
by GC-MS (Scheme 5).  Presumably, ketones 16 and 17 will undergo fragmentation in the 
mass spectrum to afford the most stable oxonium cation (m/z 109), but a mixture of 18c and 
19c would afford two different oxonium cations (m/z 108 and m/z 110), which should be 
easily detected by mass spectral analysis.  Indeed, from the MS spectrum obtained, the 
intensity of the peaks m/z 108 (C7D3H2O+) and m/z 110 (C7D5O+) are less than 5% of the  
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Scheme 4. Proposed Formation of the Deuterium Labeled Product 
D
D
D
D
X
D
Pd
t-Bu
MeMe
t-Bu
PdX
D
D
D
DD
D X
D
D
D
D
t-Bu
MeD
D
D
D
Pd
Me
t-Bu
D
D
D
D
D
PdXPd t-Bu
D
D
D
D
D
PdX
t-Bu
H
D
D
D
D
Pd t-Bu
D
X H
D
D
D
Dt-Bu
D
 H
D
D
D
D
PdX
O2CCMe3D
t-Bu
HD
D
D D
H
H
Me3CCO2-
+ DX
+ HX
cat. Pd(0)
5
6
9
8
10
712c
D
Me t-Bu
11
 
Scheme 5. Analysis of the Deuterated Esters 
t-Bu
O2CCMe3H
D
D
D
D
D(H)
H
D
D
D
D O2CCMe3
D(H)
t-Bu
1. O3
2. Me2S
O
O2CCMe3H
D
D
D
D
OH
D
D
D
D O2CCMe3
D(H)
t-Bu
GC-MS O
H
D
D
D
D
12c
O
H
H
D
D
D
C7D3H2O+  
m/z 108
C7D4HO+  
m/z 109
16
17
1. O3
2. Me2S
GC-MS O
D
D
D
D
D
C7D3H2O+  
m/z 110
+
H
H
D
D
D O2CCMe3
D(H)
t-Bu
D
D
D
D
D O2CCMe3
D(H)
t-Bu
+
12a/b
18c
19c
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peak m/z 109 (C7D4HO+), which indicates the former two species are not important.  Thus, 
the hydrogen attached to the phenyl ring in compounds 12a-c is only incorporated into one of 
the two ortho positions of the arene.     
The results from this deuterium labeling experiment are consistent with the proposed 
mechanism, except for the fact that a relatively low allylic deuterium content is observed.  
However, the deuterium content can be increased by adding 10 equiv of D2O to the reaction.  
(E/Z)-4,4-Dimethyl-2-phenylpent-2-enyl pivalate (13a/b) and 1-tert-butyl-2-phenyl-2-
propenyl pivalate (13c) were obtained in a ratio similar to what was obtained from the 
reaction conducted in the absence of D2O.  The resulting ester 13c contained 55% of one 
hydrogen in the ortho position of the arene and 75% deuterium in the allylic position (Table 
3, entry 2).  The product esters 13a-c were treated with O3 and Me2S, and the ketones 
obtained were analyzed by GC-MS.  The intensity of the peak m/z 110 (C7D5O+) and the 
peak m/z 109 (C7D4HO+) are almost the same, which is consistent with the ratio (about 1:1) 
of hydrogen and deuterium observed in the 1H NMR spectrum.   The loss of deuterium in the 
allylic position of 13c presumably arises by deuterium/hydrogen exchange through an 
equilibrium between organopalladium(IV) intermediate 5 and palladacycle 6 or perhaps 
direct exchange of the metal hydride/deuteride in intermediate 5 (Scheme 4).  The deuterium 
incorporation in the allylic position is dependant on the competition between H/D exchange 
and palladium migration, and it appears that neither one is dominant in this case.  The 
reaction of bromobenzene-d5 and 4,4-dimethyl-2-pentyne was repeated in the presence of 10 
equiv of H2O, and the esters (E/Z)-4,4-dimethyl-2-phenylpent-2-enyl pivalate (14a/b) and 1-
tert-butyl-2-phenyl-2-propenyl pivalate (14c) obtained contain  the same amount of vinylic 
deuterium incorporation and aryl hydrogen incorporation as esters 12a-c (entry 3).  A similar 
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exchange of hydrogen and deuterium has been observed in aryl-norbornyl palladacycles.12  
When bromobenzene-H5 and 4,4-dimethyl-2-pentyne were allowed to react in the presence of 
10 equivs of D2O, the ester 15c, which was obtained, had incorporated 40% deuterium in one 
of the ortho positions of the arene and 40% deuterium in the allylic position (entry 4).  This 
experiment suggests that H-D exchange occurs during both of the two migration steps.     
Although the experimental data is consistent with the proposed aryl to allylic palladium 
migration mechanism, an alternative mechanism involving an organopalladium(II) 
palladacycle and an allylpalladium-arene complex stabilized by a pi, η1 interaction is also 
possible (Scheme 6).13 
Scheme 6 
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We have also carried out a palladium migration reaction using aryl iodide 20, which would 
be expected to generate arylpalladium intermediate D (see Scheme 3) directly (Table 4, entry 
1).  This species should undergo palladium migration to produce the same mixture of pivalate 
esters as we obtained via the consecutive rearrangements discussed earlier.  Under the same 
reaction conditions used previously, we have obtained a 65% yield of the anticipated product 
mixture 2a, 2b and 2c in a 1:2:20 ratio.  Although the ratio of the regioisomer 2c to 2a/b is a 
little higher than that observed in the consecutive migration process, the results are still 
consistent with our proposed mechanism.   
We have also examined the reaction of aryl iodide 21 under our usual reaction conditions, 
but at 145 oC (entry 2).  This reaction affords a 45% yield of the allylic pivalate 25.  Thus, it 
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appears that the arylpalladium intermediate corresponding to 21 is able to undergo migration 
to a secondary allylic position.  Aryl iodide 22 was also prepared and treated in the same 
fashion.  After one day of reaction, a 55% yield of two isomeric esters 26a/b was obtained 
with a small amount of inseparable impurities (entry 3).  
Table 4. Aryl to Allylic Palladium Migrationa 
entry aryl iodide  product  % yield 
1 
Me
t-Bu
I  
20 
t-Bu
Me3CCO2
t-Bu
O2CCMe3
 
2a/2b 
 
2c 
65 
(1:2:20) 
2 
I
Me Me
Me
Me
 
21 
O2CCMe3
Me Me
Me
Me
 
25 45b 
3 
Me
I  
22 
Me3CCO2
(Z/E)
 
26a/b 55c 
4 
Br  
23 
Me3CCO2
 
27 messy 
5 
I
Ph
 
24 
PhMe3CCO2
 
28 0 
aThe reaction was conducted on a 0.25 mmol scale using 10 mol % Pd(OAc)2, 10 mol 
% dppm, 125 oC,  and 5 mL of DMA in the presence of 2 equiv of CsO2CCMe3.  bThe 
reaction was conducted at 145 oC.  cThe yield was determined by 1H NMR 
spectroscopy due to inseparable impurities.  
When aryl bromide 23 was subjected to our standard migration conditions, the reaction was 
very messy and we did not observe any of the desired ester product for reasons that we still 
do not understand (entry 4).  The reaction employing 24 does not afford the expected ester 
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28, but about 20% of [1,1';4',1'']terphenyl was obtained after one day of reaction, which 
presumably is due to facile β-H elimination in the pi-allylpalladium intermediate and 
subsequent palladium-catalyzed dehydrogenation of the resulting cyclohexadiene (entry 5). 
Mechanistically, an intermediate like D (Scheme 3) could also be generated by the 
carbopalladation of the allene 4,4-dimethyl-1,2-pentadiene (29), which might arise by 
isomerization of 4,4-dimethyl-2-pentyne (Scheme 7).  However, this process when run with 
pentadeuterated bromobenzene in D2O would not introduce a hydrogen into the ortho 
position of the arene or a deuterium into the allylic position of the final ester  
Scheme 7. Possible Allene Mechanism 
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product, unless the palladium moiety could reversibly migrate from the allylic to the aryl to 
the vinylic position.  Only then could one observe a hydrogen in the ortho position of the 
arene and a deuterium in the vinylic position, plus deuterium incorporation into the allylic 
position.   
To test the reversibility of this palladium migration process, the reaction using aryl iodide 
20 was conducted in the presence of 10 equiv of D2O (Scheme 8).  The isolated product 2c 
contained 40% of deuterium in one of the ortho positions of the arene by GC-MS analysis, 
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and no deuterium in the vinylic or allylic positions.  Ester 2c was treated with O3 and Me2S, 
and the ketone obtained was analyzed by GC-MS.  The peak m/z 105 (C7H5O+) and the peak 
m/z 106 (C7DH4O+) exhibited similar intensities, but the peak m/z 107 (C7D2H3O+) displayed 
less than 5% of the intensity of the peaks at m/z 105 and m/z  
Scheme 8. Reversibility of Palladium Migration 
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106, which indicates that deuterium is incorporated in only one of the two ortho positions of 
the arene. This suggests that the vinylic to aryl migration is not a reversible process.  Because 
no deuterium incorporation in the methylene or allylic positions was observed, we can also 
rule out reversible palladium migration from the allylic to the aryl position. 
Mechanistic Studies on Aryl to Aryl Palladium Migrations.  Recently, we and others 
observed a palladium migration process between the ortho positions of unsymmetrical biaryls 
(eq. 1).3 Heck and Suzuki reactions have been employed to trap the migrated palladium 
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moiety.10  Plus, this aryl to aryl palladium migration process has been employed to prepare 
numerous heterocycles and carbocycles.3c  
We propose a possible mechanism (Scheme 9) for the aryl to aryl palladium migration in the 
organopalladium intermediates derived from o-halobiaryls, which involves oxidative addition 
of the aryl halide to Pd(0) to generate intermediate i, which can either (a) undergo oxidative 
addition of a neighboring C-H bond to produce a hydridopallada(IV)cycle (ii), followed by 
reductive elimination of CH to generate either iii or i, or (b) electrophilic palladation to 
generate intermediate iv, followed by either protonolysis of a C-Pd bond to generate i or iii or 
oxidative addition of HX to generate ii.  With regard to the mechanism, we would like to 
point out that not all ligands on palladium are shown for simplicity.  We believe that the 
intermediacy of iv is unlikely for two main reasons.  First, it is improbable that intermediate 
iv could react with HI under the basic reaction conditions we have employed.  Second, 
Catellani and Chiusoli have demonstrated that pallada(II)cycles analogous to intermediate iv 
Scheme 9. Plausible Mechanism for Aryl to Aryl Palladium Migration 
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easily undergo oxidative addition to aryl and alkyl halides to generate palladium(IV) 
intermediates generating characteristic polycyclic compounds,14 which have not been 
observed under our reaction conditions.  As a result, we favor the reversible interconversion 
between i and iii via hydridopallada(IV)cycle ii.  Organopalladium(IV) species are well 
known,11 although no such hydride-containing species have ever been isolated.  It is also 
important to realize that palladium migration involves intramolecular C-H activation, 
possibly through an electrophilic palladium species.   
To better understand this aryl to aryl palladium migration process, we have carried out 
additional mechanistic studies.  Our first experiments involved incorporation of deuterium 
into the product by running one of these migration reactions in the presence of a large excess  
Scheme 10. Deuterium Labeling Experiments 
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of D2O.  In the presence of D2O, deuterium incorporation in the ortho positions would be 
expected if the migration proceeds through formation of iv.  In fact, if the equilibration is 
substantially faster than the reaction with an olefin (the Heck reaction), then virtually 
complete D incorporation would be expected in the three available ortho positions, as shown 
in Scheme 10.  Lack of deuterium incorporation would, of course, imply that no intermediate 
with exchangeable hydrogen was involved, and thus eliminate iv.  The rate of hydrogen 
exchange in an intermediate like ii is unknown.  However, if it were slow enough, migration 
could occur without incorporation of deuterium. 
Thus, we first treated 2-iodobiphenyl and 4 equiv of ethyl acrylate with 5 mol % Pd(OAc)2, 
5 mol % dppm, 1 equiv of TBAC, 2 equiv of NaHCO3 in 1 mL of DMF and 0.05 mL of D2O 
(conditions A) (Table 5, entry 1), conditions under which migration has not previously been 
observed.10  No deuterium incorporation in the ortho positions of the coupled product is 
expected, because only the original position of the iodide substituent is ever activated.  This 
expectation was met for the ester product, as analyzed by 1H NMR spectroscopy and GC-MS.  
However, when this same reaction was conducted using 0.2 mL of D2O instead of 0.2 mL 
of H2O (condition B), approximately 2 of the ortho hydrogens on average were substituted by 
deuterium, as indicated by the 1H NMR spectrum of the ester product obtained (entry 2).  A 
broad peak in the 2H NMR spectrum at 7.4 ppm was also observed, consistent with deuterium 
incorporation occurring at more than one carbon atom.  Mass spectral data indicated that 
comparable amounts of the nondeuterated (m/z 252), monodeuterated (m/z 253), dideuterated 
(m/z 254), and trideuterated (m/z 255) esters were observed.  
This result indicates that our “equilibrating” conditions (conditions B) are not such that the 
migration of the palladium species is orders of magnitude faster than the coupling step.  
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Otherwise, the overwhelming majority of material would be trideuterated.  However, it does 
not clearly distinguish between the intermediacy of ii and iv, because, while it is obvious that 
H exchange would occur with formation of iv, it is also reasonable that H exchange could 
occur with ii as the key intermediate even if iv were never formed. A second experiment 
involving the formation of iv via an alternate synthetic pathway was carried out (Scheme 11).  
Biphenylene has been reported to react under some conditions with Pd(0) to generate 
Table 5. Mechanistic Studiesa  
entry ArI % Pd  additive product(s) % yield % d 
1 
Ph
I
 
5 10 D2O 
Ph
CO2Et
 
90a 0 
2 
Ph
I
 
5 10 D2O CO2Et
D
 
CO2Et
D
D
 
CO2Et
D
D
D
 
90b 67 
3 
 
5 10 D2O 
Ph
CO2Et
 
0b - 
4  5 10 D2O 
1 DCl 
 0b - 
5  100 10 D2O  0b - 
aConditions A: the reaction was run using 0.25 mmol of the iodobiaryl, 4 equivs of ethyl 
acrylate (EA), 2 equivs of NaHCO3, and 1 equiv of n-Bu4NCl (TBAC), where indicated, in 
4 ml of DMF at 100 oC.  bConditions B: the reaction was run using 0.25 mmol of the 
iodobiaryl, 1 equiv of ethyl acrylate (EA), 2 equivs of CsPiv, in 4 ml of DMF at 100 oC. 
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iv (X = H), which can also undergo Heck and Suzuki couplings.15   Assuming this process 
will occur under our “optimal” equilibration reaction conditions, the same ester products 32 
should be observed from biphenylene as from 2-iodobiphenyl.   
However, biphenylene was not an effective precursor under our standard palladium 
migration conditions. When biphenylene was allowed to react with 1 equiv of ethyl acrylate 
(0.25 mmol) in the presence of 5 mol % Pd(OAc)2, 5 mol % dppm, 2 equiv of CsPiv in 3.8 
mL of DMF and 0.2 mL of D2O, GC-MS spectral analysis indicated that, after reaction for 1 
day, none of the anticipated Heck product 32 was obtained and only the starting biphenylene 
was present (Table 5, entry 3).  Since one equiv of HI acid is usually generated in our Heck 
palladium migration reactions, this reaction was repeated in the presence of 1 equiv of DCl.  
Again, none of the anticipated Heck product was obtained.  This reaction was also conducted 
using 1 equiv of Pd(OAc)2.  After reaction for 1 day, only biphenylene was evident by GC-
MS spectral analysis. 
Scheme 11  
Pd(0) Pd + CO2Et
CO2Et
32  
This result is, again, mechanistically ambiguous regarding the palladium migration.  The 
most likely cause of the problem may be that the conditions were not conducive to palladium 
insertion into the biphenylene C-C bond.  Indeed, Gallagher has demonstrated a kinetic 
preference for palladium insertion into aryl bromides over biphenylene.16  Alternatively, our 
failure to observe Heck-type products in these biphenylene reactions may occur because iv is 
reversibly formed, but unreactive, under our reaction conditions (and thus excluded 
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mechanistically from the palladium migration chemistry).  However, without any other 
evidence for the formation of iv, such a conclusion cannot be drawn. 
Conclusions 
We have established an unusual consecutive vinylic to aryl to allylic palladium migration 
process, which affords a novel new way to generate pi-allylpalladium complexes.  This 
migration process appears to involve an equilibrium between organopalladium(IV) hydrides 
and organopalladium(II) intermediates, which undergo facile exchange with a H source in 
solution.  However, we cannot rule out direct exchange of the palladium(IV) hydride.  A 
mechanistic study of the aryl to aryl palladium migration process provides some new 
information.  For example, the palladium shift is a reversible process and a proton shift 
mechanism is not favored.  However, the results are still mechanistically ambiguous. 
Experimental Section 
 General Procedures.  All 1H and 13C NMR spectra were recorded at 300 MHz and 75.5 
MHz respectively.  Thin layer chromatography was performed using commercially prepared 
60-mesh silica gel plates (Whatman K6F), and visualization was effected with short 
wavelength UV light (254 nm) and a basic KMnO4 solution.  High resolution mass spectra 
were recorded on a Kratos MS50TC double focusing magnetic sector mass spectrometer 
using EI and 70 eV. 
Reagents.  All reagents were used directly as obtained commercially unless otherwise 
noted.  Anhydrous forms of THF, DMF, DMA, diethyl ether, ethyl acetate, hexanes, and 4,4-
dimethyl-2-pentyne were purchased from Lancaster Synthesis, Inc.  Iodobenzene, 
bromobenzene, bromobenzene-d5, p-iodoanisole, p-chloroiodobenzene, ethyl 4-
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bromobenzoate, and 1-phenyl-1-propyne, were purchased from Aldrich Chemical Co., Inc.  
Cesium pivalate was prepared according to the procedure of Campo and Larock.3b 
(E)-2-(2-Iodophenyl)-4,4-dimethyl-2-pentene (20). 
(E)-2-Iodo-4,4-dimethyl-2-pentene was prepared by a literature procedure,17 and subjected 
to a Suzuki reaction with 2-bromophenylboronic acid.  The reaction employed 2.0 mmol of 
vinylic iodide, 2.5 mmol of arylboronic acid, 5 mol % Pd(OAc)2, 10 mol % PPh3, and 2 equiv 
of Na2CO3 in 2 mL of water and 8 mL of DMF at room temperature for 12 h.  The aryl 
bromide obtained was treated with 1.2 equiv of  n-BuLi at -78 oC, and then 1.2 equiv of I2 to 
afford aryl iodide 20: 1H NMR (CDCl3) δ 1.23 (s, 9H), 2.02 (d, J = 1.5 Hz, 3H), 5.27 (q, J = 
1.5 Hz, 1H), 6.90 (td, J = 7.5, 1.8 Hz, 1H), 7.15 (dd, J = 7.5, 1.8 Hz, 1H), 7.27 (td, J = 7.5, 
1.8 Hz, 1H), 7.81 (dd, J = 7.6, 1.8 Hz, 1H); 13C NMR (CDCl3) 19.3, 30.9, 33.0, 99.0, 128.0, 
128.2, 128.9, 138.2, 139.2, 141.1, 151.9; IR (CDCl3) 2960, 2904, 2866, 1461 cm-1; HRMS 
m/z 300.0379 (calcd for C13H17I, 300.0375). 
1-(2-Iodophenyl)-3, 3, 5, 5-tetramethylcyclohexene (21).  
The corresponding aryl bromide was prepared utilizing a Suzuki reaction of 1-iodo-3,3,5,5-
tetramethylcyclohexene18 and 2-bromophenylboronic acid, and the resulting aryl bromide was 
converted to the corresponding iodide by the n-BuLi procedure reported earlier: 1H NMR 
(CDCl3) δ 1.07 (s, 6H), 1.10 (s, 6H), 1.40 (s, 2H), 1.99 (d, J = 1.5 Hz, 2H), 5.33 (t, J = 1.5 
Hz, 1H), 6.87 (td, J = 7.4, 1.7 Hz, 1H ), 7.08 (dd, J = 7.5, 1.7 Hz, 1H), 7.24 (td, J = 7.5, 1.2 
Hz, 1H), 7.80 (dd, J = 7.5, 1.2 Hz, 1H); 13C NMR (CDCl3)  30.5, 31.2, 31.4, 33.2, 43.5, 49.8, 
98.8, 128.2, 128.3, 129.2, 136.5, 137.7, 139.5, 149.1; IR (CDCl3) 2954, 2902, 2866, 1462 
cm-1;  HRMS m/z 340.0696 (calcd for C16H21I, 340.0688). 
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Representative procedure for the palladium-catalyzed migration reactions.  The 
appropriate aryl halide (0.5 mmol), Pd(OAc)2 (5.6 mg, 0.025 mmol), 
bis(diphenylphosphino)methane (dppm) (9.6 mg, 0.025 mmol) and CsO2CCMe3 (CsPiv) 
(0.234 g, 1.0 mmol) in DMA (5 mL) were stirred under Ar at 125 oC for 24 h.  The reaction 
mixture was allowed to cool to room temperature, diluted with diethyl ether (50 mL) and 
washed with brine (30 mL).  The aqueous layer was reextracted with diethyl ether (25 mL).  
The organic layers were combined, dried (MgSO4), filtered, and the solvent removed under 
reduced pressure.  The residue was purified by flash chromatography on silica gel.   
(E)- and (Z)-2-(4-Methoxyphenyl)-3-phenyl-2-propenyl pivalate (1a/b). 
1H NMR (CDCl3) δ 1.13 (s, 9H), 1.15 (s, 9H), 3.81 (s, 3H), 3.84 (s, 3H), 4.89 (d, J = 1.4 
Hz, 2H), 5.10 (s, 2H), 6.63 (s, 1H), 6.85 (d, J = 8.8 Hz, 2H), 6.91 (d, J = 8.9 Hz, 2H), 7.02-
7.45 (m, 15H); 13C NMR (CDCl3) 27.3, 27.4, 39.0, 39.1, 55.4, 55.5, 62.2, 69.2, 114.0, 114.2, 
127.2, 127.5, 127.8, 128.2, 128.5, 128.6, 129.1, 129.5, 130.2, 130.4, 131.6, 133.0, 136.0, 
136.6, 137.0, 137.1, 159.2, 159.5, 178.3, 178.6; IR (CDCl3) 2973, 2936, 1719 cm-1;  HRMS 
m/z 324.1731 (calcd for C21H24O3, 324.1725).   
When using 4,4-dimethyl-2-pentyne and ArX as the starting materials, GC-mass spectral 
analysis of the products indicated three close peaks with the same m/z values, corresponding 
to the three isomers reported, and the ratio of isomers was determined by 1H NMR 
spectroscopy.  Pure 2c, 3c and 4c have been isolated from the respective product mixtures 
and fully characterized, but we were not able to separate and obtain the pure a and b 
stereoisomers from 2a/b, 3a/b and 4a/b.  After column chromatography, we obtained 2a/b 
containing a minor amount of 2c and 3a/b containing a minor amount of 3c.  The 1H NMR 
spectra reported for 2a/b and 3a/b were taken on those incompletely separated mixtures.  
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(E)- and (Z)-4,4-Dimethyl-2-phenylpent-2-enyl pivalate (2a/b). 
1H NMR (CDCl3) δ 0.88 (s, 9H), 1.08 (s, 9H), 1.11 (s, 9H), 1.23 (s, 9H), 4.60 (d, J = 1.2 
Hz, 2H), 5.07 (s, 2H), 5.70 (s, 1H), 5.95 (s, 1H), 7.14-7.53 (m, 10H). 
1-tert-Butyl-2-phenyl-2-propenyl pivalate (2c). 
Product 2c could be isolated from the product mixture: 1H NMR (CDCl3) δ 0.86 (s, 9H), 
1.27 (s, 9H), 5.19 (s, 1H), 5.30 (s, 1H), 5.41 (s, 1H), 7.22-7.34 (m, 3H), 7.55 (d, J = 6.8 Hz, 
2H); 13C NMR (CDCl3) 26.6, 27.3, 35.7, 39.2, 81.7, 115.3, 127.2, 127.7, 128.6, 142.8, 148.6, 
177.9; IR (CDCl3) 2974, 2907, 2872, 1715, 1478 cm-1; HRMS m/z 274.1936 (calcd for 
C18H26O2, 274.1933). 
Bromobenzene-d5 (99.5% deuterium) and 4,4-dimethyl-2-pentyne were allowed to react 
using the reaction conditions reported in footnote c of Table 1 to afford product 12c: 1H 
NMR (CDCl3) δ 0.86 (s, 9H), 1.27 (s, 9H), 5.19 (s, 1H), 5.30 (s, 1H), 5.41 (s, 0.6H), 7.55 (s, 
0.95H).   
The reaction of bromobenzene-d5 and 4,4-dimethyl-2-pentyne conducted in the presence of 
10 equiv of D2O afforded product 13c: 1H NMR (CDCl3) δ 0.86 (s, 9H), 1.27 (s, 9H), 5.19 (s, 
1H), 5.30 (s, 1H), 5.41 (s, 0.27H), 7.55 (s, 0.55H).  The product esters were treated with O3 
and Me2S, and the ketones obtained were analyzed by GC-MS.  The intensity of the peak m/z 
110 (C7D5O+) and the peak m/z 109 (C7D4HO+) were almost the same, which is consistent 
with the ratio of hydrogen to deuterium (about 1:1) observed in the 1H NMR spectrum.    
Bromobenzene-H5 and 4,4-dimethyl-2-pentyne were allowed to react under the same 
reaction conditions in the presence of 10 equiv of D2O to afford product 15c: 1H NMR 
(CDCl3) δ 0.86 (s, 9H), 1.27 (s, 9H), 5.19 (s, 1H), 5.30 (s, 1H), 5.41 (s, 0.60H), 7.55 (d, J = 
6.8 Hz, 1.65H). 
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 Aryl iodide 20 was also subjected to our standard migration conditions in the presence of 
10 equiv of D2O to afford product 12c: 1H NMR (CDCl3) δ 0.86 (s, 9H), 1.27 (s, 9H), 5.19 (s, 
1H), 5.30 (s, 1H), 5.41 (s, 1H), 7.55 (d, J = 6.8 Hz, 1.55H).   
(E)- and (Z)-Ethyl 4-[4,4-dimethyl-1-(pivaloyloxy)pent-2-en-2-yl]benzoate (3a/b). 
1H NMR (CDCl3) δ 0.78 (s, 9H), 1.07 (s, 9H), 1.10 (s, 9H), 1.24 (s, 9H), 1.36-1.42 (m, 6H), 
4.33-4.40 (m, 4H), 4.60 (s, 2H), 5.09 (s, 2H), 5.75 (s, 1H), 6.02 (s, 1H), 7.23-7.24 (d, J = 7.8 
Hz, 2H), 7.35 (d, J = 7.8 Hz, 2H), 7.95-8.00 (m, 4H).    
Ethyl 4-[4,4-dimethyl-3-(pivaloyloxy)pent-1-en-2-yl]benzoate (3c). 
Product 3c could be isolated from the product mixture: 1H NMR (CDCl3) δ 0.84 (s, 9H), 
1.27 (s, 9H), 1.38 (t, J = 7.1 Hz, 3H), 4.36 (q, J = 7.1 Hz, 2H), 5.27 (s, 1H), 5.37 (s, 1H), 5.38 
(s, 1H), 7.62 (d, J = 8.6 Hz, 2H), 8.00 (d, J = 8.6 Hz, 2H); 13C NMR (CDCl3) 14.6, 26.5, 
27.3, 35.8, 39.1, 61.1, 81.5, 116.8, 127.1, 129.7, 130.0, 147.2, 148.0, 166.7, 177.9; IR 
(CDCl3) 2975, 1711, 1478 cm-1;  HRMS m/z 346.2150  (calcd for C21H30O4, 346.2144).  
1-tert-Butyl-2-(4-chlorophenyl)-2-propenyl pivalate (4c). 
Product 4c could be isolated from the product mixture: 1H NMR (CDCl3) δ 0.85 (s, 9H), 
1.27 (s, 9H), 5.20 (s, 1H), 5.28 (d, J = 0.9 Hz, 1H), 5.31 (s, 1H), 7.27 (d, J = 8.4 Hz, 2H), 
7.49 (d, J = 8.5 Hz, 2H); 13C NMR (CDCl3) 26.6, 27.3, 35.8, 39.2, 81.6, 116.0, 128.5, 133.5, 
141.4, 147.7, 177.9; IR (CDCl3) 2972, 2907, 2872, 1716, 1479, 1091 cm-1;  HRMS m/z 
308.1547 (calcd for C18H25ClO2, 308.1543). 
4,4,6,6-Tetramethyl-2-phenylcyclohex-3-enyl pivalate (25). 
1H NMR (CDCl3) δ 0.98 (s, 3H), 1.05 (s, 12H), 1.11 (s, 3H), 1.15 (s, 3H), 1.41 (d, J = 13.2 
Hz, 1H), 1.64 (d, J = 13.2 Hz, 1H), 5.63 (s, 1H), 5.84 (s, 1H), 7.20-7.31 (m, 5H); 13C NMR 
(CDCl3)  26.0, 27.3, 27.31, 31.0, 32.5, 33.0, 35.3, 39.1, 45.8, 74.7, 126.4, 127.0, 128.4, 
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134.0, 138.9, 140.8, 178.1; IR (CDCl3) 2959, 1712, 1478 cm-1;  HRMS m/z 314.2246 (calcd 
for C21H30O2, 314.2250). 
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CHAPTER 2.  SYNTHESIS OF SUBSTITUTED CARBAZOLES, INDOLES AND 
DIBENZOFURANS BY DIRECTED VINYLIC TO ARYL PALLADIUM 
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Abstract. Substituted carbazoles, indoles and dibenzofurans are readily prepared in moderate 
to excellent yields by the palladium-catalyzed cross-coupling of alkynes and appropriately 
substituted aryl iodides.  This process proceeds by carbopalladation of the alkyne, 
heteroatom-directed vinylic to aryl palladium migration, and ring closure via intramolecular 
arylation or a Mizoroki-Heck reaction. Results from the deuterium labeling experiments are 
consistent with the proposed mechanism. 
 
Introduction 
The palladium-catalyzed activation of unfunctionalized C-H bonds is considered a highly 
atom-efficient and environmentally-friendly strategy for organic synthesis.
Recently, a number of palladium migration examples involving intramolecular C-H 
activation have been disclosed by our group and others.1  This through-space shift of 
palladium appears to be fairly general and can take place between a wide variety of carbon 
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atoms.  Specifically, vinylic to aryl,2 aryl to aryl,3 alkyl to aryl,4 and vinylic to aryl to allylic5 
palladium migration processes have been reported. These novel palladium migration 
processes are not only mechanistically important, but also synthetically useful, because they 
afford an alternative way to introduce a palladium moiety into an organic molecule.  
Recently, we reported a nitrogen-directed vinylic to aryl palladium migration, which 
provides an efficient way to prepare biologically interesting carbazoles as shown in Scheme 
1.2c,6  This process proceeds by carbopalladation of the internal alkyne, and then the 
palladium moiety migrates from the vinylic position to the aryl position through an 
intramolecular C-H activation process.  The arylpalladium intermediate generated 
subsequently undergoes intramolecular arylation to afford the carbazole products.  Herein, we  
Scheme 1.  Synthesis of Substituted Carbazoles via Vinylic to Aryl Palladium Migration 
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wish to report a complete account of this nitrogen-directed palladium migration, an extension 
of this methodology to the synthesis of biologically interesting dibenzofurans7, and the 
synthesis of indoles8 in which the arylpalladium intermediate is trapped by an intramolecular 
Mizoroki-Heck reaction.   Furthermore, substrates labeled with deuterium have also been 
prepared and employed in this process to explore the mechanistic details of this 
rearrangement. 
Results and Discussion 
  
31 
1. Optimization of Reaction Conditions.  In our initial work on this carbazole synthesis, 
we treated N-phenyl-3-iodoaniline and 1 equiv of 1-phenyl-1-butyne with 5 mol % Pd(OAc)2, 
10 mol % PPh3, and 2 equiv of NaOAc in N,N-dimethylformamide (DMF) at 100 oC for 24 h 
(Table 1, entry 1).  Unfortunately, only a trace of the desired carbazole product 1a was 
observed by GC-MS analysis.    This reaction was subsequently  
Table 1.  Optimization of the Carbazole Synthesis 
Ph
Et
cat. Pd(0)
1a 1b
N
R
I
+
N
R
Et
Ph
Ph
Et
+
 
entry R base ligand additive time (h) 
% yield  
(1a:1b)a 
1 H 2 NaOAc 10%  PPh3 - 24 trace 
2 H 2 Na2CO3 10%  PPh3 - 24 0 
3 H 2 NEt3 10%  PPh3 - 24 0 
4 H 2 NaOAc 10%  PPh3 1 TBAC 24 20 (10:1) 
5 H 2 CsPiv 10%  PPh3 - 12 60b (10:1) 
6 H 2 CsPiv 5%  dppm - 6 73 (10:1) 
7 H 2 CsPiv 5%  dppm 1 TBAC 6 71b (10:1) 
8 Me 2 CsPiv 5%  dppm - 12 trace 
9 Ph 2 CsPiv 5%  dppm - 12 0 
aAll reactions were conducted on a 0.25 mmol scale at 100 oC in 4 mL of DMF, and 
the ratio of aryl iodide to alkyne was 1:1 (sealed vial, under Ar). The ratio of 1a to 
1b, as determined by 1H NMR spectroscopy, is reported in parentheses.  bGC yield. 
carried out using both an inorganic base Na2CO3 (entry 2) and an organic base NEt3 (entry 3), 
but none of the desired carbazole product was observed.  When 1 equiv of n-Bu4NCl (TBAC) 
was added to the NaOAc reaction, a 20% yield of a 10:1 ratio of isomeric carbazoles 1a and 
1b was obtained (entry 4).   We next conducted the model reaction in the presence of 2 equiv 
of CsO2CCMe3 (CsPiv) because of its superior solubility in DMF.  To our delight, a 60% 
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yield of the desired products was obtained (entry 5).  By simply replacing PPh3 with a 
bidentate ligand bis(diphenylphosphino)methane (dppm), a 73% yield of the two 
regioisomers was isolated by flash chromatography (entry 6).  We then repeated the same 
reaction in the presence of 1 equiv of TBAC, but it appears that the presence of chloride 
source is unnecessary for this transformation (entry 7).  The lack of a substitutent on the 
aniline nitrogen is also crucial, because the corresponding amines with Me and Ph 
substitutents produced none of the anticipated carbazoles (entries 8 and 9).  In conclusion, the 
“optimal” reaction conditions for this nitrogen-directed vinylic to aryl palladium migration 
utilizes 5 mol % Pd(OAc)2, 5 mol % bis(diphenylphosphino)methane (dppm), and 2 equiv of 
CsO2CCMe3 (CsPiv) in DMF at 100 oC.   
2. Synthesis of Carbazoles by Nitrogen-directed Vinylic to Aryl Palladium Migration.  
We next examined the reaction using various internal alkynes in order to determine the scope 
and limitations of this process.  The results are shown in Table 2.  Theoretically, when 4,4-
dimethyl-2-pentyne was allowed to react with N-phenyl-3-iodoaniline, the previously 
reported consecutive vinylic to aryl to allylic palladium migration could also occur, and a pi-
allylpalladium complex I would be generated as shown in Scheme 2. 5  However, as 
determined by GC-MS analysis, only the expected carbazole product was found, and a 44% 
yield of one regioisomer 2a was isolated (Table 2, entry 2).  When 4-octyne was employed as 
the starting material, the reaction was very messy, and only a 35% yield of the carbazole 3 
was obtained (entry 3).  In this system, the vinylpalladium intermediate generated from 
carbopalladation may undergo β-H elimination to afford an allene, which may account for the 
low yield of carbazole in this reaction.  To avoid loss of the volatile alkyne (the boiling point 
of 4,4-dimethylpentyne is only 70 oC) or possible β-H elimination, 2,2-dimethyl-3-octyne 
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Scheme 2. Other Possible Palladium Migration Reactions  
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was prepared and allowed to react with our diarylamine.  However, only a 48% yield of the 
desired product 4a was isolated (entry 4).  1-Phenyl-1-propyne afforded a 65% yield of two 
regioisomers 5a and 5b in a 12:1 ratio (entry 5).  In the case of diphenyl acetylene, the 
arylpalladium intermediate formed by vinylic to aryl Pd migration might be expected to 
undergo direct arylation of one of the phenyl groups of the diphenyl acetylene, affording 
phenylamino-substituted benzylidenefluorenes II or III (Scheme 2).2 Surprisingly, a 69% 
yield of a single isomer 6 was isolated from this reaction (entry 6), and no 
benzylidenefluorene products were observed.  We have also examined the reaction of this 
aniline with a couple of other aryl acetylenes bearing diverse functionalities on the arene.  
When 1-(4-nitrophenyl)-1-butyne was employed in our carbazole synthesis, a very messy 
reaction was observed and none of the desired product was evident by GC-MS analysis (entry 
7).  However, when a moderate electron-withdrawing ester group (CO2Et) was present on the 
phenyl ring of the alkyne, a 71% yield of a single regioisomer 7a was isolated by flash 
chromatography (entry 8).  Presumably, the improved regioselectivity is due to the fact that
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Table 2.  Synthesis of Substituted Carbazolesa 
entry aryl iodide alkyne product(s) % yield  (a:b)b 
1 
N
H
I
 
Et Ph
 
N
H
Et
Ph
Ph
Et
+
 
          1a                 1b 
73 (10:1) 
2  Me t-Bu 
N
H
Me
t-Bu
2a 
44 
3  n-Pr n-Pr
 
N
H
n-Pr
n-Pr
3 
35c 
4  n-Bu t-Bu 
N
H
n-Bu
t-Bu
4a 
48 
5  Me Ph 
N
H
Me
Ph
Ph
Me
+
 
           5a               5b 
65 (12:1) 
6  Ph Ph
 
N
H
Ph
Ph
6 
69 
7  Et NO2
 
         - 0 
8  Et CO2Et
 
N
H
Et
C6H4CO2Et-p
7a 
71 
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Table 2. (Continued) 
entry aryl iodide alkyne product(s) % yield  (a:b)b 
9  Et
MeO
 
 
N
H
Et
C6H4OMe-o
o-MeOC6H4
Et
+
       
             8a                 8b 
68 (10:1) 
10  MeO2C Ph
 
             - 0 
11 
N
H
I
Me
 
Ph Ph
 
N
H
Ph
Ph
Me
9 
61 
12 
N
H
I
OMe
 
Ph Ph
 
N
H
Ph
Ph
OMe
10 
75 
13 
N
H
I
OMe
 
Et Ph
 
N
H
Et
Ph
Ph
Et
+
OMe
 
          11a               11b 
77 (10:1) 
14 
N
H
I
CO2Me
 
Ph Ph
 
N
H
Ph
Ph
CO2Me
12 
71 
15 
N
H
I
Cl
 
Et Ph
 
N
H
Et
Ph
Ph
Et
+
Cl
 
          13a               13b 
65 (10:1) 
16 
N
H
I
 
Et Ph
 
N
H
Et
Ph
Ph
Et
+
 
           14a             14b 
64 (10:1) 
  
 
36 
Table 2. (Continued) 
entry aryl iodide alkyne product(s) % yield  (a:b)b 
17 
N
H
I
 
Ph Ph
 
N
H
Ph
Ph
      15 
68 
aAll reactions were conducted on a 0.25 mmol scale at 100 oC, using 5 mol % Pd(OAc)2, 
5 mol % bis(diphenylphosphino)methane (dppm), and 2 equiv of CsO2CCMe3 (CsPiv) in 
DMF (4 mL), and the ratio of aryl iodide to alkyne was 1:1 (sealed vial, under Ar).  bThe 
ratio of a to b, as determined by 1H NMR spectroscopy, is reported in parentheses.  cThe 
isolated products contain impurities, which cannot be separated by flash chromatography, 
thus the yield has been determined by GC analysis. 
the electron-withdrawing group tends to stabilize the vinylpalladium intermediate generated,9 
and thus enhances the regioselectivity of carbopalladation.  We can only surmise that the 
presence of the NO2 group stabilizes the resulting vinylpalladium intermediate so much that 
it no longer undergoes palladium migration and side reactions ensue, consuming all starting 
materials.  An analogous alkyne bearing an ortho-methoxy group on the arene afforded a 
68% yield of the anticipated 10:1 mixture of carbazoles 8a and 8b, respectively (entry 9).   
When methyl phenylpropynoate was employed in this process, after a 24 h reaction, none of 
the desired carbazole product was evident (entry 10).   
We have also examined the reaction of a number of anilines bearing functionality on the 
aromatic ring undergoing substitution by the arylpalladium intermediate generated by the 
vinylic to aryl palladium migration  (see the later mechanistic discussion).  The reaction of N-
(4-methylphenyl)-3-iodoaniline and diphenyl acetylene afforded a 61% yield of carbazole 9 
(entry 11).  A more electron-rich substrate bearing a methoxy group afforded a 75% yield of a 
single carbazole product 10 (entry 12).  The reaction of N-(2-methoxyphenyl)-3-iodoaniline 
and 1-phenyl-1-butyne was also studied (entry 13).  Statistically, the methoxy group ortho to 
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the nitrogen would be expected to reduce the opportunities for intramolecular arylation, plus, 
the favored molecular configuration for the arylpalladium intermediate is expected to be one 
in which the aromatic ring is perpendicular to the other aromatic ring, which should disfavor 
intramolecular arylation.  However, a 77% yield of a 10:1 mixture of regioisomeric 
carbazoles was obtained, probably because the oxygen atom of the methoxy group 
coordinates to the palladium moiety and perhaps stabilizes the arylpalladium intermediate 
generated.  Substrates bearing either an electron-withdrawing 4-methoxycarbonyl or 4-chloro 
group also afforded a 71% yield of carbazole 12 and a 65% yield of two isomeric carbazoles 
13a and 13b in a 10:1 ratio, respectively (entries 14 and 15).  We have also examined the 
regioselectivity of ring closure by employing N-(3-iodophenyl)naphthalen-1-amine (entry 
16).  Here, cyclization might occur at either the 2 position or the 8 position of the naphthalene 
ring.  However, the only products observed are those formed by ring closure at the 2 position 
of the naphthalene by the presumed intermediacy of a 6-membered ring palladacycle, as 
opposed to the analogous 7-membered ring palladacycle required to generate the product of 
attack at the 8 position of the naphthalene.  A tetrahydronaphthylamine compound was also 
prepared and allowed to react with diphenyl acetylene, and a 68% yield of carbazole 15 was 
isolated by flash chromatography (entry 17). 
3. Synthesis of Substituted Indoles by Vinylic to Aryl Palladium Migration Followed 
by Intramolecular Mizoroki-Heck Reaction.  The arylpalladium intermediates generated 
by aryl to aryl palladium migration have been shown to undergo an intermolecular Mizoroki-
Heck reaction and a Suzuki-Miyaura reaction,10 and the arylpalladium species generated from 
alkyl to aryl palladium migration have also been shown to be easily trapped by an 
intermolecular Mizoroki-Heck reaction.4  An arylpalladium species generated from vinylic to 
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aryl palladium migration has also been trapped by a Stille coupling reaction.2c  Since the 
intramolecular Mizoroki-Heck reaction is a very powerful method for C-C bond formation in 
organic synthesis, and a plethora of natural products and biologically interesting compounds 
have been synthesized employing this methodology,11 we were encouraged by our carbazole 
synthesis to  
Scheme 3.   Synthesis of Substituted Indoles 
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examine possible intramolecuar Heck reactions as a trap for the arylpalladium intermediate 
generated.  As shown in Scheme 3, after carbopalladation, vinylpalladium intermediate IV is 
generated.  Once the palladium moiety undergoes nitrogen-directed vinylic to aryl migration 
to afford  arylpalladium species V, an intramolecular Heck reaction, followed by 
aromatization, should generate indole derivatives.  N-Allyl-3-iodoaniline and 1 equiv of 1-
phenyl-1-butyne were allowed to react with 5 mol % Pd(OAc)2, 5 mol % dppm, and 2 equiv 
of CsO2CCMe3 in 4 mL DMF at 100 oC.  After 3 h, the aryl iodide was completely consumed 
and a 45% yield of two isomeric indoles 16a and 16b was obtained in a 10:1 ratio (Table 3, 
entry 1).  Two equiv of N-allyl-3-iodoaniline was allowed to react with this alkyne.   
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Table 3.  Synthesis of Substituted Indolesa 
entry aryl iodide alkyne product   % yield (a:b)b 
1 
N
H
I
 
Et Ph
 
 
 
N
H
Et
Ph
Me
Ph
Et
+
 
         16a                16b 
45 (10:1) 
2  Ph Ph
 
  
N
H
Ph
Ph
Me
17 
31 
3  Me Ph
 
N
H
Me
Ph
Me
Ph
Me
+
 
       18a             18b 
26 (15:1) 
4 
N
H
I O
 
Ph Ph
 
N
H
Ph
Ph
O
19 
40c 
aThese reactions were conducted on a 0.25 mmol scale at 100 oC for 3 h, using 5 mol 
% Pd(OAc)2, 5 mol % bis(diphenylphosphino)methane (dppm), and 2 equiv of 
CsO2CCMe3 (CsPiv) in DMF (4 mL), and the ratio of aryl iodide to alkyne was 1:1 
(sealed vial, under Ar).  bThe ratio of a to b, as determined by 1H NMR spectroscopy, 
is reported in parentheses. cThe reaction was conducted at 125 oC, using 10 mol % 
Pd(OAc)2, 10 mol % bis(diphenylphosphino)methane (dppm), and 2 equiv of 
CsO2CCMe3 (CsPiv) in DMF (2 mL) for 24 h.  
However, a lower yield was obtained.   We have been very reluctant to dramatically change 
the reaction conditions, because the palladium migration chemistry is generally very sensitive 
to variations in the reaction conditions, especially the base.  However, we did try a few things 
to optimize the reaction conditions in order to achieve higher yields. The reaction was 
conducted at both 80 oC and 125 oC, in more concentrated or diluted solutions, in the 
presence of TBAC or Ag2CO3, and using electron-rich ligands, like P(t-Bu)3.  Unfortunately, 
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none of our efforts were fruitful.  A set of other alkynes and imine starting materials have 
been screened, and only moderate yields (26-40%) have been obtained (entries 2-4).  The 
major problem in this process is probably the fact that the arylpalladium intermediate 
generated by oxidative addition, the vinylpalladium intermediate IV, and the arylpalladium 
intermediate V can all react with N-allyl-3-iodoaniline.  Although the desired process is an 
intramolecular reaction, which should have some advantage over those intermolecular 
processes, at this time we are unable to get higher yields.  An additional complication is that 
the vinylic to aryl palladium migration is presumably the slow step in this domino process, 
which leaves plenty of time for side reactions. 
4. Synthesis of Substituted Dibenzofurans.  After having investigated the nitrogen-
directed vinylic to aryl palladium migration, we wondered if we could expand this protocol to 
the synthesis of substituted dibenzofurans, although Pd-O coordination would be expected to 
be much weaker than Pd-N coordination.  3-Iodophenyl phenyl ether and 1-phenyl-1-butyne 
were treated with 5 mol % Pd(OAc)2, 5 mol % dppm, and 2 equiv of CsO2CCMe3 in DMF at 
100 oC, but the reaction was very messy, and only a 30% yield of an 8:1 mixture of two 
isomeric dibenzofurans 20a and 20b was observed by GC-MS analysis (Table 4, entry 1).  
Previous aryl to aryl palladium migration studies in our group have indicated that palladium 
tends to reside on the more electron-rich aromatic ring.  Thus, we felt that an increase in 
electron density in the arene undergoing vinylic to aryl palladium migration should facilitate 
this through-space migration.  Indeed, the reaction of 1-iodo-3,5-diphenoxybenzene with 1-
phenyl-1-butyne afforded a 75% yield of a 9:1 mixture of two regioisomeric dibenzofurans 
21a and 21b (entry 2).  The increased reaction efficiency could be a result of the increased 
electron density of the arene favoring Pd migration.  However, this process may also be more  
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Table 4.  Synthesis of Substituted Dibenzofuransa 
entry aryl iodide alkyne product(s) % yield  (a:b)b 
1 
O
I
 
Et Ph
 
O
Et
Ph
Ph
Et
+
 
         20a               20b 
30 
2 
O
I
PhO
 
Et Ph
 
O
Et
Ph
Ph
Et
+
PhO
 
                21a            21b 
75 (9:1) 
3 
O
I
MeO
 
Et Ph
 
O
Et
Ph
Ph
Et
+
MeO
 
                22a              22b 
80 (9:1) 
4  Me Ph 
O
Me
Ph
Ph
Me
+
MeO
 
           23a              23b 
78 (9:1) 
5  Me t-Bu 
O
Me
t-Bu
MeO 24a 
42 
6  n-Pr n-Pr
 
O
n-Pr
n-Pr
MeO 25 
44 
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Table 4. (Continued) 
entry aryl iodide alkyne product(s) % yield  (a:b)b 
7  Ph Ph
 
O
Ph
Ph
MeO 26 
76 
8  Et CO2Et
 O
Et
C6H4CO2Et-p
p-EtO2CC6H4
Et
+
MeO
 
                27a             27b 
60 (15:1) 
9  Et
MeO
 O
Et
C6H4OMe-o
o-MeOC6H4
Et
+
MeO
     
28a              28b 
37 (7:1) 
aAll reactions were conducted on a 0.25 mmol scale at 100 oC for 12 h, using 5 mol % 
Pd(OAc)2, 5 mol % bis(diphenylphosphino)methane (dppm), and 2 equiv of 
CsO2CCMe3 (CsPiv) in DMF (4 mL), and the ratio of aryl iodide to alkyne was 1:1 
(sealed vial, under Ar).  bThe ratio of a to b, as determined by 1H NMR spectroscopy, is 
reported in parentheses. 
efficient, because migration to either of the two ortho positions of the arene is now possible, 
doubling the probability of intramolecular arylation.  To further examine the effect of an 
electron-rich substituent, 3-iodo-5-phenoxyanisole was prepared and allowed to react with 1-
phenyl-1-butyne.  A 78% yield of two isomeric dibenzofurans 22a and 22b was obtained 
(entry 3), which clearly suggests that an increase in the electron-density of the arene is the 
major reason for the improved reaction efficiency.  Several other internal alkynes have been 
allowed to react with this iodoarene, and moderate to excellent yields have generally been 
obtained.  1-Phenyl-1-propyne afforded a 78% yield of two regioisomers 23a and 23b in a 
9:1 ratio (entry 4).  4,4-Dimethyl-2-pentyne afforded a  42% yield of a single regioisomer 24, 
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as expected (entry 5).  4-Octyne afforded a 44% yield of dibenzofuran 25 (entry 6).  When 
employing diphenyl acetylene, a 76% yield of a single isomer 26 was obtained (entry 7).  
When methyl 4-(but-1-ynyl)benzoate was employed in this reaction, a 60% yield of two 
isomeric dibenzofurans 27a and 27b was obtained in a 15:1 ratio (entry 8).  An analogous 
alkyne bearing an ortho-methoxy group afforded a 37% yield of a 7:1 mixture of 
dibenzofuran products 28a and 28b (entry 9). 
To further extend this protocol to the synthesis of other heteroatom-containing rings, we 
also prepared several heteroatom-containing aryl iodides as shown in Chart 1.  The reactions 
of aryl iodides 29 and 30 with 1-phenyl-1-butyne were very messy and the anticipated 
dihydrophenanthridines were not evident by GC-MS.  An electron-poor aryl iodide 31 was 
also allowed to react with 1-phenyl-1-butyne.  However, the reaction was sluggish, and, after 
24 h, none of the desired fluoren-9-one product was generated.  In the case of the moderately 
electron-rich ring system 32, none of the expected palladium migration product was 
observed.  
Chart 1. Other Heteroatom-containing Aryl Iodides 
 
HN
I
NH
I
29 30 31 32
O
I I
OMeMe
 
 
5. Mechanism.  A plausible mechanism for this palladium rearrangement is proposed in 
Scheme 4.  Intermediate A is first generated by oxidative addition of the aryl iodide to Pd(0).  
Subsequent intermolecular carbopalladation would be expected to afford intermediate B.  The 
resulting vinylic palladium intermediate B might then undergo palladium migration from the 
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vinylic position to an aryl position to generate intermediate F, possibly through an 
organopalladium(IV) hydride C (route a), although such Pd(IV)hydride intermediates have 
not previously been reported.12  An  equilibrium between organopalladium(IV) hydride C and 
organopalladium(II) intermediate D is also possible, although palladacycle D could also be 
generated directly from intermediate B.  Intermediate F eventually undergoes either 
palladium insertion into the C-H bond of the neighboring arene or electrophilic aromatic 
substitution to afford the six-membered ring palladacycle G.  Alternatively, intermediate D 
can undergo intramolecular C-H activation to generate an interesting organopalladium(IV)  
Scheme 4.  Proposed Mechanism 
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hydride E; subsequent reductive elimination could also generate intermediate G (route b).   
When R is a phenyl group, the palladium moiety can migrate to either of two ortho positions 
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of the arene originally bearing the iodo group and then be trapped by arylation to generate 
either the observed carbazole (dibenzofuran) or a fluorene.  While we have previously 
reported such a fluorene synthesis,2 only the carbazole (dibenzofuran) products are observed, 
which suggests that the palladium only migrates to the position ortho to the heteroatom.  This 
interesting selectivity may be due to coordination between the ortho heteroatom and the 
palladium moiety, which is not available if the palladium migrates to the position para to the 
heteroatom.  Alternatively, the palladium may prefer the position ortho to the heteroatom due 
to stabilization of the arylpalladium intermediate by inductive electron withdrawal, as 
suggested by recent results in our laboratories, which are supported by calculations.10 
6. Deuterium Labeling Experiments.  In order to clarify the ambiguities in the 
mechanism, we prepared the deuterium labeled starting material 33-d (90% deuterium 
incorporation in each position of the arene, as shown in Scheme 5)13 and allowed this 
compound to react with diphenyl acetylene under our usual palladium migration conditions.  
According to the proposed mechanism shown in Scheme 6, if the reaction 
Scheme 5. Synthesis of Deuterated Compound 33-d 
MeO OD
I
D D
D
i
MeO OPh
I
D D
D
33-d
ii
(i) NaSMe, DMA, 140 oC (ii) (a) NaNO2, HCl (b) KI; (iii) CF3CO2D, 
reflux; (iv) 4 CsF,1.1 2-(trimethylsilyl)phenyl trifluoromethanesulfonate, MeCN.
MeO OMe MeO OH
NH2
MeO OH
iii iv
INH2
 
only proceeds through route a, the deuterium originally ortho to the oxygen atom and the 
iodine atom will shift to the vinylic position after the vinylic to aryl palladium migration.  
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Thus, we should obtain dibenzofuran 34-d.  On the other hand, if this reaction only goes 
through the mechanism described in route b, product 34-h should be obtained.   Indeed, an 
80% yield of dibenzofuran 34-d was isolated by flash chromatography, with 70% deuterium 
incorporation in the vinylic position (determined by 1H NMR spectroscopy).  This result 
clearly suggests the involvement of route a.  The loss of deuterium could be due to H-D 
exchange through an equilibrium between palladacycle K and palladacycle P or the direct H- 
Scheme 6.  Deuterium Labeling Experiment 
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D exchange between intermediate K and an H source in the reaction solution.  Alternatively, 
it could be due to the involvement of route b, because the aryl deuterium presumably would 
be washed out upon formation of intermediate P.  To address these issues, we conducted the 
same reaction in the presence of 10 equiv of D2O,  and 85% deuterium incorporation was 
observed in the vinylic position of the isolated dibenzofuran product 34-d, which suggests 
that the previous deuterium loss is probably the result of H-D exchange in intermediate K, 
instead of the alternative mechanistic route b. 
Conclusions 
In conclusion, we have established the scope and limitations of a mechanistically important 
palladium migration process, which affords an efficient way to prepare biologically 
interesting carbazoles, indoles and dibenzofurans.  The advantage of this chemistry is that an 
alkenyl substituent can be efficiently incorporated into the heterocyclic ring during the course 
of the cyclization, which can be still further modified to other functional groups.  This 
reaction is quite general for the synthesis of carbazoles, but only moderate yields can be 
obtained in the synthesis of indoles, and excellent yields can be achieved in the synthesis of 
dibenzofurans only if electron-rich aryl iodides are employed.  The relatively modest 
regiochemistry of alkyne insertion also presents problems.  The results of deuterium labeling 
experiments showed a high degree of deuterium incorporation in the vinylic position of the 
dibenzofuran product obtained, affording convincing evidence for the proposed palladium 
migration mechanism.  The H-D exchange also suggests that the migration process involves 
an equilibrium between Pd(II) and Pd(IV) intermediates, which is consistent with a 
previously reported consecutive vinylic to aryl to allylic palladium migration5 and does not 
favor the direct Pd-H shift mechanism reported elsewhere.2d 
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Experimental Section 
I. General Procedures.   
All 1H and 13C NMR spectra were collected in CDCl3 unless noted otherwise. Thin layer 
chromatography was performed using 60-mesh silica gel plates, and visualization was 
affected using short wavelength UV light (254 nm) and a basic KMnO4 solution.  All high 
resolution mass spectra were recorded using EI. 
All reagents were used directly as obtained commercially unless otherwise noted.  
Anhydrous forms of acetonitrile, DMF, diethyl ether, ethyl acetate, hexanes, and 4,4-
dimethyl-2-pentyne were purchased from Lancaster Synthesis, Inc.  3-Iodoaniline, 2-
(trimethylsilyl)phenyl trifluoromethanesulfonate, cesium fluoride, 1,3-diiodobenzene,  1,1'-
bis(diphenylphosphino)ferrocene (dppf), sodium tert-butoxide, p-toluidine, p-anisidine, p-
chloroaniline, o-methoxyaniline, methyl  4-aminobenzoate, 1-naphthylamine, 5,6,7,8-
tetrahydronaphthalen-1-ylamine,  1-phenyl-1-butyne, 1-phenyl-1-propyne, 4-octyne, diphenyl 
acetylene, 3,5-dimethoxyaniline, sodium thiomethoxide, and trifluoroacetic acid-d were 
purchased from Aldrich Chemical Co., Inc.  Cesium pivalate was prepared according to the 
procedure of Campo and Larock.14  The substituted alkynes were prepared by the 
Sonogashira coupling of aryl iodides with 1-butyne using 5 mol % of PdCl2(PPh3)2, 2 mol % 
of CuI in  Et3N solvent at room temperature.15 
II. Noncommercial compounds.  
N-Phenyl-3-iodoaniline.   
This compound was prepared according to the reported procedure.16  1H NMR (CDCl3) δ 
5.67 (s, 1H), 6.94-7.10 (m, 5H), 7.23-7.41 (m, 4H); 13C NMR (CDCl3) 95.2, 116.5, 119.1, 
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122.3, 125.9, 129.7, 129.8, 131.1, 142.2, 145.1; IR (CDCl3) 3427, 3061, 3034, 1584 cm-1; 
HRMS m/z 294.9858 (calcd for C12H10NI, 294.9863).   
Other aniline starting materials were prepared through a palladium-catalyzed amination 
reaction.17  The typical yield is ~30%. 
N-p-Tolyl-3-iodoaniline. 
  
1H NMR (CDCl3) δ 2.34 (s, 3H), 5.58 (s, 1H), 6.93-7.26 (m, 7H), 7.34 (s, 1H); 13C NMR 
(CDCl3) 21.1, 95.3, 115.7, 120.2, 124.9, 129.0, 130.3, 131.0, 132.3, 139.3, 145.9; IR (CDCl3) 
3427, 3028, 2922, 1587 cm-1; HRMS m/z 309.0018 (calcd for C13H9IN, 309.0015). 
N-(2-Methoxyphenyl)-3-iodoaniline. 
  
1H NMR (CDCl3) δ 3.89 (s, 3H), 6.15 (s, 1H), 6.92-7.01 (m, 4H), 7.09-7.12 (m, 1H), 7.26-
7.35 (m, 2 H), 7.51 (t, J = 1.7 Hz, 1H); 13C NMR (CDCl3) 55.9, 95.2, 111.0, 116.2, 117.2, 
121.1, 121.3, 126.5, 129.9, 131.0, 131.9, 144.7, 149.0; IR (CDCl3) 3418, 3060, 2962, 1244 
cm-1; HRMS m/z 324.9969 (calcd for C13H9INO, 324.9964). 
N-(4-Methoxyphenyl)-3-iodoaniline. 
  
1H NMR (CDCl3) δ 3.83 (s, 3H), 5.51 (s, 1H), 6.82-7.23 (m, 8H); 13C NMR (CDCl3) 55.9, 
95.5, 114.7, 115.1, 123.5, 123.9, 128.3, 131.1, 134.7, 147.1, 156.1; IR (CDCl3) 3425, 3006, 
2957, 1245 cm-1; HRMS m/z 324.9967 (calcd for C13H9INO, 324.9964). 
Methyl N-(3-iodophenylamino)benzoate. 
  
1H NMR (CDCl3) δ 3.88 (s, 3H), 6.10 (s, 1H), 6.98-7.13 (m, 4H), 7.35 (d, J = 7.8 Hz, 1H), 
7.50 (s, 1H), 7.92 (d, J = 8.7 Hz, 1H); 13C NMR (CDCl3) 52.1, 95.0, 115.6, 119.1, 122.2, 
128.6, 131.1, 131.8, 131.9, 142.7, 147.3, 167.1; IR (CDCl3) 3340, 2945, 1694, 1580 cm-1; 
HRMS m/z 352.9913 (calcd for C14H12INO2, 352.9918).     
N-(4-Chlorophenyl)-3-iodoaniline. 
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1H NMR (CDCl3) δ 5.64 (s, 1H), 6.96-7.00 (m, 4H), 7.23-7.28 (m, 3H), 7.36 (s, 1H); 13C 
NMR (CDCl3) 95.3, 116.8, 120.1, 126.1, 126.8, 129.7, 130.2, 131.2, 140.9, 144.6; IR 
(CDCl3) 3427, 3061, 3034, 1583 cm-1; HRMS m/z 328.9473 (calcd for C12H9ClIN, 
328.9468). 
N-(3-Iodophenyl)naphthalen-1-amine. 
  
1H NMR (CDCl3) δ 5.83 (s, 1H), 6.85-6.97 (m, 2H), 7.21 (dt, J = 7.6, 1.3 Hz, 1H), 7.30 (t, J 
= 1.9 Hz, 1H), 7.37-7.56 (m, 4H), 7.65 (d, J = 7.8 Hz, 1H), 7.88-8.00 (m, 2H); 13C NMR 
(CDCl3) 95.2, 115.9, 118.2, 122.1, 124.5, 125.3, 126.2, 126.6, 128.6, 128.8, 129.1, 131.0, 
134.9, 137.7, 146.9; IR (CDCl3) 3415, 3060, 1574 cm-1; HRMS m/z 345.0018 (calcd for 
C18H12IN, 345.0015). 
N-(3-Iodophenyl)-5,6,7,8-tetrahydronaphthalen-1-amine. 
  
1H NMR (CDCl3) δ 1.79-1.90 (m, 4H), 2.60 (t, J = 6.1 Hz, 2H), 2.84 (t, J = 6.1 Hz, 2H), 
5.31 (s, 1H), 6.87-6.90 (m, 2H), 6.96 (t, J = 7.7 Hz, 1H), 7.11 (d, J = 4.3 Hz, 2H), 7.20-7.22 
(dd, J = 7.6, 0.9 Hz, 1H), 7.30 (s, 1H); 13C NMR (CDCl3) 23.0, 23.3, 25.0, 30.2, 95.3, 116.1, 
117.6, 124.4, 125.5, 126.1, 128.9, 129.0, 131.0, 139.1, 140.0, 146.1; IR (CDCl3) 3396, 3054, 
2927, 1578 cm-1; HRMS m/z 349.0331 (calcd for C16H16IN, 349.0328). 
N-Allyl-3-iodoaniline. 
  
 This compound was prepared according to the reported procedure.18  1H NMR (CDCl3) δ 
3.74 (d, J = 5.1 Hz, 2H), 3.81 (s, 1H), 5.19-5.33 (m, 2H), 5.87-5.99 (m, 1H), 6.57 (dd, J = 
8.1, 2.4 Hz, 1H), 6.89 (t, J = 8.1 Hz, 1H), 6.97 (t, J = 1.6 Hz, 1H), 7.05 (d, J = 7.8 Hz, 1H); 
13C NMR (CDCl3) 46.5, 95.6, 112.5, 116.9, 121.7, 126.6, 130.9, 135.0, 149.5; IR (CDCl3) 
3417, 3076, 2847, 1590 cm-1; HRMS m/z 258.9862 (calcd for C9H10NI, 258.9858). 
3-(3-Iodophenylamino)cyclohex-2-enone. 
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  3-Iodoaniline (2 mmol) and cyclohexane-1,3-dione (2 mmol) were dissolved in 10 mL of 
toluene and then the mixture was heated at 100 oC in the presence of 8 mmol of  anhydrous 
MgSO4 and a catalytic amount of TsOH.  After 12 h, the reaction mixture was filtered, and 
the toluene was removed from the filtrate.  The residue obtained was purified by flash 
chromatography to afford a 90% yield of the imine product: 1H NMR (CDCl3) δ 1.96-2.02 
(m, 2H), 2.32 (t, J = 6.2 Hz, 2H), 2.50 (t, J = 6.2 Hz, 2H), 5.51 (s, 1H), 7.00 (t, J = 8.0 Hz, 
1H), 7.10 (dd, J = 8.0, 0.9 Hz, 1H), 7.40-7.48 (m, 3H); 13C NMR (CDCl3) 22.0, 29.8, 36.7, 
123.3, 130.9, 132.8, 134.6, 139.8, 162.8, 198.9; IR (CDCl3) 3247, 3056, 2945, 1566 cm-1; 
HRMS m/z 312.9968 (calcd for C12H12INO, 312.9964). 
1-Iodo-3-(phenoxy)benzene. 
  This compound was prepared by the reported procedure.19 1H NMR (CDCl3) δ 6.96-7.07 
(m, 4H), 7.16 (t, J = 7.4 Hz, 1H), 7.35-7.44 (m, 4H); 13C NMR (CDCl3) 94.5, 118.2, 119.5, 
124.2, 127.8, 130.2, 131.3, 132.4, 156.6, 158.3; IR (CDCl3) 3075, 2965, 1582 cm-1; HRMS 
m/z 295.9702 (calcd for C12H9IO, 295.9698). 
Iodo-3,5-diphenoxybenzene. 
This compound was prepared by the sequence shown below:  
i
PhO OPh
I
ii
(i) (a) NaNO2, HCl (b) KI; (ii) BBr3; (iii) 6 CsF, 2.2 2-(trimethylsilyl)phenyl trifluoromethanesulfonate, 
MeCN.
MeO OMe
NH2
HO OH
I
HO OH
iii
I
 
1H NMR (CDCl3) δ 6.63 (t, J = 2.2 Hz, 1H), 7.02-7.04 (m, 6H), 7.13-7.17 (m, 2H), 7.35-7.39 
(m, 4H); 13C NMR (CDCl3) 94.1, 108.7, 119.8, 122.0, 124.5, 130.2, 156.1, 159.4; IR 
(CDCl3) 3073, 3039, 1575 cm-1; HRMS m/z 387.9964 (calcd for C18H13IO2, 387.9960). 
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1-Iodo-3-methoxy-5-(phenoxy)benzene. 
  This compound was prepared by the sequence shown below.13  1H NMR (CDCl3) δ 3.76 (s, 
3H), 6.57 (t, J = 2.2 Hz, 1H), 6.97 (t, J = 1.5 Hz, 1H), 7.03-7.09 (m, 3H), 7.18 (t, J = 7.3 Hz, 
1H), 7.36-7.42 (m, 2H); 13C NMR (CDCl3) 55.9, 94.4, 104.9, 118.3, 119.8, 120.2, 124.3, 
130.2, 156.4, 159.3, 161.5; IR (CDCl3) 3074, 2960, 1586 cm-1; HRMS m/z 325.9808 (calcd 
for C13H11IO2, 325.9804).  
i
MeO OPh
I
ii
(i) NaSMe, DMA, 140 oC; (ii) (a) NaNO2, HCl; (b) KI; (iii) 4 CsF, 1.1 2-(trimethylsilyl)phenyl 
trifluoromethanesulfonate, MeCN.
MeO OMe
NH2
MeO OH
NH2
MeO OH
iii
I
 
Compound 29-d: 1H NMR (CDCl3) δ 3.76 (s, 3H), 6.52 (s, 0.08H), 6.92 (s, 0.11H), 6.99-7.04 
(m, 2H), 7.15 (t, J = 7.32 Hz, 1H), 7.34-7.39 (m, 2H). 
III. Experimental Procedures.   
The aryl halide (0.25 mmol), alkyne (0.25 mmol), Pd(OAc)2 (2.8 mg, 0.0125 mmol), 
bis(diphenylphosphino)methane (dppm) (4.8 mg, 0.0125 mmol) and CsO2CCMe3 (CsPiv) 
(0.117 g, 0.5 mmol) in 4 mL of DMF were stirred under Ar at 100 oC for 6 h.  The reaction 
mixture was allowed to cool to room temperature, diluted with diethyl ether (25 mL) and 
washed with 5% Na2CO3 (25 mL).  The aqueous layer was re-extracted with diethyl ether (25 
mL) twice.  The organic layers were combined, dried (MgSO4), filtered, and the solvent was 
removed under reduced pressure.  The residue was purified by flash chromatography on silica 
gel.   
For the products reported in entries 1, 5, 9, 13, 15 and 16 of Table 2; entry 1 in Table 3; 
and entries 2-4, 8, and 9 in Table 3, GC-mass spectral analysis shows two regioisomers, 
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which cannot be separated by flash chromatography.  The ratio of these isomers was 
determined by 1H NMR spectroscopy.  
 (E)-4-(1-Phenylbut-1-enyl)-9H-carbazole (1a). 
  
1H NMR (CDCl3) δ 1.11 (t, J = 7.4 Hz, 3H), 2.94 (q, J = 7.4 Hz, 2H), 6.74 (s, 1H), 7.11-
7.20 (m, 2H), 7.35-7.53 (m, 9H), 8.05 (s, 1H), 8.20 (d, J = 7.9 Hz, 1H); 13C NMR (CDCl3) 
13.4, 25.9, 109.4, 110.7, 119.6, 120.2, 120.9, 123.0, 123.3, 125.7, 125.8, 126.9, 128.7, 128.9, 
129.0, 138.2, 139.9, 139.9, 140.1, 144.6; IR (CDCl3) 3471, 3056, 2968, 2934, 1599 cm-1; 
HRMS m/z 297.1522 (calcd for C22H19N, 297.1518). 
(E)-4-(4,4-Dimethylpent-2-en-2-yl)-9H-carbazole (2). 
  
1H NMR (CDCl3) δ 1.34 (s, 9H), 2.28 (d, J = 1.3 Hz, 3H), 5.67 (d, J = 1.4 Hz, 1H), 6.96 
(dd, J = 6.9, 1.2 Hz, 1H), 7.19-7.42 (m, 5H), 8.06 (s, 1H), 8.14 (d, J = 7.8 Hz, 1H); 13C NMR 
(CDCl3) 19.2, 31.2, 33.1, 108.8, 110.6, 119.4, 119.7, 120.2, 123.0, 123.2, 125.6, 125.9, 
134.8, 139.6, 139.8, 139.9, 143.3; IR (CDCl3) 3473, 2960, 2867, 1600 cm-1; HRMS m/z 
263.1679 (calcd for C19H21N, 263.1674). 
4-[1-(2,2-Dimethylpropylidene)pentyl]-9H-carbazole (4a). 
  
1H NMR (CDCl3) δ 0.81 (t, J = 7.2 Hz, 3H), 1.22-1.40 (m, 13H), 2.71-2.78 (m, 2H), 5.62 (s, 
1H), 6.97 (dd, J = 7.1, 1.1 Hz, 1H), 7.19-7.42 (m, 5H), 8.01 (s, 1H), 8.20 (d, J = 8.1 Hz, 1H); 
13C NMR (CDCl3) 14.2, 23.4, 31.4, 31.7, 32.4, 33.2, 108.7, 110.6, 119.3, 120.5, 120.7, 123.2, 
123.4, 125.5, 139.3, 139.8, 139.9, 140.1, 141.9; IR (CDCl3) 3410, 2957, 2866, 1599 cm-1; 
HRMS m/z 305.2148 (calcd for C22H27N, 305.2144).  
(E)-4-(1-Phenylprop-1-enyl)-9H-carbazole (5a). 
  
1H NMR (CDCl3) δ 2.47 (s, 3H), 6.78 (s, 1H), 7.12-7.20 (m, 2H), 7.33-7.54 (m, 9H), 8.10 
(s, 1H), 8.14 (d, J = 7.8 Hz, 1H); 13C NMR (CDCl3) 19.9, 109.4, 110.7, 119.4, 119.6, 120.2, 
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122.9, 123.1, 125.8, 125.9, 126.8, 128.6, 129.3, 129.4, 138.3 (2C), 139.9, 140.1, 141.4; IR 
(CDCl3) 3471, 3060, 3026, 1601, 1456 cm-1; HRMS m/z 283.1367 (calcd for C18H19N, 
283.1361). 
(E)-4-(1,2-Diphenylvinyl)-9H-carbazole (6). 
  
1H NMR (CDCl3) δ 7.03-7.14 (m, 3H), 7.23-7.42 (m, 14H), 8.03 (s, 1H), 8.37 (d, J = 8.1 
Hz, 1H); 13C NMR (CDCl3) 109.8, 110.8, 119.6, 121.3, 121.7, 123.0, 123.39, 125.7, 125.9, 
127.3, 127.7, 128.5, 128.7, 129.8, 130.2, 131.1, 137.6, 140.0, 140.3, 140.4, 140.7, 141.3; IR 
(CDCl3) 3414, 3054, 1599, 1455 cm-1; HRMS m/z 345.1522 (calcd for C26H19N, 345.1518). 
(E)-Ethyl 4-[1-(9H-carbazol-4-yl)but-1-enyl]benzoate (7a). 
  
1H NMR (CDCl3) δ 1.90 (t, J = 7.5 Hz, 3H), 1.44 (t, J = 7.2 Hz, 3H), 1.91 (q, J = 7.5 Hz, 
2H), 4.43 (q, J = 7.2 Hz, 2H), 6.73 (s, 1H), 7.10 (dd, J = 6.7, 1.7 Hz, 1H), 7.15 (td, J = 6.8, 
1.5 Hz, 1H), 7.37-7.46 (m, 4H), 7.53 (d, J = 8.1 Hz, 2H), 8.10-8.20 (m, 4H); 13C NMR 
(CDCl3) 13.3, 14.6, 26.0, 6.19, 109.6, 110. 8, 119.6, 119.9, 120.8, 122.8, 123.1, 125.6, 125.8, 
128.2, 128.8, 128.9, 130.0, 139.4, 139.9, 140.1, 142.8, 146.7, 166.8; IR (CDCl3) 3472, 2968, 
2873, 1710 cm-1; HRMS m/z 369.1736 (calcd for C25H23NO2, 369.1729). 
(E)-4-[1-(2-Methoxyphenyl)but-1-enyl]-9H-carbazole (8a). 
  
1H NMR (CDCl3) δ 1.00 (t, J = 7.5 Hz, 3H), 2.80 (q, J = 7.5 Hz, 2H), 3.84 (s, 3H), 6.77 (s, 
1H), 6.95 (d, J = 8.0 Hz, 1H), 6.97-7.17 (m, 3H), 7.29-7.53 (m, 6H), 8.11 (s, 1H), 8.36 (d, J = 
7.8 Hz, 1H); 13C NMR (CDCl3) 13.3, 26.1, 55.5, 109.1, 110.5, 110.8, 118.3, 119.3, 120.2, 
120.4, 121.2, 123.5, 124.7, 125.5, 125.6, 127.3, 128.3, 130.1, 139.9, 140.1, 144.0, 157.8; IR 
(CDCl3) 3472, 2966, 2934, 1245 cm-1; HRMS m/z 327.1628 (calcd for C23H21NO, 
327.1623). 
 (E)-5-(1,2-Diphenylvinyl)-3-methyl-9H-carbazole (9). 
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1H NMR (CDCl3) δ 2.36 (s, 3H), 7.02-7.05 (m, 2H), 7.20-7.40 (m, 14H), 7.95 (s, 1H), 8.10 
(s, 1H); 13C NMR (CDCl3) 21.8, 109.8, 110.4, 121.3, 121.6, 123.1, 123.5, 125.5, 127.2, 
127.2, 127.6, 128.5, 128.5, 128.6, 129.7, 130.3, 131.1, 137.8, 138.2, 140.2, 140.5, 140.7, 
141.4; IR (CDCl3) 3413, 3053, 3022, 1599, 1491 cm-1; HRMS m/z 359.1678 (calcd for 
C27H21N, 359.1674). 
(E)-5-(1,2-Diphenylvinyl)-3-methoxy-9H-carbazole (10). 
  
1H NMR (CDCl3) δ 3.58 (s, 3H), 7.02-7.07 (m, 3H), 7.22-7.42 (m, 13H), 7.81 (d, J = 2.5 
Hz, 1H), 7.98 (s, 1H); 13C NMR (CDCl3) 55.8, 105.2, 110.1, 111.5, 115.8, 121.5, 121.6, 
123.6, 125.6, 127.3, 127.8, 128.7, 129.7, 130.3, 131.3, 134.8, 137.7, 140.1, 140.5, 141.1 
(2C), 153.5; IR (CDCl3) 3415, 3054, 2949, 1582, 1478 cm-1; HRMS m/z 375.1629 (calcd for 
C27H21NO, 375.1623). 
(E)-5-(1-Benzylidenepropyl)-1-methoxy-9H-carbazole (11a). 
  
1H NMR (CDCl3) δ 1.08 (t, J = 7.5 Hz, 3H), 2.91 (q, J = 7.5 Hz, 2H), 4.0 (s, 3H), 6.7 (s, 
1H), 6.89 (d, J = 7.6 Hz, 1H), 7.06-7.10 (m, 2H), 7.30-7.50 (m, 7H), 7.77 (d, J = 8.0 Hz, 1H), 
8.37 (s, 1H); 13C NMR (CDCl3) 13.4, 25.9, 55.8, 105.8, 109.7, 115.6, 119.7, 120.0, 124.2, 
125.5, 126.8, 128.6, 128.9, 129.0, 130.3, 138.2, 139.8, 139.9, 144.5, 145.8; IR (CDCl3) 3421, 
2964, 2932, 1598 cm-1; HRMS m/z 327.1625 (calcd for C23H21NO, 327.1623).  
(E)-Methyl 5-(1,2-diphenylvinyl)-9H-carbazole-3-carboxylate (12). 
  
1H NMR (CDCl3) δ 3.72 (s, 3H), 7.03 (s, 1H), 7.09 (t, J =  4.2 Hz, 1H), 7.20-7.42 (m, 13H), 
8.07 (dd, J = 8.5, 1.4 Hz, 1H), 8.41 (s, 1H), 9.00 (d, J = 1.4 Hz, 1H); 13C NMR (CDCl3) 51.9, 
110.1, 110.2, 121.4, 121.6, 122.6, 122.9, 125.6, 126.4, 127.2, 127.5, 127.7, 128.3, 128.5, 
129.8, 130.4, 131.5, 137.5, 140.0, 140.5, 140.7, 140.9, 142.7, 167.9; IR (CDCl3) 3323, 3021, 
2947, 1691 cm-1; HRMS m/z 403.1578 (calcd for C28H21NO2, 403.1572) 
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 (E)-3-Chloro-5-(1-phenylbut-1-enyl)-9H-carbazole (13a). 
  
1H NMR (CDCl3) δ 1.09 (t, J = 7.5 Hz, 3H), 2.91 (q, J = 7.5 Hz, 2H), 6.73 (s, 1H), 7.14 (d, 
J = 7.2 Hz, 1H), 7.29-7.52 (m, 10H), 8.08 (s, 1H), 8.19 (d, J = 1.5 Hz, 1H); 13C NMR 
(CDCl3) 13.4, 25.7, 109.6, 111.7, 120.5, 122.6, 124.5, 124.9, 125.9, 126.4, 127.1, 128.8, 
129.2, 129.7, 137.9, 138.2, 140.0, 140.6, 144.0; IR (CDCl3) 3471, 2944, 2833 cm-1; HRMS 
m/z 331.1132 (calcd for C22H18NCl, 331.1128). 
(E)-7-(1-Phenylbut-1-enyl)-11H-benzo[a]carbazole (14a). 
  
1H NMR (CDCl3) δ 1.10 (t, J = 7.6 Hz, 3H), 2.95 (q, J =  7.6 Hz, 2H), 6.75 (s, 1H), 7.16 
(dd, J = 7.3, 1.2 Hz, 1H), 7.26-7.60 (m, 10H), 7.98 (d, J = 7.5 Hz, 1H), 8.14 (d, J =  8.1 Hz, 
1H), 8.23 (d, J =  8.1 Hz, 1H), 8.87 (s, 1H); 13C NMR (CDCl3) 13.3, 26.1, 109.8, 118.5, 
120.1, 120.6 (2C), 121.1, 121.8, 121.9, 124.7, 125.5, 125.7, 126.9, 128.7, 129.0, 129.1 (2C), 
132.3, 135.3, 138.2, 139.1, 139.3, 144.5; IR (CDCl3) 3472, 3060, 2969, 1572 cm-1; HRMS 
m/z 347.1682 (calcd for C26H21N, 347.1674). 
(E)-7-(1,2-Diphenylvinyl)-2,3,4,11-tetrahydro-1H-benzo[a]carbazole (15). 
  
1H NMR (CDCl3) δ 1.91-2.03 (m, 4H), 2.93 (m, 4H), 6.86 (d, J = 8.2 Hz, 1H), 6.99 (dd, J = 
7.2, 0.8 Hz, 1H), 7.07 (s, 1H), 7.23-7.40 (m, 12H), 8.01 (s, 1H), 8.09 (d, J = 8.2 Hz, 1H); 13C 
NMR (CDCl3) 23.1, 13.6, 24.6, 29.9, 109.8, 119.1, 120.0, 120.4, 121.2, 121.6, 122.0, 124.9, 
127.2, 127.6, 128.4, 128.6, 129.8, 130.2, 131.0, 134.9, 137.7, 139.1, 139.9, 140.2, 140.8, 
141.3; IR (CDCl3) 3434, 3053, 2929, 1601 cm-1; HRMS m/z 399.1993 (calcd for C30H25N, 
399.1987). 
(E)-3-Methyl-4-(1-phenylbut-1-en-2-yl)-1H-indole (16a). 
  
1H NMR (CDCl3) δ 1.09 (t, J = 7.2 Hz, 3H), 2.36 (s, 3H), 2.77 (q, J = 7.2 Hz, 2H), 6.47 (s, 
1H), 6.96-6.99 (m, 2H), 7.18 (t, J = 7.8 Hz, 1H), 7.27-7.32 (m, 2H), 7.41 (d, J = 4.1 Hz, 4H), 
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7.93 (s, 1H); 13C NMR (CDCl3) 13.2, 13.4, 27.1, 110.0, 112.5, 119.7, 121.7, 122.9, 125.6, 
126.6, 128.5, 128.9, 129.0, 137.3, 137.9, 138.4, 144.4; IR (CDCl3) 3418, 3021, 2964, 1598 
cm-1; HRMS m/z 261.1518 (calcd for C19H19N, 261.1521). 
(E)-4-(1,2-Diphenylvinyl)-3-methyl-1H-indole (17). 
  
1H NMR (CDCl3) δ 2.24 (d, J = 0.8 Hz, 3H), 6.68 (s, 1H), 6.89 (dd, J = 7.2, 0.8 Hz, 1H), 
6.99 (d, J = 1.0 Hz, 1H), 7.11-7.32 (m, 12H), 7.99 (s, 1H); 13C NMR (CDCl3) 13.7, 110.4, 
112.8, 121.7, 121.8, 123.2, 126.8, 127.3, 128.3 (2C), 128.4, 129.6, 130.5, 137.6, 137.9, 
138.1, 141.3, 141.4; IR (CDCl3) 3422, 3053, 3021, 1695 cm-1; HRMS m/z 309.1522 (calcd 
for C23H19N, 309.1518). 
(E)-3-Methyl-4-(1-methyl-2-phenylvinyl)-1H-indole (18a). 
  
1H NMR (CDCl3) δ 2.34-2.35 (m, 6H), 6.51 (d, J = 1.0 Hz, 1H), 6.96-6.99 (m, 2H), 7.18 (t, 
J = 8.0 Hz, 1H), 7.26-7.31 (m, 3H), 7.39-7.43 (m, 4H), 7.96 (s, 1H); 13C NMR (CDCl3) 12.8, 
21.8, 110.1, 112.4, 119.1, 121.9, 122.8, 126.5, 128.4, 129.2, 129.4, 137.3, 138.5 (2C), 139.8; 
IR (CDCl3) 3416, 3051, 2919, 1597 cm-1; HRMS m/z 247.1365 (calcd for C18H17N, 
247.1361). 
(E)-5-(1,2-Diphenylvinyl)-1,2,3,9-tetrahydrocarbazol-4-one (19). 
  
1H NMR (CDCl3) δ 2.05-2.12 (m, 2H), 2.48 (t, J = 6.1 Hz, 2H), 2.80 (t, J = 6.2 Hz, 2H), 
6.51 (s, 1H), 7.02-7.34 (m, 13H), 9.72 (s, 1H); NMR (CDCl3) 23.4, 23.8, 38.8, 110.8, 113.9, 
123.9, 124.4, 125.4, 126.2, 126.8, 127.2, 127.3, 127.9, 128.0, 129.5, 134.0, 137.0, 138.5, 
143.4, 144.2, 191.9; IR (CDCl3) 3168, 3052, 2952, 1621 cm-1; HRMS m/z 363.1631 (calcd 
for C26H21NO, 363.1623). 
(E)-1-(1-Benzylidenepropyl)-3-(phenoxy)dibenzofuran (21a). 
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1H NMR (CDCl3) δ 1.11 (t, J = 7.5 Hz, 3H), 7.87 (q, J = 7.5 Hz, 2 H), 6.76 (s, 1H), 7.05 (d, 
J = 2.2 Hz, 1H), 7.04-7.58 (m, 14H), 8.01 (dd, J = 7.7, 0.6 Hz, 1H); 13C NMR (CDCl3) 13.3, 
25.6, 100.9, 111.7, 114.5, 117.8, 119.3, 122.2, 123.0, 123.9, 124.2, 126.4, 127.3, 128.4, 
128.8, 129.8, 130.2, 137.6, 140.9, 142.5, 156.9, 157.4, 157.5; IR (CDCl3) 3023, 2966, 1628 
cm-1; HRMS m/z 390.1624 (calcd for C28H22O2, 390.1620). 
(E)-1-(1-Benzylidenepropyl)-3-methoxydibenzofuran (22a). 
  
1H NMR (CDCl3) δ 1.11 (t, J =  7.6 Hz, 3H), 2.88 (q, J = 7.6 Hz, 2H), 3.94 (s, 3H), 6.73 (s, 
1H), 6.87 (s, 1H), 7.05 (s, 1H), 7.21-7.57 (m, 8H), 7.82 (d, J = 7.2 Hz, 1H); 13C NMR 
(CDCl3) 13.2, 25.6, 56.0, 95.2, 111.0, 111.5, 115.5, 121.9, 122.8, 124.6, 125.7, 127.2, 128.7, 
129.5, 137.7, 140.6, 142.9, 156.7, 158.0, 159.7;  IR (CDCl3) 3056, 3022, 2964, 1627 cm-1; 
HRMS m/z 328.1468 (calcd for C23H20O2, 328.1463). 
(E)-3-Methoxy-1-(1-methyl-2-phenylvinyl)dibenzofuran (23a). 
  
1H NMR (CDCl3) δ 2.45 (d, J = 1.3 Hz, 3H), 3.9 (s, 3H), 6.81 (s, 1H), 6.88 (d, J = 2.2 Hz, 
1H), 7.07 (d, J = 2.2 Hz, 1H), 7.25-7.57 (m, 8H), 7.93 (d, J = 7.2 Hz, 1H);  13C NMR 
(CDCl3) 19.6, 56.0, 95.2, 110.6, 111.5, 114.7, 121.9, 122.8, 124.4, 125.8, 127.1, 128.7, 
129.3, 130.2, 130.2, 136.5, 137.8, 142.2, 156.7, 158.0, 159.9; IR (CDCl3) 3054, 2938, 2835, 
1627 cm-1; HRMS m/z 314.1311  (calcd for C22H18O2, 314.1307). 
(E)-3-Methoxy-1-(1,3,3-trimethylbut-1-enyl)dibenzofuran (24a). 
  
1H NMR (CDCl3) δ 1.31 (s, 9H), 2.23 (d, J = 1.0 Hz,  1H), 3.90 (s, 1H), 5.68 (d, J = 1.0 Hz, 
1H), 6.69 (d, J = 1.7 Hz, 1H), 6.97 (d, J =  1.7 Hz, 1H), 7.25-7.38 (m, 3H), 7.51 (d, J =  6.1 
Hz, 1H), 7.88 (d, J =  6.0 Hz, 1H); 13C NMR (CDCl3) 18.9, 31.2, 56.0, 94.5, 110.7, 111.4, 
121.8, 122.6, 124.5, 125.5, 130.1, 133.2, 140.5, 143.8, 156.5, 157.8, 159.8; IR (CDCl3) 2956, 
2865, 1628 cm-1; HRMS m/z 294.1624 (calcd for C20H22O2, 294.1620). 
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(E)-3-Methoxy-1-(1-propylpent-1-enyl)dibenzofuran (25). 
  
1H NMR (CDCl3) δ 0.89 (t, J = 7.3 Hz, 3H), 1.02 (t, J = 7.4 Hz, 3H), 1.32-1.45 (m, 2H), 
1.48-1.60 (m, 2H), 2.31 (q, J = 7.3 Hz, 2H), 2.58 (t, J = 7.4 Hz, 2H), 3.90 (s, 3H), 5.67 (t, J = 
7.2 Hz, 1H), 6.71 (d, J = 2.2 Hz, 1H), 6.99 (d, J = 2.2 Hz, 1H), 7.22-7.38 (m, 2H), 7.52 (d, J 
= 8.2 Hz, 1H), 7.88 (d, J = 7.8 Hz, 1H); 13C NMR (CDCl3) 14.3, 14.4, 22.0, 23.2, 30.6, 33.6, 
55.9, 94.5, 111.3, 111.4, 115.2, 121.9, 122.6, 124.7, 125.5, 130.9, 138.8, 141.4, 156.6, 157.8, 
159.6; IR (CDCl3) 2957, 2930, 2869 cm-1; HRMS m/z 308.1781 (calcd for C21H24O2, 
308.1776). 
(E)-1-(1,2-Diphenylvinyl)-3-methoxydibenzofuran (26). 
 
1H NMR (CDCl3) δ 3.86 (s, 3H), 6.72 (s, 1H), 7.06-7.37 (m, 14H), 7.54 (d, J = 8.1 Hz, 1H), 
7.92 (d, J = 8.1 Hz, 1H);  13C NMR (CDCl3) 56.0, 95.7, 111.5, 112.8, 115.8, 122.0, 122.8, 
124.5, 125.9, 127.5, 127.9, 128.5, 128.8, 129.8, 130.3, 131.6, 137.1, 140.0, 140.1, 140.9, 
156.8, 158.2, 159.6; IR (CDCl3) 3054, 3022, 2958, 1629 cm-1; HRMS m/z 376.1470 (calcd 
for C27H20O2, 376.1463).   
(E)-1-(2-Deutero-1,2-diphenylvinyl)-2,4-dideutero-3-methoxydibenzofuran (26-d). 
This compound contains 70% deuterium in the vinylic position: 1H NMR (CDCl3) δ 3.86 
(s, 3H), 6.72 (s, 0.30H), 7.09-7.37 (m, 12H), 7.54 (d, J = 8.1 Hz, 1H), 7.92 (d, J = 8.1 Hz, 
1H).  Compound 26-d obtained from the reaction conducted in the presence of 10 equiv of 
D2O: 1H NMR (CDCl3) δ 3.86 (s, 3H), 6.72 (s, 0.13H), 7.37-7.37 (m, 12H), 7.54 (d, J = 8.1 
Hz, 1H), 7.92 (d, J = 8.1 Hz, 1H).    
(E)-Ethyl 4-[2-(3-methoxydibenzofuran-1-yl)but-1-enyl]benzoate (27a). 
  
1H NMR (CDCl3) δ 1.09 (t, J = 7.4 Hz, 3H), 1.43 (t, J = 7.1 Hz, 3H), 2.86 (q, J = 7.4 Hz, 
2H), 3.93 (s, 3H), 4.42 (q, J = 7.1 Hz, 2H), 6.72 (s, 1H), 6.83 (d, J =  2.2 Hz, 1H), 7.06 (d, J 
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=  2.1 Hz, 1H), 7.22 (t, J = 7.7 Hz, 1H), 7.33-7.55 (m, 4 H), 7.87 (d, J =  7.7 Hz, 1H), 8.12 (d, 
J = 8.3 Hz, 2H); 13C NMR (CDCl3) 13.2, 14.6, 25.7, 56.0, 61.2, 95.4, 111.0, 111.6, 115.3, 
121.7, 122.8, 124.4, 125.8, 128.8, 128.8, 129.1, 129.9, 140.0, 142.2, 145.0, 156.7, 158.0, 
159.7, 166.7; IR (CDCl3) 2969, 2935, 2873, 1716 cm-1; HRMS m/z 400.1679 (calcd for 
C26H24O4, 400.1675). 
(E)-3-Methoxy-1-[1-(2-methoxybenzylidene)propyl]dibenzofuran (28a). 
  
1H NMR (CDCl3) δ 1.01 (t, J = 7.6 Hz, 3H), 2.77 (q, J = 7.5 Hz, 2H), 3.84 (s, 3H), 3.93 (s, 
3H), 6.79 (s, 1H), 6.87 (d, J = 2.2 Hz, 1H), 6.95 (d, J = 8.2 Hz, 1H), 7.03-7.08 (m, 2H), 7.19-
7.25 (m, 1H), 7.30-7.38 (m, 2H), 7.47-7.54 (m, 2H), 8.14 (d, J =  7.2 Hz, 1H); 13C NMR 
(CDCl3) 13.3, 25.8, 55.5, 56.0, 95.0, 110.8, 110.9, 111.3, 115.7, 120.5, 122.4, 122.6, 124.7, 
125.6, 126.8, 128.6, 130.0, 140.5, 142.3, 156.6, 157.7, 157.9, 159.6; IR (CDCl3) 2962, 2933, 
2834, 1627 cm-1; HRMS m/z 358.1573 (calcd for C24H22O3, 358.1569). 
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CHAPTER 3.  AN ARYL TO IMIDOYL PALLADIUM MIGRATION PROCESS 
INVOLVING INTRAMOLECULAR C-H ACTIVATION 
 
Based on a full paper submitted to the Journal of American Chemical Society 
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larock@iastate.edu 
 
Abstract. Biologically-interesting fluoren-9-one and xanthen-9-one derivatives have been 
prepared by a novel aryl to imidoyl palladium migration, followed by intramolecular 
arylation.  The fluoren-9-one synthesis appears to involve both a palladium migration 
mechanism and a C-H activation process proceeding through an unprecedented 
organopalladium(IV) hydride intermediate. The results from deuterium labeling experiments 
are consistent with the proposed duel mechanism. 
 
Introduction 
Transitional-metal catalyzed reactions are widely used in organic synthesis.  Recently, the 
through-space shift of a metal has been disclosed for both palladium- and rhodium-catalyzed 
reactions.1  It appears that palladium migration is a fairly general rearrangement that has been 
observed to occur in a wide variety of systems.  The through-space shift of palladium 
generally involves an intramolecular C-H activation process.2 Specifically, vinylic to aryl,3 
aryl to aryl,4 alkyl to aryl,5 vinylic to aryl to allylic,6 and aryl to benzyl7 palladium migration 
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processes have been reported.  Palladium migration is synthetically useful, because it affords 
an alternative way to introduce a palladium moiety into a specific position of an organic 
molecule, which may not be readily accessible by conventional methods.  Indeed, palladium 
migration chemistry has been utilized to prepare a number of structurally diverse fused 
polycycles.3-5 
In the reported palladium migration processes, a 5- or 6-membered palladacycle 
intermediate is generally involved, as shown in Scheme 1.  Although the mechanism of 
palladium migration is still under investigation, the evidence obtained from our previous 
work on the vinylic to aryl to allylic palladium migration appears to favor a mechanism 
which involves a palladacycle(IV) hydride i or a palladacycle(II) intermediate ii, which also 
successfully explains the H-D exchange observed.6  A recent theoretical study suggests a one-
step proton transfer mechanism for a related palladium migration process in which an 
energetically favored transition state iii is presumably involved.3d  However, this mechanism 
fails to account for the hydrogen-deuterium exchange observed in many of our migration 
processes, when such processes are run in the presence of D2O.   
Scheme 1.  
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We recently briefly communicated the synthesis of fluoren-9-ones by an aryl to imidoyl 
palladium migration process (Scheme 2).8  Herein, we wish to report a full account of this 
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novel palladium migration process, which affords a fairly general and efficient synthesis of 
biologically-interesting fluoren-9-ones and xanthen-9-ones, plus we also wish to provide 
evidence with regard to the reaction mechanism, which appears to involve both the usual 
palladium migration mechanism and an unprecedented mechanism proceeding through an 
organopalladium(IV) hydride intermediate.   To the best of our knowledge, although imines 
have been widely employed in Pd-mediated reactions, especially chelation-assisted reactions, 
the direct activation of imidoyl C-H bonds by catalytic palladium is unknown.  In the past, 
imidoyl palladium complexes have generally been obtained by the oxidative addition of 
imidoyl halides to Pd(0) species.9   
Scheme 2  
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Results and Discussion 
 Synthesis of Fluoren-9-ones via Aryl to Imidoyl Palladium Migration.   Fluoren-9-
ones are the core structures of many biologically-interesting and pharmaceutically-important 
compounds.10  The most useful syntheses of fluoren-9-ones include Friedel-Crafts ring 
closures of biarylcarboxylic acids,11 intramolecular [4 + 2] cycloaddition reactions of 
conjugated enynes,12  the oxidation of fluorenes,13 the remote metalation of 2-
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biphenylcarboxamides or 2-biphenyloxazolines,14 and the palladium-catalyzed 
cyclocarbonylation of o-halobiaryls.15  Those methods generally suffer from the use of strong 
acids, strong bases, toxic CO gas or harsh reaction conditions.   
Our previous work indicated that the aryl-3,4 or alkylpalladium5 intermediates generated by 
palladium migration processes can be readily trapped by intramolecular arylation to afford a 
variety of polycyclic structures.  Therefore, we envisioned that an imidoyl palladium 
intermediate generated from an aryl to imidoyl palladium migration process might also 
undergo facile intramolecular arylation to afford biologically-interesting fluoren-9-one 
derivatives.  To examine this possibility, we first treated imine 1a (0.25 mmol) with 5 mol % 
Pd(OAc)2, 5 mol % bis(diphenylphosphino)methane (dppm), and 2 equivs of CsO2CCMe3 
(CsPiv) in DMF (4 mL) at 100 oC (Table 1, entry 1).  After 12 h reaction, the crude imine 
product obtained was hydrolyzed by aqueous HCl in acetone to afford a 95% yield of the 
desired fluoren-9-one 2a after flash chromatography.  It appears that the “optimal” palladium 
migration conditions, which have been successfully employed in a number of previously 
reported palladium migration reactions, work well in this fluoren-9-one synthesis.  
We next investigated the scope and limitations of this process, as shown in Table 1.  The 
effect of substituents on the arene which would bear the imidoyl palladium moiety was first 
examined.   A 5- methoxy-substituted imine 1b was prepared and allowed to react in the 
usual fashion, and a 90% yield of the fluoren-9-one 2b was obtained (entry 2).  However, 
imine 1c bearing a methyl group on the 4 position of the arene, only affords a 56% yield of 
the desired product 2c (entry 3).  In this case, the electron density on the imidoyl group is 
presumably increased by the para methyl group, which apparently retards imidoyl C-H 
activation.  The 5-fluoro-substituted imine 1d affords an 80% yield of the fluoren-9-one  
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Table 1. Synthesis of Fluoren-9-onesa 
entry imine  time (h) product(s)  % yield 
 
N123
4
5
6
I
X
 
  
O
X
 
  
1 X =  H 1a 12  2a 95 
2 5-OMe 1b 12  2b 90 
3 4-Me 1c 24  2c 56 
4 5-F        1d 12  2d 80 
 
N
1
2
3
4
5
6 I
Y
 
 
 
O
Y
 
 
 
5 Y =  4-Me 1e 4  2e 97 
6 4-OMe 1f 2  2b 100 
7 4-CO2Me 1g 12  2f 100 
8 4-NO2 1h 12  2g 100 
9 2-Cl 1i 48  2h 65 
10 
N
I
FF
 
1j 6 
O F
F 
2i 95 
11 
N
I
MeMe  
1k 24 
O Me
Me 
2j 92 
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Table 1. (Continued) 
entry imine  time (h) product(s)  % yield 
12 
N
I
 
1l 4 
O
     
 
O
    
2k 
 
 
2l 
91 (9:1)b 
13 
N
I
O
 
1m 2 
NPh
O
 
2m 82c 
aThe reaction was carried out employing 0.25 mmol of the imine, 5 mol % Pd(OAc)2, 5 
mol % (Ph2P)2CH2 (dppm) and 2 equivs of CsO2CCMe3 (CsPiv) in DMF (4 mL) at 100 
oC unless otherwise noted.  bThe ratio of products 2k:2l was determined by GC analysis.  
cThe reaction was run at 110 oC.  dCompound 2m is not stable under our usual hydrolysis 
conditions; omitting the hydrolysis step, the imine intermediate 2m was isolated in an 
82% yield. 
product 2d (entry 4).     
We then investigated the effect of substituents on the arene, which undergoes the 
cyclization reaction.  Surprisingly, almost quantitative yields of fluoren-9-ones have been 
obtained for both electron-rich and electron-poor functionally-substituted substrates, which 
raises some question as to whether the intramolecular arylation step proceeds via 
electrophilic aromatic substitution as usually assumed (entries 5-8).   These results also 
suggest that the palladium migration could be the rate-determining step in this overall 
transformation.  The only exception to the high yields was the reaction employing the 
substrate 1i with a 2-chloro group, where only a 65% yield of the fluoren-9-one 2j was 
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obtained, possibly due to competing oxidative addition of the aryl chloride or perhaps 
hindered reaction of the aromatic ring or simply reduction in the number of ortho positions 
available for reaction (entry 9).  Imines 1j and 1k afforded 95% and 92% yields of the 
expected fluoren-9-ones, respectively (entries 10 and 11).  Once again neither electron-
donating nor electron-withdrawing groups on the ring undergoing substitution seem to have a 
significant effect on the yield.  When the naphthalene substrate 1l was prepared and allowed 
to react under our usual reaction conditions, arylation took place in both the 3 and 1 positions 
of the naphthalene in a 91% overall yield, with the less hindered product 2k predominant 
(9:1) (entry 12).  The furan- containing ring present in imine 1m facilitates electrophilic 
aromatic substitution and within 2 h the reaction was complete (entry 13).  However, because 
the resulting 8H-indeno[2,1-b]furan-6-one was not stable under our hydrolysis conditions, we 
were only able to isolate a 50% yield of the ketone.  Omitting the hydrolysis step, the 
corresponding imine 2m was obtained in an 82% yield.   
Mechanistic Studies of the Fluoren-9-one Synthesis.  After we investigated the reaction 
scope and limitations, we examined the reaction mechanism of this fascinating process.  In 
fact, it appears that this reaction proceeds through a rather unusual mechanism.  Presumably, 
Pd(0) first undergoes oxidative addition to the aryl iodide 1a to generate intermediate A.  The 
palladium moiety may then undergo further oxidative addition of the imidoyl C-H bond to 
afford a palladacycle(IV) intermediate B, which can undergo reductive elimination to form 
palladacycle(II) C or the imidoyl palladium intermediate D.  Alternatively, palladacycle(II) C 
may be directly generated from A or it may be formed through the intermediacy of B, where 
an equilibrium between B and C may be involved.  A similar equilibrium has been 
demonstrated in a previously reported example of a consecutive vinylic to aryl to allylic  
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Scheme 3. Plausible Palladium Migration Mechanism (Route A).  
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palladium migration.6  Intermediate C can also lead to intermediate D, which then undergoes 
intramolecular arylation to afford the cyclization product E, and the imine product after 
reductive elimination.   According to this proposed mechanism, the imidoyl hydrogen (Ha) 
shifts to the ortho position of the aniline, when the palladium moiety migrates from the aryl 
position to the imidoyl position.  By observing the movement of Ha, we should be able to 
detect the through-space shift of the palladium moiety.  This proton shift should be readily 
determined by an appropriate isotope labeling experiment (Scheme 4).  Indeed, deuterium-
substituted imine 1n was allowed to react under our “optimal” reaction conditions, and the 
aniline (3) obtained upon hydrolysis of the resulting imine was isolated (eq. 1).  Thirty five 
percent deuterium incorporation was observed in one of the two ortho positions of the aniline 
as determined by 1H NMR spectroscopy and GC-MS analysis.  This reaction was repeated in 
the presence of 10 equiv of D2O hoping that higher deuteriumincorporation could be 
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Scheme 4. Deuterium Labeling Experiments. 
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observed in the aniline (3).  However, only slightly higher 45% deuterium incorporation was 
observed, which is apparently inconsistent with the proposed mechanism (route A).  If the 
aryl to imidoyl palladium migration is a reversible process as observed with the analogous 
aryl to aryl palladium migrations,4,16 we should be able to observe deuterium incorporation in 
both of the ortho positions when the reaction is conducted in the presence of a deuterium 
source.  However, incorporation of only one deuterium was observed.   
We have also attempted to trap the aryl and imidoyl palladium intermediates by a Heck 
reaction (Scheme 5) as we did in our aryl to aryl palladium migration chemistry.4,16  
Analogous Heck reactions of acylpalladium intermediates are well known.17  However, after 
a 24 h reaction, only ester 6 was observed by GC-MS analysis, and ester 7, which presumably 
should be generated from the Heck reaction of the postulated imidoyl palladium intermediate 
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was not evident.   These results indicate that the aryl to imidoyl palladium migration process 
is probably not a reversible process in the absence of intramolecular arylation as a driving 
force.  Indeed, the whole process appears to be rather unusual compared with previously 
reported examples of palladium migration.  Although H-D exchange occurs during the course 
of the palladium migration, this leads to low deuterium incorporation.  It is difficult to 
attribute all of the deuterium loss to H-D exchange, since the yield of deuterated product was 
only slightly improved when the reaction was conducted in the presence of an additional 
deuterium source.   
Scheme 5 
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An alternative pathway for generation of the fluoren-9-one product without invoking an 
imidoyl hydrogen shift is proposed in Scheme 6.  In this mechanism, the arylpalladium 
intermediate A undergoes intramolecular C-H activation to afford palladacycle(IV) B; 
subsequent reductive elimination could generate palladacycle(II) C.  It is also possible that 
palladacycle(II) C could be generated directly from arylpalladium intermediate A.  At this 
point, the palladium moiety might insert into the C-H bond of the neighboring arene to afford 
an unprecedented palladacycle(IV) intermediate F.  Such a palladacycle might be expected to 
undergo reductive elimination to afford palladacycle E, which after a second reductive  
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Scheme 6. Plausible C-H Activation Mechanism (Route B). 
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elimination would generate the expected imine product.  In this mechanism, Ha is lost to the 
solution when forming intermediate C, but Hb shifts from the biphenyl moiety to one of the 
two ortho positions of the aniline.  Deuterium labeled substrate 1o (Scheme 4, eq. 2) was 
prepared and allowed to react under the standard reaction conditions.  If this mechanism is in 
force, we expect to see some deuterium at one of the two ortho positions of the resulting 
aniline if the reaction goes through route B.  Indeed, we observed 35% deuterium 
incorporation in one of the two ortho positions of the resulting aniline.  At this point, we 
reasoned that this fluoren-9-one synthesis actually goes through a duel mechanism, a 
palladium migration mechanism (Scheme 3, route A) and an unprecedented intramolecular 
C-H activation mechanism (Scheme 6, route B).  Based on this assumption, one would expect 
that higher deuterium incorporation would be obtained if both Ha and Hb are labeled with 
deuterium.  Indeed, when substrate 1p (Scheme 4, eq. 3) was employed in this reaction, 75% 
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deuterium incorporation in the aniline ring was observed, which is consistent with our 
hypothesis.   
The final intramolecular arylation step of route A (Scheme 3) would release one equivalent 
of HX or DX into solution, which might add to palladacycle(II) C to afford a new 
palladacycle(IV) intermediate G.  Subsequent reductive elimination could afford the ortho 
deuterated aniline product (Scheme 7).  This can also explain the deuterium incorporation 
into the aniline observed in the experiment described in Scheme 4, eq. 2.  However, if one 
equiv of DX can afford as much as 35% deuterium incorporation, even when the 
concentration of DX is quite low because it is gradually released into the solution, the 
analogous reaction run in the presence of 10 equiv of D2O should afford very high deuterium 
incorporation, at least comparable to the results obtained from the experiments described in 
Scheme 4, eq. 3 in which two equiv of DX are released.  However, we did not observe a 
significant increase in deuterium incorporation when 10 equiv of D2O was present; only 45% 
deuterium incorporation was observed.  Remember that these migration reactions have been 
conducted in the presence of 2 equiv of CsPiv  
Scheme 7       
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base, which should quickly neutralize the DX acid generated by the final arylation step.  
Thus, this pathway for the introduction of deuterium into the aniline in the reaction reported 
in Scheme 3, eq. 2, is highly unlikely.   
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It has been shown previously that palladium can migrate more than once in these migration 
reactions.4,6  Thus, an interesting question is whether the imidoyl palladium intermediate can 
migrate the palladium to a second aryl position.  As shown in Scheme 8, imine 1q was 
prepared and allowed to react under our usual reaction conditions, but this reaction failed to 
afford any of the desired product.  By heating the reaction to 120 oC, after 7 days, we were 
able to obtain a 35% yield of the desired 1-aminodibenzo[b,d]furan (2o).8  In this case, 
palladium must have migrated from the aryl to the imidoyl position  
Scheme 8 
O
N
I
Ph
PhO
N
PdI
Ph
PhO
N
Ph
PdI
PhO
N
Ph
IPd
5% Pd(OAc)2
5% dppm
2 CsPiv, DMF 
120 oC, 7 d
HCl
35%1q 2o
O
H2N
O
N
Ph
 
solely through the migration mechanism shown in Scheme 3.  According to our study of the 
vinylic to aryl palladium migration chemistry,3a the palladium moiety tends to migrate to the 
more electron-rich arene during the course of the migration.  The palladium migration from 
the phenoxy-substituted arene to the imidoyl position is probably not a very favorable 
process, but palladium migration from the imidoyl position back to the aryl position of this 
arene, which is ortho to the phenoxy group is quite possibly a favorable process.   
Activation of the imidoyl C-H bond in this fluoren-9-one synthesis proceeds through a 5-
membered ring intermediate.  One might wonder whether palladium can activate an imidoyl 
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C-H bond by a 6-membered ring intermediate.  Indeed, substrate 1r has been prepared and 
allowed to react under our usual reaction conditions.  After 24 h of reaction at 100 oC, only a 
40% yield of the desired fluoren-9-one product was obtained (Scheme 9).  Although it 
appears that 6-membered ring activation is feasible, the reaction efficiency is not high.  
Scheme 9   
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Synthesis of Xanthones via Aryl to Imidoyl Palladium Migration.  After developing a 
general and efficient synthesis of fluoren-9-one derivatives, we attempted to extend this 
protocol to the synthesis of 6-membered ring heterocycles, such as xanthones, thioxanthones 
and acridones.  Xanthones are secondary metabolites found in higher plant families, fungi and 
lichens exhibiting interesting pharmaceutical properties.18  Most common syntheses of the 
xanthone skeleton typically involve a multi-step procedure, which generally proceeds through 
the intermediacy of a benzophenone or a diaryl ether.19 Recently, we reported a one-step 
synthesis of xanthones by a tandem coupling-cyclization of 2-hydroxybenzoates and arynes.20   
In our fluoren-9-one synthesis, palladium migrates from an aryl position to an imidoyl 
position and then undergoes intramolecular arylation through a 6-membered ring 
intermediate.  We envisioned that an imidoylpalladium intermediate might also undergo 
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intramolecular arylation by a 7-membered ring intermediate to afford 6-membered ring 
heterocycles, as shown in Scheme 10.  Indeed, imine 4a was allowed to react under our 
“optimal” conditions and a 72% yield of the xanthone product 5a was obtained by flash 
chromatography.   
The reaction scope and limitations of this new xanthone synthesis are shown in Table 2.  
We first investigated the effect of the substituent on the arene bearing the imine group.  
Methyl-substituted substrate 4b affords an 80% yield of the xanthone 5b (entry 2), and 
methoxy-substituted imine 4c affords a 77% yield of product 5c (entry 3).  Imines bearing an 
electron-withdrawing group have also been prepared and subjected to the usual reaction 
conditions.  The imines 4d and 4e substituted with NO2 and CF3 groups afforded 56% and 
38% yields of the xanthone products 5d and 5e, respectively (entries 4 and 5).  Note that a 
higher temperature is required here.  Substrates bearing a functional group Y on the arene 
Scheme 10.  Plausible Mechanism for the Synthesis of Xanthones.  
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which undergoes substitution have also been prepared.  The methoxy-, chloro-, alkyl-, and 
aryl-substituted imines 4f-j have been allowed to react under our usual reaction conditions, 
and 56-77% yields of the substituted xanthones 5f-j have been obtained (entries 6-10).  
However, the reaction was very sluggish when imine 4k bearing an electron-withdrawing  
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Table 2. Synthesis of Xanthonesa 
entry imine  temp (oC) product  
% 
yield 
 
N
O
1
2
3
4
5
6
X
I
Y
 
 
 
O
O
X
Y
 
  
 X Y 
 
  
 
 
1 H                        H 4a 100  5a 72 
2 5-Me H 4b 100  5b 80 
3 5-OMe  H 4c 100  5c 77 
4 5-CF3         H 4d 120  5d 56 
5 5-NO2  H 4e 120  5e 38 
6 H  OMe 4f 100  5c 77 
7 H Cl 4g 100  5f 73 
8 H i-Pr 4h 100  5g 56 
9 H Ph 4i 100  5h 63 
10 H t-Bu 4j 100  5i 61 
11 H CO2Me 4k 120  5j 10 
12 
N
Me
OMe
O
I
 
4l 100 
O
Me
OMe
O
 
5k 79 
13 N
S
I
 
4m 120 
O
S
 
5l 0b 
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Table 2. (Continued) 
entry imine  temp (oC) product  
% 
yield 
14 
N
N
Me
I
 
4n 100 
O
N
Me
 
5m 20 
aThe reaction was carried out employing 0.25 mmol of the imine, 5 mol % Pd(OAc)2, 5 
mol % (Ph2P)2CH2 (dppm) and 2 equivs of CsO2CCMe3 (CsPiv) in DMF (4 mL) under 
Ar for 24 h.  bStarting materials were recovered. 
ester group was allowed to react.  After 1 d of reaction at 120 oC, only about 10% of the 
desired product was observed by GC-MS analysis (entry 11).  This intramolecular arylation 
presumably proceeds via an electrophilic aromatic substitution,21 although some evidence 
points towards a proton transfer mechanism.22  Thus, an electron-withdrawing substituent 
might be expected to disfavor the cyclization step, especially for this cyclization proceeding 
by a difficult 7-membered ring intermediate I.  Note, however, that cyclization to form a 
fluoren-9-one was not impeded by the presence of strong electron-withdrawing groups (see 
Table 1, entries 7 and 8).  Introducing a methoxy group ortho to the oxygen atom of the 
phenoxy group could facilitate electrophilic aromatic substitution, but might introduce some 
steric hindrance at the same time, as well as reducing statistically the number of positions 
available for cyclization.    In fact, the reaction of imine 4l affords a 79% yield of the 
xanthone product, which indicates that electronic factors apparently predominate (entry 12).  
We have also attempted to extend this protocol to the synthesis of thioxanthones, an 
important class of potential anti-cancer drugs.23   When imine 4m was treated under the 
reaction conditions used in our xanthone synthesis, we did not observe any cyclization 
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product, and we recovered most of the starting material (entry 13).  Repeating this reaction at 
120 oC afforded similar results.  The presence of the larger sulfur atom apparently disfavors 
cyclization through the now larger 7-membered ring intermediate or perhaps the sulfur 
chelates the intermediate imidoyl palladium species preventing cyclization.   
Acridones are also naturally-occurring compounds exhibiting a variety of interesting 
biological activities.  They are important anti-leishmanial, anti-fungal, anti-tumor and DNA-
intercalating anti-cancer drugs.24  We prepared imine 4n from the corresponding aldehyde 
and treated it under our standard palladium migration conditions.  After 1 d of reaction at 100 
oC, a 20% yield of the acridone 5m was obtained (entry 14).  We have also conducted this 
reaction at 120 oC, but failed to observe any improvement in the reaction efficiency. 
Conclusions 
In summary, we have established a novel 1,4-Pd migration from an aryl position to an 
imidoyl position, which affords a general synthesis of the biologically-interesting fluoren-9-
one and xanth-9-one ring systems.  Both electron-rich and electron-poor substrates have been 
screened in this process, and generally good yields of the desired product have been obtained.  
The fluoren-9-one synthesis appears to involve both a standard palladium migration 
mechanism (route A) and a C-H activation mechanism (route B), which proceeds through an 
unprecedented organopalladium(IV) hydride intermediate.  The results from the deuterium 
labeling experiments are consistent with the proposed duel mechanism.  
Experimental Section 
I. General Procedures.   
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All 1H and 13C spectra were collected in CDCl3 unless noted otherwise.  Thin layer 
chromatography was performed using 60-mesh silica gel plates, and visualization was 
affected using short wavelength UV light (254 nm) and a basic KMnO4 solution.  All high 
resolution mass spectra were recorded using EI. 
 All reagents were used directly as obtained commercially unless otherwise noted.  Cesium 
pivalate was prepared according to the procedure of Campo and Larock.25  
II. Noncommercial compounds.  
General procedure for synthesis of the biarylcarboxaldehydes.  To 10 mL of a 2:1 
DMF/H2O solution containing 5.0 mmol of 2-bromobenzaldehyde and 5.0 mmol of Na2CO3 
were added 5.0 mmol of arylboronic acid and the reaction mixture was stirred for 2 min.  
Pd(OAc)2 (5 mol %) was then added and the flask was flushed with Ar, sealed and allowed to 
stir at 25 oC for 12 h.  The reaction mixture was extracted with ethyl ether (2 x 10 mL).  The 
combined ether layers were dried over anhydrous Na2SO4 and concentrated under vacuum to 
yield the crude product, which was purified by flash chromatography on silica gel using ethyl 
acetate/hexanes as eluent. 
4-Methoxybiphenyl-2-carboxaldehyde. 
1H NMR (CDCl3) δ 3.90 (s, 3H), 7.20 (dd, J = 8.5, 2.8 Hz, 1H), 7.34-7.47 (m, 6H), 7.51 (d, 
J = 2.84 Hz, 1H), 9.95 (s, 1H); 13C NMR (CDCl3) δ 55.8, 110.1, 121.6, 128.0, 128.6, 130.5, 
132.3, 134.7, 137.7, 139.3, 159.3, 192.5; IR (CDCl3) 3028, 2936, 2850, 1686 cm-1;   HRMS 
m/z 212.0841 (calcd for C14H12O2, 212.0837). 
5-Methylbiphenyl-2-carboxaldehyde. 
1H NMR (CDCl3) δ 2.44 (s, 3H), 7.24 (s, 1H), 7.28 (d, J = 8.0 Hz, 1H), 7.35 (d, J = 7.3 Hz, 
1H), 7.41-7.47 (m, 3H), 7.95 (d, J = 8.0 Hz, 1H), 9.94 (s, 1H); 13C NMR (CDCl3) δ 22.1, 
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127.9, 128.3, 128.6, 128.9, 130.3, 131.6, 131.7, 138.1, 144.8, 146.4, 192.3; IR (CDCl3) 3027, 
2848, 1690 cm-1; HRMS m/z 196.0891 (calcd for C14H12O, 196.0888).    
4-Fluorobiphenyl-2-carboxaldehyde. 
Due to C-F coupling, the 13C NMR showed more peaks than carbon numbers. 1H NMR 
(CDCl3) δ 7.30-7.35 (m, 3H), 7.41-7.49 (m, 4H), 7.67 (dd, J = 8.9, 2.84 Hz, 1H), 9.90 (s, 
1H); 13C NMR (CDCl3) δ 113.7, 113.9, 115.6, 120.9, 121.1, 128.5, 128.8, 130.4, 133.0, 
135.4, 136.9, 142.3, 142.3, 161.1, 163.6, 191.3; IR (CDCl3) 3066, 2855, 1691 cm-1; HRMS 
m/z 200.0639 (calcd for C13H9FO, 200.0637).    
4'-Methylbiphenyl-2-carboxaldehyde.   
1H NMR (CDCl3) δ 2.42 (s, 3H), 7.24-7.29 (m, 4H), 7.42 (d, J = 8.0 Hz, 1H), 7.47 (d, J = 
7.6 Hz, 1H), 7.61 (td, J = 7.6, 1.2 Hz, 1H), 8.01 (dd, J = 8.0, 1.2 Hz, 1H), 9.99 (s, 1H); 13C 
NMR (CDCl3) δ 21.3, 127.7, 129.3, 130.2, 130.9, 133.7, 133.9, 134.9, 138.2, 146.1, 192.7 ; 
HRMS m/z 196.0891 (calcd for C14H12O, 196.0888).  
4’-Methoxybiphenyl-2-carboxaldehyde.   
1H NMR (CDCl3) δ 3.87 (s, 1H), 7.00 (d, J = 8.7 Hz, 2H), 7.30 (d, J = 8.7 Hz, 2H), 7.41-
7.48 (m, 2H), 7.61 (td, J = 7.5, 1.2 Hz, 1H), 8.00 (dd, J = 7.5, 1.2 Hz, 1H), 9.99 (s, 1H); 13C 
NMR (CDCl3) δ 55.6, 114.1, 127.5, 127.8, 130.2, 131.0, 131.5, 133.7, 133.9, 145.8, 159.9, 
192.8; HRMS m/z 212.0839 (calcd for C14H12O2, 212.0837). 
Methyl 2’-formylbiphenyl-4-carboxylate.   
1H NMR (CDCl3) δ 3.97 (s, 3H), 7.43-7.48 (m, 3H), 7.54 (t, J = 9.0 Hz, 1H), 7.70 (td, J = 
7.5, 1.5 Hz, 1H), 8.05 (dd, J = 7.8, 1.5 Hz, 1H), 8.13-8.17 (m, 2H), 9.96 (s, 1H); 13C NMR 
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(CDCl3) δ 52.5, 128.1, 128.6, 129.8, 130.1, 130.3, 130.8, 133.8, 133.9, 142.6, 144.8, 166.8, 
191.9; HRMS m/z 240.0789 (calcd for C15H12O3, 240.0786). 
4’-Nitrobiphenyl-2-carboxaldehyde.   
1H NMR (CDCl3) δ 7.44 (dd, J = 7.6, 1.2 Hz, 1H), 7.55-7.63 (m, 3H), 7.71 (td, J = 7.6, 1.6 
Hz, 1H), 8.06 (dd, J = 8.0, 1.2 Hz, 1H), 8.34 (d, J = 6.8 Hz, 2H); 9.97 (s, 1H); 13C NMR 
(CDCl3) δ 123.8, 129.1, 129.3, 130.8, 131.0, 133.8, 134.1, 143.2, 145.0, 147.9, 191.3; HRMS 
m/z 227.0592 (calcd for C13H9NO3, 227.0582). 
2’-Chlorobiphenyl-2-carboxaldehyde.   
1H NMR (CDCl3) δ 7.31-7.39 (m, 4H), 7.48-7.54 (m, 2H), 7.66 (td, J = 7.5, 1.5 Hz, 1H), 
8.04 (dd, J = 7.5, 1.5 Hz, 1H), 9.80 (s, 1H); 13C NMR (CDCl3) δ 127.0, 127.6, 128.7, 129.8, 
129.9, 131.1, 131.9, 133.7, 133.9, 134.0, 137.0, 142.9, 191.7; HRMS m/z 216.0348 (calcd for 
C13H9ClO, 216.0345). 
3’,5’-Difluorobiphenyl-2-carboxaldehyde.   
1H NMR (CDCl3) δ 6.78-6.81 (m, 3H), 7.29 (d, J = 7.8 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 
7.55 (td, J = 7.5, 1.5 Hz, 1H), 7.91 (dd, J = 7.8, 1.5 Hz, 1H), 9.87 (s, 1H); 13C NMR (CDCl3) 
δ 103.7 (t), 113.3 (q), 128.3, 128.9 (t), 130.5, 133.7 (t), 141.3 (m), 143.3 (t), 161.2 (d), 164.5 
(d), 191.4; HRMS m/z 218.0547 (calcd for C13H8F2O, 218.0543). 
3’,5’-Dimethylbiphenyl-2-carboxaldehyde.   
The spectral properties were identical to those previously reported.26 
2-(Furan-3-yl)benzaldehyde.   
1H NMR (CDCl3) δ 6.57 (s, 1H), 7.41-7.46 (m, 2H), 7.52-7.62 (m, 3H), 7.97 (dd, J = 7.8, 
1.2 Hz, 1H), 10.21 (s, 1H); 13C NMR (CDCl3) δ 112.3, 112.6, 122.6, 127.8, 127.9, 130.6, 
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133.9, 134.0, 136.4, 141.4, 143.6, 192.2; HRMS m/z 172.0528 (calcd for C11H8O2, 
172.0524). 
5-Phenoxy-2-iodoaniline.   
3-Phenoxyaniline (7.8 mmol) was added to a mixture of I2 (7.9 mmol) and AgOAc (7.9 
mmol) in ethanol (50 mL) at room temperature.  The mixture was stirred for 14 h after which 
the solid was removed by filtration and the filtrate was evaporated under vacuum to afford a 
black residue, which was dissolved in ethyl ether and washed with satd aq Na2S2O3 and 
water.  The organic layer was dried over anhydrous Na2SO4 and the solvent was removed 
under reduced pressure.  The residue was purified by flash chromatography on silica gel 
using ethyl acetate/hexanes as the eluent.  The compound was obtained as a yellow oil:  1H 
NMR (CDCl3) δ 4.07 (s, 2H), 6.17 (dd, J = 8.7, 3.0 Hz, 1H), 6.37 (d, J = 3.0 Hz, 1H), 6.98-
7.01 (m, 2H), 7.10 (tt, J = 7.5, 1.2 Hz, 1H), 7.29-7.34 (m, 2H), 7.51 (d, J = 8.7 Hz, 1H); 13C 
NMR (CDCl3) δ 76.4, 104.9, 110.9, 119.4, 123.8, 129.9, 139.7, 148.1, 156.8, 159.1; HRMS 
m/z 310.9811 (calcd for C12H10INO, 310.9808). 
N-Phenylmethylene-2-iodo-5-phenoxyaniline.   
This compound was prepared following the procedure used for the preparation of the N-
(biaryl-2-ylmethylene)-2-iodoanilines.  The resulting imine was used for the next step 
without further characterization. 
1-Aminodibenzo[b,d]furanamine (2o).   
The spectral properties were identical to those previously reported.27 
4'-Methylbiphenyl-2-carboxaldehyde-d.   
This compound was prepared through the strategy shown below.  1H NMR (CDCl3) δ 2.42 
(s, 3H), 7.24-7.29 (m, 4H), 7.40-7.47 (m, 2H), 7.61 (td, J = 7.6, 1.2 Hz, 1H), 8.02 (dd, J = 
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8.0, 1.2 Hz, 1H);  13C NMR (CDCl3) δ 21.43, 127.77, 127.78, 129.42, 130.28, 131.02, 
133.75, 135.04, 138.23, 146.20, 192.24 (t, J = 27 Hz).  
CO2Me
I
+
Me
B(OH)2
CO2Me
Me
1. LAD
2. PCC
CDO
Me
Pd(0)
 
2-(Phenyl-d5)-benzaldehyde.   
This compound was prepared through the strategy shown below.  1H NMR (CDCl3) δ 7.44-
7.52 (m, 2H), 7.63 (td, J = 7.4 Hz, 1.3 Hz, 1H), 8.04 (dd, J = 7.7 Hz, 1.2 Hz, 1H), 9.99 (d, J = 
0.6 Hz, 1H); 13C NMR (CDCl3) δ 127.80, 128.00, 121.02, 122.80, 137.79, 146.15. 
D
D
D
D
I
D
+
CHO
B(OH)2
Pd(0)
D
D
D
D
D CHO
 
2-(Phenyl-d5)-benzaldehyde-d.   
This compound was prepared through the strategy shown below.  1H NMR (CDCl3) δ 7.44-
7.52 (m, 2H), 7.63 (t, J = 7.4 Hz, 1H), 8.04 (dd, J = 7.7 Hz, 1.2 Hz, 1H).  13C NMR (CDCl3) 
δ 127.79, 128.01, 131.01, 133.84, 137.76, 146.16. 
1. LAD
2. PCC
D
D
D
D
B(OH)2
D
+
CO2Me
I
Pd(0)
D
D
D
D
D
CO2Me
D
D
D
D
D
CDO
 
General procedure for synthesis of the 2-(aryloxy)benzaldehydes.  To 10 mL of a DMA 
solution containing 5.0 mmol of 2-fluorobenzaldehyde and 5.0 mmol of phenol were added 
5.0 mmol of K2CO3 and the reaction mixture was stirred for 2 h at 170 oC under an Ar 
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atmosphere.  The reaction mixture was cooled to room temperature and worked up using the 
procedure described previously.  
2-(Phenoxy)benzaldehyde. 
The spectral properties were identical to those previously reported.28 
5-Methyl-2-(phenoxy)benzaldehyde. 
1H NMR (CDCl3) δ 2.36 (s, 3H), 6.83 (d, J = 8.5 Hz, 1H), 7.02-7.04 (m, 2H), 7.15 (t, J = 
7.4 Hz, 1H), 7.32-7.38 (m, 3H), 7.74 (d, J = 2.0 Hz, 1H), 10.45 (s, 1H); 13C NMR (CDCl3) δ 
20.8, 119.0, 119.3, 124.1, 127.1, 128.5, 130.2, 133.5, 136.8, 157.3, 157.9, 189.7; IR (CDCl3) 
3039, 2857, 1689 cm-1; HRMS m/z 212.0841 (calcd for C14H12O2, 212.0837).  
5-Methoxy-2-(phenoxy)benzaldehyde. 
1H NMR (CDCl3) δ 3.81 (s, 3H), 6.90 (d, J = 9.0 Hz, 1H), 6.96 (d, J = 7.8 Hz, 2H), 7.07-
7.12 (m, 2H), 7.29-7.35 (m, 2H), 7.39 (d, J = 3.2 Hz, 1H), 10.37 (s, 1H); 13C NMR (CDCl3) δ 
56.0, 110.1, 118.2, 121.8, 123.7, 123.9, 128.2, 130.2, 153.6, 156.1, 158.2, 189.2; IR (CDCl3) 
2940, 2858, 1686 cm-1;  HRMS m/z 228.0789 (calcd for C14H12O3, 228.0786).     
5-Trifluoromethyl-2-(phenoxy)benzaldehyde. 
1H NMR (CDCl3) δ 6.93 (d, J = 8.8 Hz, 1H), 7.13 (d, J = 8.2 Hz, 1H), 7.28 (t, J = 7.5 Hz, 
1H), 7.45 (t, J = 8.0 Hz, 1H); 7.68 (dd, J = 8.7, 2.2 Hz, 1H), 8.19 (d, J = 1.8 Hz, 1H), 10.57 
(s, 1H); 13C NMR (CDCl3) δ 117.8, 120.5, 125.8, 126.1, 126.2 (q), 126.3, 130.7, 132.4 (q), 
155.0, 162.8, 188.2; IR (CDCl3) 3068, 2870, 1695 cm-1; HRMS m/z 266.0559 (calcd for 
C14H9F3O2, 266.0555).     
5-Nitro-2-(phenoxy)benzaldehyde. 
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1H NMR (CDCl3) δ 6.90 (d, J = 9.3 Hz, 1H), 7.15-7.17 (m, 2H), 7.29-7.33 (m, 1H), 7.45-
7.49 (m, 2H), 8.23 (dd, J = 9.2, 2.9 Hz, 1H), 8.64 (d, J = 2.9 Hz, 1H), 10.52 (s, 1H); 13C 
NMR (CDCl3) δ 117.1, 121.0, 124.6, 125.6, 126.6, 130.5, 130.9, 142.7, 154.1, 164.8, 187.5; 
IR (CDCl3) 3077, 2878, 1695, 1580 cm-1; HRMS m/z 243.0535 (calcd for C13H9NO2, 243. 
0532).     
2-(4-Methoxyphenoxy)benzaldehyde. 
1H NMR (CDCl3) δ 3.80 (s, 3H), 6.78 (dd, J = 8.4, 0.6 Hz, 1H), 6.90-6.92 (m, 2H), 6.91 
(dd, J = 6.8, 2.5 Hz, 2H), 7.09 (tt, J = 7.3, 0.9 Hz, 1H), 7.42-7.46 (m, 1H), 7.89 (dd, J = 7.7, 
1.8 Hz, 1H), 10.55 (d, J = 0.8 Hz, 1H); 13C NMR (CDCl3) δ 55.9, 115.4, 117.2, 121.4, 122.7, 
126.3, 128.5, 136.0, 149.3, 156.8, 161.3, 189.7; IR (CDCl3) 2953, 2836, 1689 cm-1; HRMS 
m/z 228.0789 (calcd for C14H12NO3, 228.0786).  
2-(4-chlorophenoxy)benzaldehyde. 
1H NMR (CDCl3) δ 6.88 (d, J = 8.4 Hz, 1H), 6.98-7.01 (m, 2H), 7.19 (t, J = 7.6 Hz, 1H), 
7.32-7.35 (m, 2H), 7.50-7.55 (m, 1H), 7.92 (dd, J = 7.8, 1.7 Hz, 1H), 10.47 (s, 1H); 13C NMR 
(CDCl3) δ 118.7, 120.8, 124.0, 127.2, 128.9, 129.7, 130.2, 136.1, 155.3, 159.7, 189.2; IR 
(CDCl3) 3073, 2856, 1691 cm-1; HRMS m/z 232.0294 (calcd for C13H9ClO2, 232.0291). 
2-(4-i-Propylphenoxy)benzaldehyde. 
1H NMR (CDCl3) δ 1.27 (d, J = 7.0 Hz, 6H), 2.88-2.99 (m, 1H), 6.88 (d, J = 8.3 Hz, 1H), 
6.99-7.02 (m, 2H), 7.14 (t, J = 7.5 Hz, 1H), 7.24 (d, J = 8.6 Hz, 2H), 7.46-7.50 (m, 1H), 7.93 
(dd, J = 7.8, 1.8 Hz, 1H), 10.54 (s, 1H); 13C NMR (CDCl3) δ 24.4, 33.8, 118.3, 119.7, 123.2, 
126.9, 128.2, 128.5, 135.9, 145.3, 154.3, 160.7, 189.6; IR (CDCl3) 2960, 2869, 1690 cm-1; 
HRMS m/z 238.0997 (calcd for C16H14O2, 238.0994).  
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2-(4-Phenylphenoxy)benzaldehyde. 
1H NMR (CDCl3) δ 7.00 (dd, J = 8.3, 0.6 Hz, 1H), 7.15-7.18 (m, 2H), 7.21-7.25 (m, 1H), 
7.37-7.41 (m, 1H), 7.46-7.50 (m, 2H), 7.53-7.57 (m, 1H), 7.60-7.66 (m, 4H), 7.99-8.02 (m, 
1H), 10.59 (d, J = 0.8 Hz, 1H); 13C NMR (CDCl3) δ 118.9, 119.9, 123.8, 127.2, 127.2, 127.6, 
128.8, 129.0, 129.2, 136.1, 137.7, 140.4, 156.2, 160.1, 189.5; IR (CDCl3) 3046, 3032, 1689 
cm-1; HRMS m/z 274.0999 (calcd for C19H14O2, 274.0994). 
2-(4-t-Butylphenoxy)benzaldehyde. 
1H NMR (CDCl3) δ 1.35 (s, 9H), 6.89-6.91 (m, 1H), 6.98-7.02 (m, 2H), 7.14 (t, J = 7.5 Hz, 
1H), 7.39-7.50 (m, 3H), 7.93 (dd, J = 7.8, 1.7 Hz, 1H), 10.54 (d, J = 0.7 Hz, 1H); 13C NMR 
(CDCl3) δ 31.8, 34.7, 118.4, 119.3, 123.2, 126.9, 127.2, 128.5, 136.0, 147.6, 154.0, 160.6, 
189.6; IR (CDCl3) 3038, 2962, 1868, 1691 cm-1; HRMS m/z 254.1307 (calcd for C17H18O2, 
254.1307). 
Methyl 4-(2-formylphenoxy)benzoate. 
1H NMR (CDCl3) δ 3.84 (s, 3H), 6.94-7.01 (m, 3H), 7.20-7.24 (m, 1H), 7.50-7.55 (m, 1H), 
7.88-8.00 (m, 3H), 10.33 (s, 1H); 13C NMR (CDCl3) δ 52.3, 118.1, 120.2, 124.9, 125.8, 
127.8, 129.0, 132.1, 136.1, 158.4, 161.1, 166.4, 188.8; IR (CDCl3) 3075, 2999, 2856, 1722, 
1691 cm-1; HRMS m/z 256.0740 (calcd for C15H12O4, 256.0736). 
2-(2-Methoxy-4-methylphenoxy)benzaldehyde. 
1H NMR (CDCl3) δ 2.38 (s, 3H), 3.78 (s, 3H), 6.68-6.83 (m, 3H), 6.95 (d, J = 7.9 Hz, 1H), 
7.08 (t, J = 7.7 Hz, 1H), 7.38-7.44 (m, 1H), 7.89 (dd, J = 7.8, 1.8 Hz, 1H), 10.65 (s, 1H); 13C 
NMR (CDCl3) 21.6, 56.1, 114.1, 116.2, 121.8, 122.1, 122.3, 125.7, 128.2, 135.8, 136.3, 
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141.6, 151.5, 161.4, 189.9; IR (CDCl3) 2937, 2857, 1691 cm-1; HRMS m/z 242.0946 (calcd 
for C15H14O3, 242.0943). 
2-(Phenylsulfanyl)benzaldehyde. 
This compound was prepared using a literature procedure.29   
2-(Methylphenylamino)benzaldehyde.  
This compound was prepared using a literature procedure.30  
III. Experimental Procedures.                                             
General procedure for synthesis of the biaryl-2-ylmethyleneanilines.  To a solution of 
biarylcarboxaldehyde (0.25 mmol) and 2-iodoaniline (0.25 mmol) in toluene (3 mL) under N2 
was added anhydrous MgSO4 (0.50 mmol).  The reaction mixture was stirred at 100 oC until 
TLC analysis indicated the disappearance of the starting aldehyde.  The reaction mixture was 
then filtered and the resulting solvent was evaporated under reduced pressure to afford the 
crude product, which was used without further characterization. 
General procedure for the palladium-catalyzed migration reaction.  The appropriate 
imine (0.25 mmol), Pd(OAc)2 (2.8 mg, 0.0125 mmol), 1,1-bis(diphenylphosphino)methane 
(dppm) (4.8 mg, 0.0125 mmol), and CsO2CCMe3 (CsPiv) (0.117 g, 0.5 mmol) in DMF (4 
mL) under Ar at 100 oC were stirred for the specified length of time.  The reaction mixture 
was then cooled to room temperature, diluted with diethyl ether (35 mL) and washed with 
brine (30 mL).  The aqueous layer was reextracted with diethyl ether (15 mL).  The organic 
layers were combined, dried over MgSO4, filtered, and the solvent removed under reduced 
pressure to afford the crude imine product, which was used for the hydrolysis without further 
characterization. 
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General procedure for hydrolysis of the imines.  To an acetone (5 mL) solution of the 
crude imine product, 1.0 N HCl (2 mL) was added.  The resulting reaction mixture was 
stirred until disappearance of the starting material as indicated by thin layer chromatography.  
The mixture was then diluted with H2O and extracted with diethyl ether (2 x 15 mL).  The 
organic layers were combined, dried over MgSO4, filtered and the solvent was removed 
under reduced pressure to afford the crude fluoren-9-one, which was purified by flash 
chromatography on silica gel using ethyl acetate/hexanes as the eluent. 
IV. Characterization Data for Selected Compounds.       
Fluoren-9-one (2a). 
The spectral properties were identical to those previously reported.25  
2-Methoxyfluoren-9-one (2b). 
1H NMR (CDCl3) δ 3.82 (s, 3H), 6.94 (dd, J = 8.4, 2.8 Hz, 1H), 7.14-7.18 (m, 2H), 7.34-
7.41 (m, 3H), 7.56 (d, J = 7.6 Hz, 1H); IR (CH2Cl2) 1717 cm-1; HRMS m/z 210.0684 (calcd 
for C14H12O2, 210.0681).  
3-Methylfluoren-9-one (2c). 
 
1H NMR (CDCl3) δ 2.42 (s, 3H), 7.08 (dq, J =  8.7, 0.6 Hz, 1H), 7.26-7.30 (m, 1H), 7.32-
7.33 (m, 1H), 7.44-7.50 (m, 2H), 7.54 (d, J = 7.5 Hz, 1H), 7.63 (dt, J = 7.4, 0.9 Hz, 1H); 13C 
NMR (CDCl3) δ 22.5, 120.3, 121.5, 124.4, 124.5, 129.2, 129.8, 132.1, 124.6, 124.9, 144.5, 
145.0, 146.0, 193.9; IR (CDCl3) 3044, 2919, 1711 cm-1; HRMS m/z 194.0734 (calcd for 
C14H10O, 194.0732).  
3-Fluorofluoren-9-one (2d). 
 Due to C-F coupling, the 13C NMR exhibited more peaks than the number of carbons 
present.  1H NMR (CDCl3) δ 7.12-7.17 (m, 1H), 7.24-7.28 (m, 1H), 7.31-7.33 (m, 1H), 7.44-
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7.48 (m, 3H), 7.62-7.65 (m, 1H); 13C NMR (CDCl3) δ 112.1, 112.3, 120.3, 120.4, 121.0, 
121.2, 121.8, 121.9, 124.8, 129.0, 135.3, 140.3, 140.4, 144.1, 162.5, 165.0, 192.7; IR 
(CDCl3) 3064, 2923, 1715 cm-1; HRMS m/z 198.0483 (calcd for C13H7FO, 198.0481). 
2-Methylfluoren-9-one (2e).   
1H NMR (CDCl3) δ 2.33 (s, 3H), 7.19-7.24 (m, 2H), 7.33 (d, J = 7.6 Hz, 1H), 7.04-7.41 (m, 
3H), 7.58 (d, J = 7.2 Hz, 1H); 13C NMR (CDCl3) δ 21.4, 120.0, 120.2, 124.2, 125.0, 128.6, 
134.3, 134.4, 134.7, 135.1, 139.3, 141.8, 144.7, 194.2.  The other spectral properties were 
identical to those previously reported.7 
Methyl fluorenone-2-carboxylate (2f).   
1H NMR (CDCl3) δ 3.95 (s, 3H), 7.37 (t, J = 7.2 Hz, 1H), 7.54 (t, J = 7.6 Hz, 1H), 7.60 (d, 
J = 8.0 Hz, 2H), 7.71 (d, J = 7.6 Hz, 1H), 8.21 (dd, J = 8.0, 1.6 Hz, 1H), 8.30 (s, 1H); 13C 
NMR (CDCl3) δ 52.6, 120.4, 121.4, 124.8, 125.6, 130.4, 131.3, 134.4, 135.0, 135.2, 136.5, 
143.5, 148.6, 166.3, 192.9; IR (CDCl3) 2920, 2848, 1718 cm-1; HRMS m/z 238.0634 (calcd 
for C15H10O3, 238.0630). 
2-Nitrofluoren-9-one (2g). 
1H NMR (CDCl3) δ 7.46 (td, J = 7.6, 1.2 Hz, 1H), 7.61 (td, J = 7.6, 1.2 Hz, 1H), 7.67-7.71 
(m, 2H), 7.77 (d, J = 7.2 Hz, 1H), 8.42 (dd, J = 8.0, 2.0 Hz, 1H), 8.47 (d, J = 1.6 Hz, 1H); 13C 
NMR (CDCl3) δ 119.8, 120.9, 122.0, 125.3, 130.1, 131.2, 135.2, 135.3, 135.7, 142.5, 149.0, 
149.9, 191.1; IR (CDCl3) 3096, 1712, 1518 cm-1; HRMS m/z 225.0429 (calcd for C13H7NO3, 
225.0426). 
Benzo[b]fluoren-11-one (2k).   
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1H NMR (CDCl3) 7.35 (dt, J = 7.4, 0.9 Hz, 1H), 7.47 (td, J = 8.1, 1.2 Hz, 1H), 7.55 (td, J 
= 8.1, 1.3 Hz, 1H), 7.56 (td, J = 7.4, 1.1 Hz, 1H), 7.72 (dt, J = 7.5, 0.8 Hz, 1H), 7.75 (dt, J = 
8.2, 0.7 Hz, 1H), 7.83 (dd, J = 8.1, 0.6 Hz, 1H), 7.87 (s, 1H), 7.89 (dt, J = 8.1, 0.6 Hz, 1H), 
8.17 (s, 1H); 13C NMR (CDCl3) 119.5, 121.4, 124.9, 126.1, 127.4, 129.2, 129.4, 129.6, 
131.2, 133.2, 134.1, 135.4, 136.6, 137.4, 138.8, 145.3, 193.5; IR (CDCl3) 3043, 1699 cm-1; 
HRMS m/z 230.0734 (calcd for C17H10O, 230.0732). 
1,3-Dimethylfluoren-9-one (2j).   
The spectral properties were identical to those previously reported.32 
1,3-Difluorofluoren-9-one (2i).   
1H NMR (CDCl3) δ 6.66 (td, J = 9.2, 1.6 Hz, 1H), 7.05 (dd, J = 7.6, 1.6 Hz, 1H), 7.38 (td, J 
= 7.6, 1.6 Hz, 1H), 7.50-7.55 (m, 2H), 7.68 (d, J = 7.2 Hz, 1H); 13C NMR (CDCl3) δ 104.9, 
105.2 (q), 116.7 (d), 121.0, 124.7, 130.6, 134.6, 134.9, 142.1, 148.5 (q), 158.8 (d), 161.3, 
166.8 (d), 169.4 (d), 188.8; IR (CH2Cl2) 3054, 2930, 1711 cm-1; HRMS m/z 216.0390 (calcd 
for C13H6F2O, 216.0387). 
4-Chlorofluoren-9-one (2h). 
1H NMR (CDCl3) δ 7.24 (t, J = 7.2 Hz, 1H), 7.34 (t, J = 7.2 Hz, 1H), 7.41 (d, J = 8.4 Hz, 
1H), 7.55 (d, J = 7.6 Hz, 1H), 7.59 (d, J = 7.2 Hz, 1H), 7.71 (d, J = 7.2 Hz, 1H), 8.18 (d, J = 
7.6 Hz, 1H); 13C NMR (CDCl3) δ 122.8, 124.3, 124.7, 129.7, 129.8, 130.2, 134.3, 135.2, 
136.4, 136.6, 140.9, 143.4, 192.8; IR (CH2Cl2) 1718 cm-1; HRMS m/z 214.0192 (calcd for 
C13H7ClO, 214.0189). 
N-(Indeno[1,2-d]furan-6-ylidene)aniline (2m).   
1H NMR (CDCl3) δ 6.51 (d, J = 2.0 Hz, 1H), 7.15-7.25 (m, 5H), 7.29 (t, J = 7.6 Hz, 1H), 
7.33 (d, J = 2.0 Hz, 1H), 7.41 (t, J = 7.2 Hz, 2H), 7.73 (d, J = 7.2 Hz, 1H); 13C NMR (CDCl3) 
  
 
94 
δ 106.2, 119.8, 121.5, 123.4, 125.6, 127.3, 128.9, 131.1, 134.8, 138.9, 141.0, 150.1, 150.5, 
150.8, 152.4; HRMS m/z 245.0843 (calcd for C17H11NO, 245.0841). 
Aniline (3).   
The extent of deuterium incorporation was determined by 1H NMR spectroscopy and mass 
spectral analysis.  Aniline 3 obtained from the reaction illustrated in eq. 1, Scheme 4: 1H 
NMR (CDCl3) δ 3.61 (s, 2H), 6.68-6.80 (m, 2.68H), 7.17 (t, J = 7.5 Hz, 2H); peak intensity 
of m/z 93 is 100%, peak intensity of m/z 94 is 55%.   Aniline 3 obtained from the reaction 
illustrated in eq. 2, Scheme 4: 1H NMR (CDCl3) δ 3.61 (s, 2H), 6.68-6.80 (m, 2.63H), 7.17 (t, 
J = 7.5 Hz, 2H); peak intensity of m/z 93 is 100%, peak intensity of m/z 94 is 60%.   Aniline 
3 obtained from the reaction illustrated in eq. 3, Scheme 4: 1H NMR (CDCl3) δ 3.61 (s, 2H), 
6.68-6.80 (m, 2.28H), 7.17 (t, J = 7.5 Hz, 2H); peak intensity of m/z 93 is 50%, peak 
intensity of m/z 94 is 100%. 
Xanthen-9-one (5a). 
1H NMR (CDCl3) δ 7.37 (t, J = 6.0 Hz, 2H), 7.48 (d, J = 6.4 Hz, 2H), 7.70-7.74 (m, 2H), 
8.33 (dd, J = 6.0, 1.2 Hz, 2H); 13C NMR (CDCl3) 118.2, 122.1, 124.1, 126.9, 135.0, 156.4, 
177.4; IR (CDCl3) 2914, 2874, 1654, 1456 cm-1; HRMS m/z 196.0527 (calcd for C13H8O2, 
196.0524).   
2-Methylxanthen-9-one (5b). 
1H NMR (CDCl3) δ 2.45 (s, 3H), 7.32-7.52 (m, 4H), 7.66-7.72 (m, 1H), 8.10 (s, 1H), 8.32 
(dd, J = 7.9, 1.6 Hz, 1H); 13C NMR (CDCl3) 21.1, 117.9, 119.2, 121.7, 122.0, 123.9, 126.2, 
126.9, 133.9, 134.8, 136.3, 154.6, 156.4, 177.5; IR (CDCl3) 3060, 2921, 2862, 1657 cm-1; 
HRMS m/z 210.0684 (calcd for C14H10O2, 210.0681).   
2-Methoxyxanthen-9-one (5c). 
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1H NMR (CDCl3) δ 3.91 (s, 3H), 7.30-7.49 (m, 4H), 7.68-7.73 (m, 2H), 8.34 (dd, J = 7.9, 
1.6 Hz, 1H); 13C NMR (CDCl3) 56.1, 106.0, 118.2, 119.6, 121.4, 122.3, 123.9, 125.1, 126.9, 
134.8, 151.2, 156.2, 156.3, 177.3; IR (CDCl3) 3014, 2980, 1664 cm-1; HRMS m/z  226.0633 
(calcd for C14H10O3, 226.0630). 
2-(Trifluoromethyl)xanthen-9-one (5d). 
1H NMR (CDCl3) δ 7.40-7.44 (m, 1H), 7.50-7.52 (m, 1H), 7.59 (d, J = 8.8 Hz, 1H), 7.74-
7.79 (m, 1H), 7.92 (dd, J = 8.8, 2.2 Hz, 1H), 8.33 (dd, J = 8.0, 1.6 Hz, 1H), 8.62 (d, J = 1.6 
Hz, 1H); 13C NMR (CDCl3) 115.6, 118.3, 119.3, 121.8, 124.9, 125.0, 125.1, 127.1, 131.3, 
135.7, 156.2, 176.4; IR (CDCl3) 3083, 2961, 1666 cm-1; HRMS m/z 264.0403 (calcd for 
C14H7F3O2, 264.0398). 
2-Nitroxanthen-9-one (5e). 
1H NMR (CDCl3) δ 7.46-7.50 (m, 1H), 7.56 (dd, J = 8.5, 0.6 Hz, 1H), 7.65 (dd, J = 9.2, 0.3 
Hz, 1H), 7.80-7.84 (m, 1H), 8.34-8.37 (m, 1H), 8.56 (dd, J = 9.1, 2.8 Hz, 1H), 9.21-9.22 (m, 
1H); 13C NMR (CDCl3) 118.4, 119.9, 121.6, 121.9, 123.8, 125.5, 127.2, 129.3, 136.1, 156.1, 
159.4, 175.9; IR (CDCl3) 3077, 1667, 1611 cm-1; HRMS m/z 241.0379 (calcd for C13H7NO4, 
241.0375). 
2-Chloroxanthen-9-one (5f). 
1H NMR (CDCl3) δ 7.37-7.41 (m, 1H), 7.43-7.49 (m, 2H), 7.64 (dd, J = 8.9, 2.7 Hz, 1H), 
7.72-7.76 (m, 1H), 8.27-8.32 (m, 2H); 13C NMR (CDCl3) 118.3, 120.0, 121.7, 122.9, 124.5, 
126.2, 127.0, 129.9, 135.1, 135.4, 154.7, 156.2, 176.3; IR (CDCl3) 3079, 1662 cm-1; HRMS 
m/z 230.0137 (calcd for C13H7ClO2, 230.0135). 
2-i-Propylxanthen-9-one (5g). 
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1H NMR (CDCl3) δ 1.32 (d, J = 6.8 Hz, 6H), 2.98-3.12 (m, 1H), 7.34-7.49 (m, 3H), 7.60 
(dd, J = 8.7, 2.3 Hz, 1H), 7.68-7.74 (m, 1H), 8.18 (d, J = 2.3 Hz, 1H), 8.35 (dd, J = 7.9, 1.7 
Hz, 1H); 13C NMR (CDCl3) 24.2, 33.9, 118.1, 121.8, 122.0, 123.7, 123.9, 127.0, 134.0, 
134.8, 144.9, 154.8, 156.4, 177.6; IR (CDCl3) 2960, 2869, 1661 cm-1; HRMS m/z 238.0997 
(calcd for C16H14O2, 238.0994).  
2-Phenylxanthen-9-one (5h). 
1H NMR (CDCl3) δ 7.37-7.41 (m, 2H), 7.46-7.52 (m, 3H), 7.56 (d, J = 8.7 Hz, 1H), 7.67-
7.76 (m, 3H), 7.96 (dd, J = 8.7, 2.4 Hz, 1H), 8.36 (dd, J = 8.0, 1.6 Hz, 1H), 8.55 (d, J = 2.4 
Hz, 1H); 13C NMR (CDCl3) 118.6, 118.7, 122.0, 122.1, 124.2, 124.8, 127.0, 127.3, 127.9, 
129.2, 133.2, 133.9, 135.1, 137.3, 139.6, 155.8, 156.4, 177.4; IR (CDCl3) 3062, 3034, 1661 
cm-1; HRMS m/z 272. 0842 (calcd for C19H12O2, 272.0837). 
2-t-Butylxanthen-9-one (5i). 
1H NMR (CDCl3) δ 1.40 (s, 9H), 7.35-7.39 (m, 1H), 7.43-7.49 (m, 2H), 7.67-7.73 (m, 1H), 
7.79 (dd, J = 8.8, 2.6 Hz, 1H), 8.32-8.36 (m, 2H); 13C NMR (CDCl3) 31.6, 35.0, 117.8, 
118.1, 121.3, 122.0, 122.6, 123.9, 127.0, 133.0, 134.8, 147.3, 154.5, 156.4, 177.7; IR 
(CDCl3) 2963, 2869, 1661 cm-1; HRMS m/z 252.1154 (calcd for C17H16O2, 252.1150). 
4-Methoxy-2-methylxanthen-9-one (5k). 
1H NMR (CDCl3) δ 2.44 (d, J = 0.6 Hz, 3H), 4.00 (s, 3H), 7.03 (d, J = 1.9 Hz, 1H), 7.34-
7.38 (m, 1H), 7.57-7.59 (m, 1H), 7.67-7.73 (m, 2H), 8.32-8.33 (m, 1H); 13C NMR (CDCl3) 
21.7, 56.6, 117.0, 117.1, 118.5, 121.9, 122.5, 124.1, 126.8, 133.7, 134.8, 144.9, 148.5, 156.1, 
177.4; IR (CDCl3) 2971, 2918, 1658 cm-1; HRMS m/z 240.0790 (calcd for C15H12O3, 
240.0786). 
10-Methyl-10H-acridin-9-one (5m). 
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1H NMR (CDCl3) δ 3.88 (s, 3H), 7.28 (t, J = 7.2 Hz, 2H), 7.50 (d, J = 8.7 Hz, 2H), 7.69-
7.73 (m, 2H), 8.55 (dd, J = 8.0, 1.2 Hz, 2H); 13C NMR (CDCl3) 33.9, 115.0, 121.5, 122.7, 
128.0, 134.0, 142.8, 178.3; IR (CDCl3) 2917, 2850, 1637 cm-1; HRMS m/z 209.0843 (calcd 
for C14H11NO, 209.0841). 
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CHAPTER 4.  SYNTHESIS OF XANTHONES, THIOXANTHONES AND 
ACRIDONES BY THE COUPLING OF ARYNES AND SUBSTITUTED 
BENZOATES 
 
Based on a communication published in Organic Letters and a full paper published 
in the Journal of Organic Chemistry 
Jian Zhao and Richard C. Larock* 
Department of Chemistry, Iowa State University, Ames, IA 50011 
larock@iastate.edu 
 
Abstract. The reaction of silylaryl triflates, CsF and ortho heteroatom-substituted benzoates 
affords a general and efficient way to prepare biologically-interesting xanthones, 
thioxanthones and acridones.  This chemistry presumably proceeds by a tandem 
intermolecular nucleophilic coupling of the benzoate with an aryne and subsequent 
intramolecular electrophilic cyclization.   
 
Introduction 
Xanthones are secondary metabolites found in higher plant families, fungi and lichens.1  
This class of compounds exhibits interesting pharmaceutical properties; specifically, anti-
bacterial, anti-inflammatory, anti-cancer, and anti-viral activities have been observed.2  Some 
xanthone-containing plants, for example, cratoxylum cochinchinense (Lour.) Blume, have 
been used as traditional medicines to treat fever, coughing, diarrhea, itching, ulcers and 
abdominal complaints.3  Thioxanthone derivatives also exhibit interesting anti-cancer 
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activities.4  Xanthones are usually synthesized through the intermediacy of benzophenones or 
diaryl ethers under harsh reaction conditions and/or in the presence of 
X
O
X = O
X = S
X = NR
R1
R2
R3
R4 R5
R6
R7
R8
Xanthones
Thioxanthones
Acridones
 
strong acids or toxic metals.5   Acridones are naturally-occurring compounds exhibiting a 
variety of biological activities.  They are important anti-leishmanial, anti-fungal, anti-tumor 
and DNA-intercalating anti-cancer drugs.6  Acridones are usually prepared by the acid-
induced ring closure of N-phenyl anthranilic acids,  which are usually obtained from Ullmann 
condensation of anilines with ortho halogen-substituted benzoic acids.  However, harsh 
reaction conditions and tedious workup procedures are generally required.7  An efficient and 
general synthesis of each of these heterocycles is thus highly desirable.   
Benzyne, a highly reactive intermediate, was first proposed by Wittig in 1942,8 and the 
structure was confirmed by Roberts in 1956 using 14C isotope labeling.9  Since then, many 
methods have been developed to generate benzynes, for example, the base-promoted 
elimination of hydrogen halide from aryl halides,10 the elimination of o-dihaloaromatics with 
lithium amalgam or magnesium,11 or the recently reported decomposition of 2-magnesiated 
aryl sulfonates.12  In 1983, Kobayashi first reported a novel way to generate arynes from 
silylaryl triflate precursors in the presence of CsF.13  Later, nucleophiles bearing neighboring 
electrophiles, such as ureas,14 trifluoroacetanilides and sulfinamides,15 and β-keto esters16 
have been shown to react with these aryne precursors to afford the C-N bond or C-C bond 
insertion products (Scheme 1).   These nucleophiles first undergo intermolecular nucleophilic 
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attack on the aryne.  Subsequent intramolecular electrophilic cyclization, followed by 
fragmentation, affords the final insertion product.   
Scheme 1.  Aryne Insertion Reactions. 
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Recently, we communicated a novel annulation reaction utilizing readily accessible 
salicylates and silylaryl triflates plus CsF, which affords an efficient one-step synthesis of 
biologically-interesting xanthones and thioxanthones (eq. 1).17  This chemistry presumably 
proceeds by a tandem intermolecular nucleophilic coupling of the benzoate and aryne, and 
subsequent intramolecular electrophilic cyclization.  A fragmentation step, which is 
inevitable in the insertion examples, is not involved in this annulation process, because the 
intermediate obtained from the cyclization is a stable 6-membered ring system.  Herein, we 
provide a full account of this efficient synthesis of xanthones and thioxanthones, plus, we 
also wish to report an extension of this coupling-cyclization strategy to the synthesis of 
biologically-interesting acridones. 
CO2R3
XH X
O
X = O, S
R1 R1 R2
CsF
+
TfO
TMS
R2 (1)
 
Results and Discussion 
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Optimization Studies.  The reaction of methyl salicylate (1a) and the commercially 
available aryne precursor o-(trimethylsilyl)phenyl triflate (2a) was first conducted in the 
presence of 4 equiv of CsF in 5 mL of MeCN.  After 12 h reaction at room temperature, an 
80% combined yield of methyl 2-phenoxybenzoate (3a) and xanthone (4a) was obtained in a 
40:60 ratio (Table 1, entry 1).  Presumably, this reaction proceeds through the key 
intermediate B generated by nucleophilic coupling of the aryne and the aryloxide A (Scheme 
2).  The carbanion B can either undergo H abstraction to afford benzoate 3a or intramolecular 
electrophilic cyclization to generate the xanthone (4a).  The major problem here is the proton 
abstraction process, which could be suppressed by adjusting the reaction conditions, for 
example, using different solvents and concentrations.  Thus,  
Table 1. Optimization Studies. 
entry fluoride source solvent temp (oC) time (h) % yield (3a:4a)a 
1 4 CsF MeCN rt 12 80 (40:60) 
2 4 CsF acetone rt 4 75 (38:62) 
3 4 CsF CH2Cl2 rt 24 trace 
4 4 CsF THF rt 24 20 (5:95) 
5 4 CsF toluene 100 48 trace 
6 4 CsF MeNO2 rt 24 - 
7 4 CsF THF 65 24 82 (8:92) 
8 4 CsF THF 90 12 80 (14:86) 
9 4 CsF THF 50 24 30 (6:94) 
10 4 CsF DME 65 24 70 (25:75) 
11 4 TBAF THF 65 3 60 (83:17) 
12 2 CsF THF 65 24 65 (8:92) 
aAll reactions were conducted on a 0.25 mmol scale in 5 mL of solvent (sealed vial).  
The ratio of methyl salicylate to aryne precursor is 1 to 1.1.  The ratio of 3a to 4a in 
parentheses has been determined by GC-MS analysis. 
we next conducted the coupling-cyclization reaction in acetone, and a 75% yield of diaryl 
ether 3a and xanthone (4a) was obtained in a 38:62 ratio (entry 2), which suggests that a less 
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polar solvent should be examined.  We then performed the reaction in CH2Cl2.  However, 
only a trace of the xanthone (4a) was observed by GC-MS analysis after 24 h (entry 3).  
When THF was used as the solvent at room temperature, after 24 h reaction, a 20% yield of 
products 3a and 4a was obtained, and a lot of the starting materials 1a and 2a was observed 
by GC-MS analysis.  However, the ratio of 3a to 4a was 5:95, suggesting that proton 
abstraction has been almost completely suppressed (entry 4).  When this reaction was 
conducted in toluene, only a trace of the product was evident by GC-MS analysis (entry 5).  
MeNO2 also turned out to be an unsuitable solvent for this reaction (entry 6).  At this point, 
THF seemed to be the best solvent, at least as far as the reaction selectivity was concerned.  
The same reaction was then carried out at 65 oC in THF for 24 h.  A 75% yield of xanthone 
(4a) was isolated by flash chromatography and GC-MS analysis indicated only a trace of the 
diaryl ether 3a was obtained (entry 7).   
Scheme 2 
CO2Me
OH
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OTf O
O
CO2Me
O Cs O
Cs O OMe
O
OMe
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Further investigation indicated that a reaction temperature of 90 oC or 50 oC reduces the 
amount of xanthone product (entries 8 and 9).  When DME was used as the solvent, the 
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reaction afforded only a 70% yield of two isomers formed in a 25:75 ratio (entry 10).  The 
effect of the fluoride source has also been examined in this process.  When 
tetrabutylammonium fluoride (TBAF) was used as the fluoride source, the reaction proceeded 
much faster.  After 3 h, all of the starting materials were consumed and the proton abstraction 
product 3a predominated (entry 11).  A 65% yield of an 8:92 ratio of 3a and 4a was obtained 
when this reaction was carried out in the presence of 2 equiv of CsF (entry 12).  In 
conclusion, the “optimal” reaction conditions for this one-step synthesis of xanthone utilize 4 
equiv of CsF in THF solvent at 65 oC for 24 h (entry 7). 
Synthesis of Xanthones.  Employing our “optimal” reaction conditions, we have 
investigated the reaction scope and limitations of this process.  These results are summarized 
in Table 2.  We first examined the effect of a methoxy substituent on the salicylate ring to 
determine which position on the salicylate ring affords the best yield of xanthone.  Thus, 
salicylates 1b, 1c, 1d and 1e were employed, and 35-69% yields of substituted xanthones 4b-
4e were obtained (entries 2-5).  Having an electron-donating methoxy group in the 5 position 
of the salicylate ring gave the highest yield (entry 4).  The yields of xanthones from the 3- and 
4-methoxy starting materials were only slightly lower, but the 6-methoxy isomer gave a much 
lower yield.   When methyl 5-acetylsalicylate (1f) with an electron-withdrawing group in the 
5 position was used as the starting material, a 58% yield of xanthone 4f was isolated by flash 
chromatography (entry 6).  On the other hand, the reaction of methyl 5-fluorosalicylate (1g) 
and aryne precursor 2a affords an 83% yield of xanthone 4g (entry 7).  The reaction of methyl 
5- bromosalicylate (1h) with aryne 2a affords a 75% yield of the product 4h (entry 8).  The 
phenyl- and methyl-substituted salicylates 1i and 1j afforded 64% and 71% yields of the 
corresponding xanthone products respectively (entries 9 and 10).  When methyl 5- 
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Table 2. Synthesis of Xanthones.a 
entry salicylate   aryne product(s) 
 
% yield 
 OH
CO2Me
X 1
2
3
4
5
6
 
X 
  
O
O
X
 
 
 
1 H 1a 2a  4a 75 
2 3-OMe 1b 2a  4b 59 
3 4-OMe 1c 2a  4c 62b 
4 5-OMe 1d 2a  4d 69 
5 6-OMe 1e 2a  4e 35 
6 5-COMe 1f 2a  4f 58 
7 5-F 1g 2a  4g 83 
8 5-Br 1h 2a  4h 75 
9 5-Ph 1i 2a  4i 64 
10 5-Me 1j 2a  4j 71 
11 
OH
CO2MeHO
 
1k 2a 
O
O
PhO
 
4k 52 
12 
OH
CO2Ph
 
1l 2a 
O
O
 
4a 81 
13 
OH
CO2H
 
1m 2a  4a 0 
14 CO2Me
OH
 
1n 2a O
O
 
4l 73 
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Table 2. (Continued) 
entry salicylate   aryne product(s) 
 
% yield 
15 
OH
CO2Me
 
1o 2a 
O
O
 
4m 46c 
16 
N CO2Me
OH
 
1p 2a N
O
O
 
4n 0 
17 
OH
CO2Me
 
1a 2b 
O
O OMe
 
4e 62b 
18  1a 2c 
O
O
OMe
OMe
 
4o 57b 
19  1a 2d 
O
O
Me
Me
 
4p 51b 
20 
 1a 2e O
O
Me
 
4j 
 
59b (1:1) 
 
    
O
O
Me
 
4q  
21  1a 2f 
O
O
 
4r 45b 
aAll reactions were conducted on a 0.25 mmol scale in the presence of  4 equiv of CsF 
and 1.1 equiv of silylaryl triflate in 5 mL of THF at 65 oC for 24 h (sealed vial) unless 
otherwise stated.  bThe reaction was conducted in 5 mL of THF at 90 oC.  cThe yield has 
been determined by GC analysis due to the impurities in the product. 
hydroxysalicylate (1k) is allowed to react with 2.5 equiv of aryne precursor 2a, the O-arylated 
xanthone product 4k was isolated in a 52% yield (entry 11).  We have previously reported the 
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facile arylation of phenols by these same aryne precursors.18  From these results with 5-
substituted salicylates, there is no obvious correlation between the electronic properties of the 
substituent and the yield.  Phenyl salicylate (1l) has been employed in this reaction and an 
81% yield of xanthone 4a was obtained (entry 12).  Assuming that 2-hydroxybenzoic acid 
would first form the corresponding phenyl ester 1l,18 which should then afford the 
corresponding xanthone (4a), we treated 2 equiv of benzyne precursor 2a and 2-
hydroxybenzoic acid (1m) in the usual fashion.  Unfortunately, none of the desired product 
was observed for reasons we do not really understand at this time (entry 13).  Interestingly, 
the cross coupling of methyl 1-hydroxy-2-naphthoate (1n) with silylaryl triflate 2a affords a 
73% yield of xanthone 4l, but the reaction using methyl 2-hydroxy-3-naphthoate (1o) only 
generates a 48% yield of the product 4m (entries 14 and 15).  This latter reaction produced 
several side products which have not been identified.  The annulation of 1p, which contains a 
pyridine ring, afforded none of the xanthone product under our “optimal” conditions (entry 
16).  Again, we are uncertain why this latter reaction failed.   
Scheme 3. Aryne Precursors. 
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After investigating the effect of varying the salicylate structure, we examined the reaction 
efficiency using different aryne precursors (Scheme 3).  A 62% yield of a single isomeric 
methoxyxanthone 4e was obtained from the reaction of methyl salicylate 1a with aryne 
precursor 2b after 24 h at 90 oC (entry 17).   Note that a somewhat higher temperature was 
required to get a good yield.  The regioselectivity of this reaction is due to the steric and 
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electronic effects in the step involving nucleophilic attack on the aryne, which has been seen 
in several previous reactions involving this aryne.18  When the dimethoxysilylaryl triflate 2c 
was employed, a 57% yield of xanthone 4o was isolated (entry 18).  Again a higher 
temperature was required.  The reaction of aryne precursor 2d with methyl salicylate (1a) 
afforded a 51% yield of xanthone 4p (entry 19).  When aryne precursor 2e was employed, a 
59% yield of two isomeric xanthones 4j and 4q was obtained in a 1:1 ratio (entry 20).  This is 
consistent with the intermediacy of an unsymmetrical methyl-substituted benzyne.  Aryne 
precursor 2f afforded a 45% yield of a single xanthone product 4r (entry 21).   
One of the major advantages of this methodology is that halogen atoms can be tolerated, 
which provides access to more structurally diverse xanthone skeletons via metal-catalyzed 
cross-coupling reactions.  As illustrated in Scheme 4, the halogen-substituted xanthone 
product 4h can be further modified by Heck19 and Suzuki20 reactions, affording interesting 
xanthone derivatives 5a and 5b for further biological examination. 
Scheme 4.  Diversification of Halogen-substituted Xanthones. 
O
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(i) 5% Pd(PPh3)4, 1 Na2CO3, 1:4 MeOH/Toluene, 80 oC, 12 h; (ii) 5% Pd(OAc)2, 2 NaHCO3, 1 TBAC, 
DMF, 100 oC, 24 h.
52%
48%
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 Synthesis of Thioxanthones.  Biologically-interesting thioxanthone derivatives have also 
been prepared by this same methodology.  All of the results are summarized in Table 3.  
Methyl thiosalicylate (6a) and 1.1 equiv of benzyne precursor 2a were treated with 4 equiv of 
CsF in 5 mL of THF at 65 oC, after 24 h, a 35% yield of thioxanthone (7a) was isolated.  The 
lower yield in this example is presumably due to oxidative homocoupling of the thiols, since 
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thiols are known to afford disulfides in the presence of CsF on a celite solid support in air.21  
In order to suppress this undesired homocoupling process, the same reaction was repeated 
under an Ar atmosphere, and a 55% yield of thioxanthone (7a) was obtained.  Further 
optimization indicated that a 64% yield of product 7a could be obtained under more dilute 
conditions, although a small amount of disulfide product and S-arylation product were 
present (Table 3, entry 1).  The reaction of this thiol with benzyne precursor 2b afforded a 
45% yield of the desired thioxanthone 7b (entry 2).   When 2d was employed as the aryne  
Table 3. Synthesis of Thioxanthones.a 
entry thiosalicylate aryne  product(s) % yield 
1 
SH
CO2Me
 
6a 2a 
S
O
 
7a 64 
2 
 6a 2b 
S
O OMe
 
7b 45b 
3 
 6a 2d 
S
O
Me
Me
 
7c 40b 
4 
 6a 2e 
S
O
Me
 
7d 56b,c (1:1) 
 
   
S
O
Me
 
7e  
5 
 6a 2f 
S
O
 
7f 62b 
aAll reactions were conducted on a 0.25 mmol scale in the presence of  4 equiv of CsF 
and 1.1 equiv of silylaryl triflate in 10 mL of THF at 65 oC under Ar.  bThe reaction was 
conducted in 10 mL of THF at 90 oC under Ar (sealed tube).  cThe ratio in parentheses has 
been determined by 1H NMR spectroscopy. 
precursor in this reaction, a 40% yield of the product 7c was isolated (entry 3).  The reaction 
of 2e afforded a 56% yield of two regioisomers 7d and 7e in a 1:1 ratio (entry 4).  Finally, 
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aryne precursor 2f was allowed to react with thiosalicylate 6a, and a 62% yield of 
thioxanthone 7f was isolated by flash chromatography (entry 5).   
Synthesis of Acridones.  After we had a general and efficient synthesis of xanthones and 
thioxanthones in hand, we attempted to expand this methodology to the synthesis of 
acridones, a well-known class of anti-fungal, anti-tumor and anti-cancer compounds.6  
Acridones have been prepared by the coupling of 3-halogeno-4-methoxybenzynes generated 
from 5-(3-halogeno-4-methoxyphenyl)thianthrenium perchlorates and LDA in THF at reflux 
with 2-aminobenzoate.22  However, this protocol employs a fairly unusual aryne precursor, 
and it also suffers from the moisture-sensitive reagents and conditions.  Methyl 2-
aminobenzoate (8a) was first prepared and allowed to react with aryne precursor 2a, and a 
50% yield of the acridone product 9a was obtained (Table 4, entry 1).  Methyl 2-(N-
methylamino)benzoate (8b) was then allowed to react with aryne precursor 2a.  After 1 day 
of reaction, a 72% yield of acridone 9b was isolated by flash chromatography(entry 2).  
However, the reaction employing methyl 2-(N-phenylamino)benzoate (8c) was very sluggish;  
after 2 days of reaction, only a 7%  yield of the desired product 9c was observed by GC-MS 
analysis.  The low yield is presumably due to the steric hindrance introduced by the presence 
of the phenyl substituent (entry 3). Interestingly, the reaction of methyl 2-(N,N-
dimethylamino)benzoate (8d) affords a 65% yield of acridone product 9b, which indicates 
that even tertiary amines can be successfully employed in this transformation (entry 4).  
Apparently the anticipated ammonium-containing product undergoes demethylation under the 
reaction conditions. Several halogen-substituted benzoates (8e-8g) have also been prepared 
from the corresponding acids and employed in this process (entries 5-7).  Yields of 48-71% 
of the corresponding acridone products (9d-9f) have been obtained.  We have not employed 
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Table 4. Synthesis of Acridones.a 
entry benzoate aryne product(s)  % yield 
 
NR1R2
CO2Me
X 1
2
3
4
5
6
 
 
N
O
R2
X
 
  
 R1 R2 X 
 
 
 
  
1 H H H 8a 2a  9a 50 
2 H Me H 8b 2a  9b 72 
3 H Ph H 8c 2a  9c 7b 
4 Me Me H 8d 2a  9b 65 
5 H Me 4-F 8e 2a  9d 48 
6 H Me 5-F 8f 2a  9e 71 
7 H Me 5-Br 8g 2a  9f 61 
8 H Me H 8b 2b 
N
Me
O OMe
 
9g tracec 
9 H Me H 8b 2d 
N
Me
O
Me
Me
 
9h 27c 
10 H Me H 8b 2e 
N
Me
O
Me
 
9i 
 
     
N
Me
O
Me
 
9j 
51c 
(1:1) 
11 H Me H 8b 2f 
N
Me
O
 
9k 35c 
aAll reactions were conducted on a 0.25 mmol scale in the presence of  4 equiv of CsF 
and 1.1 equiv of the silylaryl triflate in 10 mL of THF at 65 oC.  bThe yield was 
determined by GC-MS analysis.  cThe reaction was conducted in 10 mL of THF at 90 
oC (sealed tube).  The ratio in parentheses has been determined by 1H NMR 
spectroscopy.      
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protecting groups on nitrogen since that could well lead to C-N insertion products.14,15  
At this point, we examined the effect of the aryne structure on the yield of acridone.  When 
silylaryl triflate 2b was employed with benzoate 8b, the reaction was very sluggish and only a 
trace amount of the desired acridone product 9g was observed by GC-MS analysis (entry 8).  
Aryne precursor 2d afforded only a 27% yield of the product 9h and this reaction had to be 
run at 90 oC (entry 9).  The reaction of aryne precursor 2e with benzoate 8a afforded a 51% 
yield of two isomeric acridones, 9i and 9j, in a 1:1 ratio (entry 10).  A 35% yield of acridone 
product 9k was obtained when aryne precursor 2f was employed (entry 11).  These last two 
reactions also had to be run at 90 oC.   
A plausible mechanism for these aminobenzoate reactions is proposed in Scheme 4.  The 
benzoate bearing an amino group presumably first undergoes nucleophilic attack on the aryne 
generated in situ from the silylaryl triflate.  When R is a proton, the actual nucleophile 
involved could be either the neutral amine or the anionic intermediate D generated by  
Scheme 4. Plausible Mechanism for the Acridone Synthesis. 
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hydrogen abstraction from the amine by CsF.  However, when the tertiary amine 8d is 
employed, although no proton is available for abstraction, this reaction still works well, 
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suggesting that the neutral amine itself is nucleophilic enough for this transformation.  
Therefore, the reaction mechanism which proceeds via intermediates F and G seems more 
likely, although we cannot rule out possible anionic nucleophilic attack on the aryne, which 
proceeds via intermediates D and E.  Subsequent intramolecular cyclization should afford the 
final acridone products.  
Conclusions 
A general one-pot synthesis of biologically-interesting xanthones, thioxanthones and 
acridones has been developed.  This chemistry presumably proceeds by a tandem 
intermolecular nucleophilic coupling of the substituted benzoates and arynes and subsequent 
intramolecular electrophilic cyclization.  The mild reaction conditions and generally high 
reaction efficiency provide advantages over previously reported multi-step procedures.  In 
generally, this strategy tolerates both electron-donating and electron-withdrawing 
functionalities on the benzoate ring, but substituents on the aryne ring appear to lower the 
yields of the desired products.   
Experimental Section 
I. General Procedures.   
All 1H and 13C NMR spectra were collected in CDCl3 unless noted otherwise. Thin layer 
chromatography was performed using 60-mesh silica gel plates, and visualization was 
affected using wavelength UV light (254 nm) and a basic KMnO4 solution.  All high 
resolution mass spectra were recorded using EI. 
All reagents were used directly as obtained commercially unless otherwise noted. MeCN 
was dried by CaH2, and THF solvent was dried over Na/benzophenone.  The salicylates 1a-d, 
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1f, 1g and 1j-o, the salicylic acids used to prepare salicylates 1e, 1h, 1i and 1p, the 
thiosalicylate 6a, the anthranilic acids used to prepare amino esters 8a-g, and the aryne 
precursor 2a and CsF are commercially available.  Aryne precursors 2b-f were prepared 
according to literature procedures.15 
II. Non-commercial compounds. 
     Non-commercial methyl salicylates were prepared from the corresponding salicylic acids 
by the following procedure.  The salicylic acid (5.0 mmol) was dissolved in 50 mL of 
methanol, and 1 mL of concentrated H2SO4 was cautiously added to the mixture.  The 
reaction mixture was refluxed for 24 h.  
CO2H
OH
X
H2SO4
CH3OH
reflux, 24 h
CO2Me
OH
X
 
Methyl 6-methoxysalicylate (1e). 
  
1H NMR (CDCl3) δ 3.83 (s, 3H), 3.92 (s, 3H), 6.38 (d, J = 8.3 Hz, 1H), 6.57 (dd, J = 8.3, 
0.6 Hz, 1H), 7.30 (t, J = 8.3 Hz, 1H), 11.50 (s, 1H); 13C NMR (CDCl3) δ 52.7, 56.4, 102.4, 
103.3, 110.3, 135.3, 161.0, 163.8, 171.8; IR (CDCl3) 3250, 3010, 2956, 1654 cm-1; HRMS 
m/z 182.0581 (calcd for C9H10O4, 182.0579).   
Methyl 5-bromosalicylate (1h). 
  
1H NMR (CDCl3) δ 3.95 (s, 3H), 6.87 (d, J = 8.9 Hz, 1H), 7.52 (dd, J = 8.9, 2.5 Hz, 1H), 
7.94 (d, J = 2.5 Hz, 1H), 10.70 (s, 1H); 13C NMR (CDCl3) δ 52.9, 110.0, 114.0, 119.8, 132.4, 
138.6, 160.8, 169.7;  IR (CDCl3) 3177, 2954, 2854, 1678 cm-1; HRMS m/z 229.9582 (calcd 
for C8H7BrO3, 229.9579).   
Methyl 5-phenylsalicylate (1i). 
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  1H NMR (CDCl3) δ 3.98 (s, 3H), 7.07 (d, J = 8.6 Hz, 1H), 7.32-7.36 (m, 1H), 7.42-7.46 (m, 
2H), 7.55-7.57 (m, 2H), 7.71 (dd, J = 8.7, 2.4 Hz, 1H), 8.08 (d, J = 2.4 Hz, 1H), 10.80 (s, 
1H); 13C NMR (CDCl3) δ 52.7, 112.7, 118.3, 126.9, 127.3, 128.4, 129.1, 132.7, 134.7, 140.1, 
161.2, 170.8; IR (CDCl3) 3220, 2960, 1675 cm-1; HRMS m/z 228.0784 (calcd for C14H12O3, 
228.0786).   
Methyl 3-hydroxypyridine-2-carboxylate (1p). 
  
1H NMR (CDCl3) δ 3.83 (s, 3H), 7.12-7.22 (m, 2H), 8.04 (s, 1H), 10.41 (s, 1H); 13C NMR 
(CDCl3) δ 53.2, 126.2, 129.6, 130.0, 141.4, 158.7, 169.8; IR (CDCl3) 3106, 2956, 1678 cm-1; 
HRMS m/z 153.0428 (calcd for C7H7NO3, 153.0426).   
      The amino esters were prepared from the corresponding anthranilic acids by the following 
procedure.  Anthranilic acid (5.0 mmol), K2CO3 (10.0 mmol), and MeI (20.0 mmol) were 
added to 50 mL of acetone and refluxed for 3 h.  Esters 8a and 8b were separated by flash 
chromatography, and 8b was converted to 8d by treating it with NaH and MeI in DMF for 24 
h. 
CO2H
NH2
2 K2CO3
4 MeI
acetone
reflux
CO2Me
NH2
CO2Me
NHMe
CO2Me
NMe2
+
8a 8b 8d
NaH
MeI, DMF
 
Methyl 2-aminobenzoate (8a). 
  
1H NMR (CDCl3) δ 3.84 (s, 3H), 5.78 (s, 2H), 6.61-6.64 (m, 2H), 7.22-7.26 (m, 1H), 7.84-
7.87 (m, 1H); 13C NMR (CDCl3) δ 51.8, 110.8, 116.4, 116.9, 131.4, 134.3, 150.8, 168.8; IR 
(CDCl3) 3481, 3372, 2950, 2903, 1695 cm-1; HRMS m/z 151.0635 (calcd for C8H9NO2, 
151.0633).   
Methyl 2-(N-methylamino)benzoate (8b). 
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 1H NMR (CDCl3) δ 2.91 (d, J = 5.0 Hz, 3H), 3.8 (s, 3H), 6.57-6.68 (m, 2H), 7.36-7.42 (m, 
1H), 7.67 (s, 1H), 7.92 (dd, J = 7.9, 1.6 Hz, 1H); 13C NMR (CDCl3) δ 29.8, 51.6, 110.1, 
110.9, 114.6, 131.8, 134.9, 152.2, 169.3; IR (CDCl3) 3368, 2990, 2871, 1685 cm-1; HRMS 
m/z 165.0792 (calcd for C9H11NO2, 165.0790). 
Methyl 2-(N-phenylamino)benzoate (8c). 
  
1H NMR (CDCl3) δ 3.9 (s, 3H), 6.77-6.81 (m, 1H), 7.15 (t, J = 5.1 Hz, 1H), 7.31-7.42 (m, 
6H), 8.02-8.05 (m, 1H), 9.60 (s, 1H); 13C NMR (CDCl3) δ 52.1, 112.2, 114.3, 117.4, 122.7, 
123.8, 129.7, 131.9, 134.4, 141.0, 148.2, 169.2; IR (CDCl3) 3365, 2965, 1667 cm-1; HRMS 
m/z 227.0966 (calcd for C14H13NO2, 227.09463). 
Methyl 2-(N,N-dimethylamino)benzoate (8d). 
 
1H NMR (CDCl3) δ 2.79 (s, 6H), 3.84 (s, 3H), 6.79 (t, J = 7.7 Hz, 1H), 6.88 (d, J = 8.3 Hz, 
1H), 7.29 (m, 1H), 7.62 (dd, J = 7.8, 1.5 Hz, 1H); 13C NMR (CDCl3) δ 43.8, 52.2, 116.8, 
118.8, 121.1, 131.8, 132.4, 152.5, 169.1; IR (CDCl3) 2986, 2948, 1717 cm-1; HRMS m/z 
179.0949 (calcd for C10H13NO2, 179.0946). 
Methyl 4-fluoro-2-(N-methylamino)benzoate (8e). 
 
 1H NMR (CDCl3) δ 2.86 (s, 3H), 3.82 (s, 3H), 6.24 (m, 2H), 7.8 (s, 1H), 7.87 (d, J = 8.8 Hz, 
1 H); 13C NMR (CDCl3) δ 29.8, 51.7, 97.0, 97.2, 102.1, 102.4, 106.7, 134.3, 134.4, 154.3, 
154.4, 166.3, 168.5, 168.8; IR (CDCl3) 3373, 2994, 2951, 1689 cm-1; HRMS m/z 183.0698 
(calcd for C9H10FNO2, 183.0696). 
Methyl 5-fluoro-2-(N-methylamino)benzoate (8f). 
   
1H NMR (CDCl3) δ 2.85 (s, 3H), 3.82 (s, 3H), 6.52 (dd, J = 9.2, 4.4 Hz, 1H), 7.07-7.12 (m, 
1H), 7.41 (s, 1H), 7.55 (dd, J = 9.7, 3.1 Hz, 1H); 13C NMR (CDCl3) δ 30.0, 51.8, 109.6, 
109.7, 111.8, 111.9, 115.6, 116.7, 122.3, 122.5, 149.0, 151.9, 154.2, 168.3, 168.4; IR 
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(CDCl3) 3392, 2957, 2915, 1684 cm-1; HRMS m/z 183.0698 (calcd for C9H10FNO2, 
183.0696). 
Methyl 5-bromo-2-(N-methylamino)benzoate (8g). 
  1H NMR (CDCl3) δ 2.87 (d, J = 4.2 Hz, 3H), 3.83 (s, 1H), 6.52 (d, J = 9.0 Hz, 1H), 7.40 (dd, 
J = 9.0, 2.5 Hz, 1H), 7.63 (s, 1H), 7.97 (d, J = 2.5 Hz, 1H); 13C NMR (CDCl3) δ 29.9, 51.9, 
105.8, 111.4, 112.8, 133.9, 137.4, 151.0, 168.2; IR (CDCl3) 3377, 2948, 2909, 1689 cm-1; 
HRMS m/z 242.9898 (calcd for C9H10BrNO2, 242.9895).    
III. Experimental Procedures.   
Representative procedure for the coupling-cyclization of arynes and salicylates.   CsF 
(1.0 mmol), the salicylate (0.25 mmol), and the silylaryl triflate (0.28 mmol) in 5 mL of 
anhydrous THF were stirred at 65 or 90 oC for 24 h.  The reaction mixture was allowed to 
cool to room temperature, diluted with diethyl ether (25 mL) and washed with brine (25 mL).  
The aqueous layer was re-extracted with diethyl ether (2 x 25 mL).  The organic layers were 
combined, dried (MgSO4), filtered, and the solvent was removed under reduced pressure.  
The residue was purified by flash chromatography on silica gel.     
Representative procedure for the coupling-cyclization of arynes and thiosalicylates.   
CsF (1.0 mmol), the thiosalicylate (0.25 mmol) and the silylaryl triflate (0.28 mmol) were 
added to 10 mL of anhydrous THF, and the reaction vial was flushed with Ar.  The whole 
reaction solution was then stirred at 65 or 90 oC for 24 h and worked up as described 
previously.  
Representative procedure for the coupling-cyclization of arynes and 2-
aminobenzoates.   CsF (1.0 mmol), the 2-aminobenzoate (0.25 mmol), and the silylaryl 
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triflate (0.28 mmol) in 10 mL of anhydrous THF were stirred at 65 or 90 oC for 24 h and 
worked up as described previously. 
9H-Xanthen-9-one (4a). 
  
1H NMR (CDCl3) δ 7.37 (t, J = 6.0 Hz, 2H), 7.48 (d, J = 6.4 Hz, 2H), 7.70-7.74 (m, 2H), 
8.33 (dd, J = 6.0, 1.2 Hz, 2H); 13C NMR (CDCl3) δ 118.2, 122.1, 124.1, 126.9, 135.0, 156.4, 
177.4; IR (CDCl3) 2914, 2874, 1654, 1456 cm-1; HRMS m/z 196.0527 (calcd for C13H8O2, 
196.0524).   
4-Methoxy-9H-xanthen-9-one (4b). 
  
1H NMR (CDCl3) δ 4.03 (s, 3H), 7.22-7.31 (m, 2H), 7.39 (t, J = 7.5 Hz, 1H), 7.60 (d, J = 
8.4 Hz, 1H), 7.71-7.75 (m, 1H), 7.90 (dd, J = 7.9, 1.5 Hz, 1H), 8.33 (d, J = 7.9 Hz, 1H); 13C 
NMR (CDCl3) δ 56.7, 115.5, 117.8, 118.5, 121.9, 122.9, 123.7, 124.3, 126.9, 135.0, 146.7, 
148.8, 156.2, 177.4; IR (CDCl3) 3026, 2951, 2849, 1660 cm-1; HRMS m/z 226.0632 (calcd 
for C14H10O3, 226.0630).   
3-Methoxy-9H-xanthen-9-one (4c). 
  
1H NMR (CDCl3) δ 3.92 (s, 1H), 6.86 (d, J = 2.3 Hz, 1H), 6.93 (d, J = 8.9 Hz, 1H), 7.34-
7.38 (m, 1H), 7.43 (d, J = 8.3 Hz, 1H), 7.66-7.70 (m, 1H), 8.27 (d, J = 8.9 Hz, 1H), 8.31 (d, J 
= 7.9 Hz, 1H); 13C NMR (CDCl3) δ 56.1, 100.4, 113.5, 116.0, 117.9, 122.2, 124.1, 126.9, 
128.5, 134.5, 156.4, 158.3, 165.3, 176.5;  IR (CDCl3) 3068, 2950, 2843, 1650 cm-1; HRMS 
m/z 226.0634 (calcd for C14H10O3, 226.0630).       
2-Methoxy-9H-xanthen-9-one (4d). 
  
1H NMR (CDCl3) δ 3.91 (s, 3H), 7.26-7.49 (m, 4H), 7.69-7.72 (m, 2H), 8.33 (dd, J = 5.9, 
0.8 Hz, 1H); 13C NMR (CDCl3) δ 56.2, 106.0, 118.2, 119.6, 121.4, 122.3, 123.9, 125.1, 
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126.9, 134.8, 151.2, 156.2, 156.3, 177.3; IR (CDCl3) 3014, 2981, 1666, 1467 cm-1; HRMS 
m/z 226.0633 (calcd for C14H10O3, 226.0630). 
1-Methoxy-9H-xanthen-9-one (4e). 
  
1H NMR (CDCl3) δ 4.00 (s, 3H), 6.77 (d, J = 8.1 Hz, 1H), 7.03 (d, J = 8.6 Hz, 1H), 7.26-
7.40 (m, 2H), 7.55-7.67 (m, 2H), 8.29 (dd, J = 8.0, 1.2 Hz, 1H); 13C NMR (CDCl3) δ 56.7, 
105.6, 110.2, 112.8, 117.5, 123.2, 124.0, 127.0, 134.4, 135.0, 155.2, 158.4, 161.0, 176.7; IR 
(CDCl3) 2971, 2946, 1666, 1474 cm-1; HRMS m/z 226.0633 (calcd for C14H10O3, 226.0630). 
2-Acetyl-9H-xanthen-9-one (4f). 
  
1H NMR (CDCl3) δ 2.71 (s, 3H), 7.42 (td, J = 5.3, 0.7 Hz, 1H), 7.51-7.56 (m, 2H), 7.76 (td, 
J = 6.2, 1.3 Hz, 1H), 8.33-8.36 (m, 2H), 8.86 (d, J =  1.6 Hz, 1H); 13C NMR (CDCl3) δ 26.9, 
118.4, 119.1, 121.4, 121.9, 124.9, 127.1, 128.6, 133.1, 134.1, 135.6, 156.2, 159.1, 176.9, 
196.6; IR (CDCl3) 3066, 2972, 1665, 1652 cm-1; HRMS m/z 238.0632 (calcd for C15H10O3, 
238.0630). 
2-Fluoro-9H-xanthen-9-one (4g). 
  
1H NMR (CDCl3) δ 7.35-7.51 (m, 4H), 7.73 (td, J = 7.2, 1.7 Hz, 1H), 7.95 (dd, J = 8.2, 2.8 
Hz, 1H), 8.30 (dd, J = 7.9, 1.7 Hz, 1H); 13C NMR (CDCl3) δ 111.6 (d, J = 13.7 Hz), 118.2, 
120.20 (d, J = 8.1 Hz), 121.2, 122.8 (d, J = 7.0 Hz), 123.1 (d, J = 25.3 Hz), 124.3, 126.9, 
135.3, 152.5 (d, J = 1.6 Hz), 156.3, 158.9 (d, J = 245.5 Hz), 176.7 (d, J = 2.4 Hz); IR 
(CDCl3) 3087, 1664, 1157 cm-1; HRMS m/z 214.0433 (calcd for C13H7FO2, 214.0430). 
2-Bromo-9H-xanthen-9-one (4h). 
   
1H NMR (CDCl3) δ 7.36-7.40 (m, 2H), 7.47 (d, J = 8.4 Hz, 1H), 7.71-7.79 (m, 2H), 8.30 
(dd, J = 8.0, 1.4 Hz, 1H), 8.42 (d, J = 2.5 Hz, 1H); 13C NMR (CDCl3) δ 117.3, 118.3, 120.2, 
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121.7, 123.3, 124.5, 127.0, 129.4, 135.4, 137.8, 155.1, 156.2, 176.2; IR (CDCl3) 3075, 2919, 
1663 cm-1; HRMS m/z 273.9634 (calcd for C13H7BrO2, 273.9630). 
2-Phenyl-9H-xanthen-9-one (4i). 
 
 1H NMR (CDCl3) δ 7.37-7.42 (m, 2H), 7.47-7.52 (m, 3H), 7.55-7.58 (m, 1H), 7.67-7.77 (m, 
3H), 7.96-7.99 (m, 1H), 8.36-8.39 (m, 1H), 8.56-8.57 (m, 1H); 13C NMR (CDCl3) δ 118.3, 
118.7, 122.1, 124.2, 124.8, 127.0, 127.3, 127.9, 129.2, 133.9, 135.1, 137.3, 139.6, 155.8, 
156.4, 177.4; IR (CDCl3) 3070, 3034, 1656 cm-1; HRMS m/z 272.0842 (calcd for C19H12O2, 
272.0837). 
2-Methyl-9H-xanthen-9-one (4j). 
  
1H NMR (CDCl3) δ 2.46 (s, 3H), 7.34-7.40 (m, 2H), 7.47 (dd, J = 8.4, 0.5 Hz, 2H), 7.53-
7.54 (m, 1H), 7.68-7.73 (m, 1H), 8.11 (d, J = 0.9 Hz, 1H), 8.33 (dd, J = 8.0, 1.6 Hz, 1H); 13C 
NMR (CDCl3) δ 21.1, 115.6, 118.0, 118.2, 121.7, 123.9, 126.2, 126.9, 133.9, 134.9, 136.3, 
154.6, 156.4, 177.5; IR (CDCl3) 3061, 2918, 2862, 1657 cm-1; HRMS m/z 210.0684 (calcd 
for C14H10O2, 210.0681). 
2-Phenoxy-9H-xanthen-9-one (4k). 
  
1H NMR (CDCl3) δ 7.04-7.06 (m, 2H), 7.15 (t, J = 7.4 Hz, 1H), 7.35-7.53 (m, 6H), 7.71-
7.75 (m, 1H), 7.87 (d, J = 2.8 Hz, 1H), 8.32 (dd, J = 8.0, 1.6 Hz, 1H); 13C NMR (CDCl3) δ 
114.4, 114.7, 118.2, 119.9, 124.1, 124.2, 126.9, 127.0, 129.7, 130.2, 130.5, 135.1, 152.3, 
153.8, 156.3, 157.1, 177.0; IR (CDCl3) 3066, 2951, 2872, 1660 cm-1; HRMS m/z 288.0790 
(calcd for C19H12O3, 288.0786). 
7H-Benzo[c]xanthen-7-one (4l). 
  
1H NMR (CDCl3) δ 7.43 (t, J = 7.7 Hz, 1H), 7.64-7.77 (m, 5H), 7.88-7.92 (m, 1H), 8.25 (d, 
J = 8.8 Hz, 1H), 8.39 (dd, J = 6.8, 1.5 Hz, 1H),  8.63 (m, 1H); 13C NMR (CDCl3) δ 117.8, 
  
 
123 
118.3, 121.7, 122.7, 123.1, 124.2, 124.3, 124.6, 126.8, 127.1, 128.3, 129.8, 134.6, 136.7, 
153.8, 156.0, 177.1; IR (CDCl3) 3061, 1654, 1439 cm-1; HRMS m/z 246.0684 (calcd for 
C17H10O2, 246.0681). 
2,3-Dimethoxy-9H-xanthen-9-one (4o). 
  
1H NMR (CDCl3) δ 3.99 (m, 6H), 6.88 (t, J = 3.7 Hz, 1H), 7.33-7.45 (m, 2H), 7.63-7.69 (m, 
2H), 8.32 (m, 1H); 13C NMR (CDCl3) δ 56.6, 56.7, 99.8, 105.5, 115.1, 117.9, 121.7, 124.0, 
126.7, 134.2, 146.9, 152.6, 155.6, 156.2, 176.3; IR (CDCl3) 2940, 2834, 1648, 1466 cm-1; 
HRMS m/z 256.0740 (calcd for C15H12O4, 256.0736). 
2,3-Dimethyl-9H-xanthen-9-one (4p). 
  
1H NMR (CDCl3) δ 2.35 (s, 3H), 2.38 (s, 3H), 7.23-7.45 (m, 3H), 7.68 (m, 1H), 8.04 (s, 
1H), 8.32 (dd, J = 7.9, 1.5 Hz, 1H); 13C NMR (CDCl3) δ 19.4, 20.8, 118.1, 118.3, 119.9, 
122.1, 123.8, 126.5, 126.9, 133.3, 134.6, 145.7, 154.9, 156.4, 177.3; IR (CDCl3) 2971, 2921, 
1656, 1462 cm-1; HRMS m/z 224.0840 (calcd for C15H12O2, 224.0837). 
2-Methyl-9H-xanthen-9-one (4j) and 3-methyl-9H-xanthen-9-one (4q). 
  These compounds were obtained as an inseparable mixture and characterized as a mixture.    
1H NMR (CDCl3) δ 2.47 (s, 3H), 2.51 (s, 3H), 7.19 (dd, J = 8.0, 0.7 Hz, 1H), 7.29 (s, 1H), 
7.35-7.41 (m, 3H), 7.48 (dd, J = 8.3, 2.1 Hz, 2H), 7.53 (dd, J = 8.5, 2.0 Hz, 1H), 7.69-7.73 
(m, 2H), 8.12 (d, J = 1.0 Hz, 1H), 8.22 (d, J = 8.1 Hz, 1H), 8.32-8.35 (m, 2H); 13C NMR 
(CDCl3) δ 21.1, 22.3, 118.0, 118.1, 119.8, 121.7, 122.0, 122.1, 123.9, 124.0, 125.7, 126.2, 
126.7, 126.9, 127.0, 133.9, 134.8, 134.9, 136.3, 146.6, 154.6, 156.3, 156.4, 156.5, 177.3, 
177.5; IR (CDCl3) 3066, 2923, 1661, 1608 cm-1; HRMS m/z 210.0684 (calcd for C14H10O2, 
210.0681). 
1,2,3,5-Tetrahydrocyclopenta[b]thioxanthen-9-one (4r). 
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1H NMR (CDCl3) δ 2.11-2.19 (m, 2H), 2.98-3.05 (m, 4H), 7.30 (s, 1H), 7.33-7.37 (m, 1H), 
7.46 (d, J = 8.2 Hz, 1H), 7.67-7.71 (m, 1H), 8.13 (s, 1H), 8.33 (dd, J = 8.0, 1.6 Hz, 1H); 13C 
NMR (CDCl3) δ 26.1, 32.2, 33.7, 113.4, 115.6, 118.1, 120.5, 121.4, 123.8, 126.9, 134.6, 
140.8, 153.3, 155.7, 156.3, 177.5; IR (CDCl3) 2962, 2839, 1654 cm-1; HRMS m/z 236.0841 
(calcd for C16H12O2, 236.0837).  
Ethyl 3-(9-oxo-9H-xanthen-2-yl)acrylate (5a). 
  
1H NMR (CDCl3) δ 1.35 (t, J = 7.2 Hz, 3H), 4.27 (q, J = 7.2 Hz, 2H), 6.49 (d, J = 1.6 Hz, 
1H), 7.39 (t, J = 7.7 Hz, 1H), 7.48 (d, J = 8.7 Hz, 2H), 7.71-7.76 (m, 2H), 7.85 (dd, J = 8.7, 
2.1 Hz, 1H), 8.31 (dd, J = 8.0, 1.4 Hz, 1H), 8.43 (d, J = 2.0 Hz, 1H); 13C NMR (CDCl3) δ 
14.6, 60.9, 118.3, 119.1, 119.4, 121.9, 122.1, 124.6, 127.0, 130.7, 133.7, 135.3, 142.9, 156.2, 
157.1, 166.9, 176.9; IR (CDCl3) 3034, 2981, 1714, 1657 cm-1; HRMS m/z 294.0897 (calcd 
for C18H14O4, 294.0892).    
2-(Furan-3-yl)-9H-xanthen-9-one (5b). 
  
1H NMR (CDCl3) δ 6.8 (q, J = 0.9 Hz, 1H), 7.36-7.40 (m, 1H), 7.47-7.51 (m, 3H), 7.70-
7.74 (m, 1H), 7.81-7.84 (m, 2H), 8.34 (dd, J = 8.0, 1.8 Hz, 1H), 8.39 (d, J = 2.3 Hz, 1H); 13C 
NMR (CDCl3) δ 109.0, 118.2, 118.8, 121.9, 122.1, 123.2, 124.2, 125.4, 127.0, 128.8, 132.7, 
135.1, 139.0, 144.2, 155.3, 156.3, 177.3; IR (CDCl3) 3069, 2924, 1660 cm-1; HRMS m/z 
262.0635 (calcd for C17H10O3, 262.0630).      
9H-Thioxanthen-9-one (6a). 
  
1H NMR (CDCl3) δ 7.48 (td, J = 6.7, 1.5 Hz, 2H), 7.56-7.65 (m, 4H), 8.62 (dd, J = 7.4, 0.8 
Hz, 2H); 13C NMR (CDCl3) δ 126.2, 126.5, 129.5, 130.1, 132.5, 137.5, 180.2; IR (CDCl3) 
2971, 2919, 1684, 1459 cm-1; HRMS m/z 212.0299 (calcd for C13H8OS, 212.0296). 
1-Methoxy-9H-thioxanthen-9-one (6b). 
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1H NMR (CDCl3) δ 4.00 (s, 3H), 6.90 (d, J = 7.4 Hz, 1H), 7.11 (d, J = 8.1 Hz, 1H), 7.39-
7.56 (m, 4H), 7.45 (dd, J = 7.8, 1.0 Hz, 1H); 13C NMR (CDCl3) δ 56.6, 109.2, 118.3, 119.8, 
125.2, 126.5, 129.9, 131.8, 132.2, 133.0, 135.5, 140.0, 162.4, 180.9; IR (CDCl3) 3057, 2943, 
1639, 1456 cm-1; HRMS m/z 242.0404 (calcd for C14H10O2S, 242.0402). 
2,3-Dimethylthioxanthen-9-one (6c). 
  
1H NMR (CDCl3) δ 2.39 (s, 3H), 2.40 (s, 3H), 7.34 (d, J = 0.5 Hz, 1H), 7.44-7.49 (m, 1H), 
7.55-7.62 (m, 2H), 8.38 (d, J = 0.4 Hz, 1H), 8.61-8.63 (m, 1H); 13C NMR (CDCl3) δ 19.9, 
20.4, 126.2, 127.5, 129.5, 130.0, 130.2, 132.2, 134.8, 136.0, 137.6, 143.0, 180.0; IR (CDCl3) 
2916, 2848, 1631 cm-1; HRMS m/z 240.0613 (calcd for C15H12OS, 240.0609).   
2-Methylthioxanthen-9-one (6d) and 3-methylthioxanthen-9-one (6e). 
  These compounds were obtained as an inseparable mixture and characterized as a mixture.  
1H NMR (CDCl3) δ 2.47 (s, 3H), 2.49 (s, 3H), 7.27-7.30 (m, 1H), 7.36-7.37 (m, 1H), 7.44-
7.63 (m, 8H), 8.43-8.47 (m, 1H), 8.50 (d, J = 8.6 Hz, 1H), 8.60-8.63 (m, 2H); 13C NMR 
(CDCl3) δ 21.5, 22.0, 126.0, 126.1, 126.2, 126.3, 126.4, 127.3, 128.1, 129.2, 129.4, 129.5, 
129.8, 130.0, 130.1, 132.3, 134.0, 136.6, 137.4, 137.5, 137.6, 143.5, 178.0; IR (CDCl3) 3059, 
2920, 1638, 1602 cm-1; HRMS m/z 226.0456 (calcd for C14H10OS, 226.0452).   
1,2,3,5-Tetrahydrocyclopenta[b]thioxanthen-9-one (7f). 
  
1H NMR (CDCl3) δ 2.11-2.18 (m, 2H), 2.99-3.05 (m, 4H), 7.41-7.48 (m, 2H), 8.46 (s, 1H), 
8.61-8.63 (m, 1H); 13C NMR (CDCl3) δ 25.8, 32.6, 33.3, 121.4, 125.2, 126.1, 126.2, 128.0, 
129.6, 130.0, 132.1, 135.5, 137.6, 144.0, 150.5, 180.2; IR (CDCl3) 2964, 2840, 1658 , 1630 
cm-1; HRMS m/z 252.0612 (calcd for C16H12OS, 252.0609). 
10-Methyl-10H-acridin-9-one (9b). 
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1H NMR (CDCl3) δ 3.88 (s, 3H), 7.28 (t, J = 7.2 Hz, 2H), 7.50 (d, J = 8.7 Hz, 2H), 7.69-
7.73 (m, 2H), 8.55 (dd, J = 8.0, 1.2 Hz, 2H); 13C NMR (CDCl3) δ 33.9, 115.0, 121.5, 122.7, 
128.0, 134.0, 142.8, 178.3; IR (CDCl3) 2917, 2850, 1637 cm-1; HRMS m/z 209.0843 (calcd 
for C14H11NO, 209.0841). 
3-Fluoro-10-methyl-10H-acridin-9-one (9d). 
  
1H NMR (CDCl3) δ 3.78 (s, 3H), 6.93-6.99 (m, 1H), 7.09 (dd, J = 15.6, 3.0 Hz, 1H), 7.24-
7.29 (m, 1H), 7.43 (d, J = 11.6 Hz, 1H), 7.65-7.71 (m, 1H), 8.47-8.54 (m, 2H); 13C NMR 
(CDCl3) δ 34.0, 101.0, 101.4, 110.0, 110.3, 115.0, 119.4, 122.0, 122.7, 127.9, 131.0, 131.1, 
134.1, 142.8, 144.3, 144.5, 164.9, 168.2, 177.3; IR (CDCl3) 2928, 1637, 1614 cm-1; HRMS 
m/z 227.0744 (calcd for C14H10FNO, 227.0746).  
2-Fluoro-10-methyl-10H-acridin-9-one (9e). 
  
1H NMR (CDCl3) δ 3.78 (s, 3H), 7.21 (t, J = 6.9 Hz, 1H), 7.35-7.41 (m, 3H), 7.64 (t, J = 6.3 
Hz, 1H), 8.06 (d, J = 5.8 Hz, 1H), 8.42 (d, J = 6.4 Hz, 1H); 13C NMR (CDCl3) δ 34.1, 111.9, 
112.1, 114.9, 115.6, 117.1, 117.2, 121.5, 121.7, 122.1, 122.3, 127.7, 134.2, 139.1, 142.4, 
156.4, 158.8, 177.3; IR (CDCl3) 2924, 1617, 1599 cm-1; HRMS m/z 227.0749 (calcd for 
C14H10FNO, 227.0746).    
2-Bromo-10-methyl-10H-acridin-9-one (9f). 
  
1H NMR (CDCl3) δ 3.79 (s, 3H), 7.23-7.27 (m, 1H), 7.30 (d, J = 9.2 Hz, 1H), 7.43 (d, J = 
10.8 Hz, 1H), 7.65-7.71 (m, 2H), 8.44 (dd, J = 8.0, 1.6 Hz, 1H), 8.55 (d, J = 2.6 Hz, 1H); 13C 
NMR (CDCl3) δ 34.0, 114.7, 115.1, 117.0, 121.8, 122.5, 123.7, 127.9, 130.1, 134.3, 136.6, 
141.3, 142.4, 176.9; IR (CDCl3) 2926, 1628, 1608 cm-1; HRMS m/z 286.9950 (calcd for 
C14H10BrNO, 286.9946).    
2,3,10-Trimethyl-10H-acridin-9-one (9h). 
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1H NMR (CDCl3) δ 2.36 (s, 3H), 2.42 (s, 3H), 3.84 (s, 3H), 7.23-7.27 (m, 2H), 7.47 (d, J = 
8.7 Hz, 1H), 7.66-7.70 (m, 1H), 8.27 (s, 1H), 8.54 (dd, J = 8.1, 1.6 Hz, 1H); 13C NMR 
(CDCl3) δ 19.3, 21.4, 33.7, 114.8, 115.5, 120.9, 121.0, 122.6, 127.7, 127.9, 130.6, 133.6, 
141.3, 142.6, 144.3, 177.9; IR (CDCl3) 2918, 1638, 1614 cm-1; HRMS m/z 237.1157 (calcd 
for C16H15NO, 237.1154). 
2,10-Dimethyl-10H-acridin-9-one (9i) and 3,10-dimethyl-10H-acridin-9-one (9j). 
  These compounds were obtained as an inseparable mixture and characterized as a mixture.    
1H NMR (CDCl3) δ 2.43 (s, 3H), 2.49 (s, 3H), 3.80 (s, 3H), 3.81 (s, 3H), 7.05 (d, J = 8.1 Hz, 
1H), 7.22-7.26 (m, 3H), 7.36 (d, J = 8.8 Hz, 1H), 7.43-7.40 (m, 3H), 7.64-7.68 (m, 2H), 8.30 
(d, J = 0.9 Hz, 1H), 8.50-8.54 (m, 2H); 13C NMR (CDCl3) δ 20.9, 22.8, 33.7, 33.8, 114.8, 
114.9, 120.6, 121.1, 121.3, 122.4, 122.5, 122.6, 123.1, 127.1, 127.8, 127.9, 131.0, 133.7, 
133.8, 135.4, 140.8, 142.7, 142.8, 144.9, 178.0, 178.2; IR (CDCl3) 2917, 2851, 1632, 1611 
cm-1; HRMS m/z 223.0998 (calcd for C15H13NO, 223.0997).  
5-Methyl-1,2,3,5-tetrahydrocyclopenta[b]acridin-10-one (9k). 
 
1H NMR (CDCl3) δ 2.10-2.17 (m, 2H), 2.97-3.05 (m, 4H), 3.83 (s, 3H), 7.22-7.26 (m, 1H), 
7.33 (s, 1H), 7.45 (d, J = 8.7 Hz, 1H), 7.64-7.69 (m, 1H), 8.34 (s, 1H), 8.53 (d, J = 8.0 Hz, 
1H); 13C NMR (CDCl3) δ 26.0, 32.1, 34.0, 110.2, 114.8, 121.0, 121.6. 122.4. 127.9, 133.5, 
138.3, 142.1, 142.5, 152.2, 178.1; IR (CDCl3) 2948, 2840, 1617, 1595 cm-1; HRMS m/z 
249.1158 (calcd for C17H15NO, 249.1154). 
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GENERAL CONCLUSIONS 
In this dissertation, several novel palladium migration processes and a coupling-cyclization 
reaction of silylaryl triflates and substituted benzoates have been investigated.  The scope, 
limitations, and applications of these reactions are presented in detail.   
Chapter 1 investigated an unusual consecutive vinylic to aryl to allylic palladium migration 
process, which affords a novel way to generate pi-allylpalladium complexes.  This migration 
process appears to involve an equilibrium between organopalladium(IV) hydrides and 
organopalladium(II) intermediates. A mechanistic study of the aryl to aryl palladium 
migration process provides some new information.   
Chapter 2 describes a synthesis of substituted carbazoles, indoles and dibenzofurans by the 
palladium-catalyzed cross-coupling of alkynes and appropriately substituted aryl iodides.  
Results from deuterium labeling experiments are consistent with the proposed mechanism. 
Chapter 3 describes the preparation of biologically-interesting fluoren-9-one and xanth-9-
one derivatives by a novel aryl to imidoyl palladium migration, followed by intramolecular 
arylation.  The results from the deuterium labeling experiments are consistent with the 
proposed duel mechanism. 
Chapter 4 reports the synthesis of xanthone, thioxanthone and acridone derivatives from 
the coupling-cyclization of silylaryl triflates and substituted benzoates.  The scope and 
limitations of this methodology and elaboration of the halogen-substituted xanthone obtained 
have been investigated. 
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